Sommaire

• • ·Posters Exhibit Task Force

    Page :A1

    Plan Plan
• • ·Poster Abstracts

    Page :A2

    
• • ·Editorial Board

    Page :A3

    
• • ·28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study

    Page :AB1

    Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Nicholas Theodosakis, R. Monina Klevens, Evelyn Lilly, Maryam Asgari, Yevgeniy R. Semenov

    
• • ·26984 iPLEDGE pharmacy deserts exist across major metropolitan cities in the United States

    Page :AB1

    Nidhi Shah, Michelle Truong, Shama Antala, A. Yasmine Kirkorian

    
• • ·25445 North American study of pediatric SJS and TEN: Setting diagnostic criteria, systematic review and retrospective cohort study comparing outcomes of common treatments

    Page :AB1

    Daniel Hekman, Sylvia Martinez Cabriales, Sarah Skillman

    
• • ·24895 It’s time for some rash changes: An analysis of representation of skin of color in online patient education images

    Page :AB1

    Elise Weisert, Renat Ahatov, Paige Hoyer, Lindy Ross

    
• • ·27573 A clinical decision tool to calculate probability of sentinel lymph node metastasis in cutaneous melanoma

    Page :AB2

    Raghav Tripathi, Karen Larson, Jeremy S. Bordeaux, Wesley Y. Yu

    
• • ·24874 Isotretinoin modifications of staphylococcal skin populations in acne

    Page :AB3

    Faisal S. Ahmad, Samantha R. Scott, Bruce A. Rosa, Young-Jun Choi, John C. Martin, Makedonka D. Mitreva, William H. McCoy

    
• • ·24887 Understanding concerns and expectations of acne respondents to improve management of the disease: Results of two large, online surveys in the United States of America

    Page :AB3

    Jerry Tan, Anna L. Chien, JP York, Alison M. Layton

    
• • ·24972 Exploring the effect of dupilumab on allergic contact dermatitis and patch testing

    Page :AB3

    Christine E. Jo, Asfandyar Mufti, Muskaan Sachdeva, Melanie Pratt, Jensen Yeung

    
• • ·25014 Interactive didactic session for residents and medical students on dermatologic care for lesbian, gay, bisexual, and transgender patients

    Page :AB3

    Ramoncito L. Caleon, Krittin Supapannachart, Devon Barrett, Laura Ragmanauskaite, Patrick McCleskey, Howa Yeung

    
• • ·25022 Necrobiosis lipoidica and its association with malignancy

    Page :AB4

    Jamison Harvey, Kevin Severson, Caitlin Brumfiel, Meera H. Patel, Duke Butterfield, Aleksandar Sekulic, Steven A. Nelson, Mark Pittelkow, Aaron R. Mangold

    
• • ·25030 Comparative efficacy of treatments for moderate-to-severe plaque psoriasis: An updated network meta-analysis (NMA)

    Page :AB4

    April W. Armstrong, Ahmed M. Soliman, Lluís Puig, Keith A. Betts, Yan Wang, Yawen Gao

    
• • ·25031 Greater disease burden associated with palmoplantar pustulosis versus plaque psoriasis: Real-world evidence from the North American–based Corrona Psoriasis Registry

    Page :AB4

    Mark Lebwohl, Nirali Kotowsky, Rose A. Medeiros, Nicole Foster, Judson Janak, Wendell C. Valdecantos, Mary Flack, Amanda K. Golembesky, Bruce Strober

    
• • ·25144 Challenges in educating and counseling patients with psoriasis and psoriatic arthritis: results from a mixed-methods needs assessment in Canada and USA

    Page :AB4

    Jeffrey Crowley, Suzanne Murray, Melinda J. Gooderham, Sacha Zahabi, Vinod Chandran, Alan Kivitz, Paul P. Doghramji, Christie Freeman, Patrice Lazure

    
• • ·25159 The history of diet and acne: From sugar and dairy to the Western diet

    Page :AB5

    Dina Zamil, Rajani Katta

    
• • ·25179 A systematic review of patient-reported outcome measures for high-risk skin cancer patients

    Page :AB5

    Myrna Eliann Reinhardt, Tiffany Sun, Catherina X. Pan, Erica H. Lee, Abigail B. Waldman

    
• • ·25230 Apremilast for the treatment of hidradenitis suppurativa in real life: Case series and systematic review

    Page :AB5

    Patricia Garbayo-Salmons, Jorge Romaní de Gabriel, Miquel Ribera Pibernat, Vicente Expósito-Serrano, Natalia Fernández Chico, Mireia Sàbat Santandreu, Mireia Yébenes Marsal, Miquel Casals Andreu, Clara Fernández Sartorio, Cristina López Llunell, Jesús Luelmo Aguilar

    
• • ·25324 The in-hospital burden of dermatomyositis on patients with acute myocardial infarction: A nationwide cross-sectional analysis from 2004 to 2015

    Page :AB5

    Alvaro J. Ramos-Rodriguez, Karina J. Cancel-Artau, Alejandro Lemor, Osward Y. Carrasquillo, Mario Lozano-Franco, Marely Santiago-Vazquez, Julian Barrera-Llaurador, Rafael F. Martin-Garcia

    
• • ·25333 A systematic review of the current state of sunscreen regulation

    Page :AB6

    Yuangao Liu, Harrison Nguyen, Kathleen E. Spitz

    
• • ·25375 The role of interleukin-6 in anemia associated with hidradenitis suppurativa

    Page :AB6

    Kayla Babbush, Mondana Ghias, Tyler Andriano, H. Dean Hosgood, Morayma Reyes Gil, Steven R. Cohen

    
• • ·25376 Leveraging virtual boot camp to alleviate first year dermatology resident anxiety

    Page :AB6

    Nagasai C. Adusumilli, Kayleigh Hausmann, Adam J. Friedman, Mary Maiberger

    
• • ·25407 Atopic dermatitis web apps: Tethered tools to support patients and providers in shared decision-making, self-management, and therapy access

    Page :AB6

    Peter A. Lio, Pamela P. Fantus, Paula J. Eichenbrenner, Marykate Nelson, Kristina I. Fajardo, Laura C. Simone, Jeffrey D. Carter

    
• • ·25417 Novel distinctions in the profiles, impact, and management of nail disease in pachyonychia congenita

    Page :AB7

    Albert G. Wu, Shari R. Lipner

    
• • ·25490 Analysis of psoriasis hospitalizations: A report from the National Inpatient Sample Database

    Page :AB7

    Ehizogie Edigin, Precious Obehi Eseaton, Hafeez Shaka

    
• • ·25513 Insta-sham?: A snapshot of Instagram-based acne content

    Page :AB7

    Suzanne C. Ward, Nathan W. Rojek

    
• • ·25532 Effects of upadacitinib on patient-reported symptoms of atopic dermatitis: Atopic Dermatitis Symptom Scale (ADerm-SS) results from two pivotal phase 3 studies (MEASURE UP 1 and MEASURE UP 2)

    Page :AB7

    Jonathan I. Silverberg, Jacob P. Thyssen, David Rosmarin, Andrew E. Pink, Brian M. Calimlim, Henrique D. Teixeira, Xiaofei Hu, Yang Yang, Diamant Thaçi

    
• • ·25553 Suicide risk among melanoma and nonepithelial skin cancer patients: A Surveillance, Epidemiology, and End Results analysis

    Page :AB8

    Zisansha Zahirsha, Justin Barnes, Matthew C. Simpson, Nosayaba Osazuwa-Peters

    
• • ·25574 The impact of PASI90 duration on patient reported outcomes among patients with psoriasis

    Page :AB8

    Andreas Pinter, Ahmed M. Soliman, Hongbo Yang, Jessie Wang, Kaitlin Hagan, Byron Padilla, Mark G. Lebwohl

    
• • ·25578 Inconsistencies in the nomenclature of chronic pruritic eruptions in older adults

    Page :AB8

    Sami Jelousi, Shreya Sreekantaswamy, Daniel Butler

    
• • ·25580 Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in the United States

    Page :AB8

    Megan H. Trager, Jonathan Lavian, Eunice Y. Lee, Dahsan Gary, Fabian Jenkins, Angela M. Christiano, Lindsey A. Bordone

    
• • ·25587 The experience of COVID-19 and its impact on management of hidradenitis suppurativa

    Page :AB9

    Gabrielle Benesh, Tyler M. Andriano, Kayla M. Babbush, Steven R. Cohen

    
• • ·25649 Comorbidities among children with hidradenitis suppurativa

    Page :AB9

    Nina Lucia Tamashunas, Christina Wong

    
• • ·25659 Spitz nevi in African Americans: A retrospective chart review of 11 patients

    Page :AB9

    Yostina Farid, Kord Honda

    
• • ·25691 An audit of the management and outcomes of toxic epidermal necrolysis in a specialist intensive care unit in the UK

    Page :AB9

    Sally Aziz, Helena Malhomme, Cristina Psomadakis, Andrew Slack

    
• • ·25692 Treatment patterns and their association with patient demographic and clinical characteristics in atopic dermatitis using claims data and regression analysis

    Page :AB10

    D. Christian Fenske, Natalie N. Boytsov, Jiaying Guo, Zach Dawson

    
• • ·25712 Retrospective review of IVIG use and cutaneous lupus in inflammatory autoimmune neuropathies

    Page :AB10

    Nathanael Jensen, Ashley M. Snyder, Jason Mathis, Aaron M. Secrest

    
• • ·25713 Ruxolitinib cream in the treatment of cutaneous lichen planus

    Page :AB10

    Aaron R. Mangold, Caitlin M. Brumfiel, Meera H. Patel, Kevin J. Severson, Nan Zhang, Mark R. Pittelkow

    
• • ·25729 Efficacy of human papillomavirus vaccination as treatment for verruca vulgaris: A retrospective, single-institutional study

    Page :AB10

    Yana Kost, Alana Deutsch, Tian Hao Zhu, Imge Hulur, Rachel Blasiak

    
• • ·25760 Are there different patient journeys from psoriasis to psoriatic arthritis?

    Page :AB11

    Geoff Red, Ye-Jin Eun, Nishitha Kambhaladinne, Jing Wu, Brett Durborow, Reginald Villacorta, Yiting Wang, Grace Wang

    
• • ·25764 Curcumin nanoparticles as a photoprotective adjuvant

    Page :AB11

    Nagasai Adusumilli, Breanne Mordorski, Joshua Nosanchuk, Joel M. Friedman, Adam J. Friedman

    
• • ·25805 Ixekizumab provides more durable improvements in skin clearance, itch, and quality of life than guselkumab in patients with moderate-to-severe psoriasis: 24-week results from IXORA-R

    Page :AB11

    Abel Jarell, Stacy Smith, Gaia Gallo, Lisa Renda, Russel Burge, Baojin Zhu, Jiaying Guo, Emily K. Blue, David Rosmarin

    
• • ·25825 Increased urine phthalate metabolites are associated with atopic dermatitis in US adults

    Page :AB11

    Youkyung Sophie Roh, Sagar P. Patel, Kyle A. Williams, Nishadh H. Sutaria, Justin Choi, Jordan R. Pollock, Natalia Fontecilla Biles, Shawn G. Kwatra

    
• • ·25830 Wound healing outcomes in patients with concomitant autoimmune diseases prescribed disease-modifying anti-rheumatic drugs

    Page :AB12

    Julianne Kiene, Suzanne Zhou, Jenna Bekeny, Ashley Rogers, Elizabeth Zolper, Paige Dekker, Kenneth Fan, Karen K. Evans, Carol Deane Benedict Mitnick, Helena Pasieka, Christopher E. Attinger

    
• • ·25905 The Ichthyosis Scoring System (ISS): Development and validation of a novel ichthyosis severity assessment instrument

    Page :AB12

    Qisi (Mary) Sun, Amy Paller, Keith Choate

    
• • ·25921 Online sunscreens are not always FDA-approved: Analysis of UV filters in online best-selling facial sunscreens in the United States

    Page :AB12

    Jennifer J. Su, Omkar N. Mayur, June Young Moon, Jordan M. Ward, Loretta S. Davis

    
• • ·25980 The predictive role of cutaneous IgA deposition in leukocytoclastic vasculitis with respect to renal involvement: A systematic review of the current evidence

    Page :AB12

    Rachel Samuelson, Jacob Kingsley, Dillon Clarey, Erica Lee, Ryan Trowbridge

    
• • ·25990 Patient and dermatologist-reported impacts of alopecia areata on patients stratified by disease severity: Results from a real-world study in the United States

    Page :AB13

    Kavita Gandhi, Peter Anderson, Mark Ray, James Piercy, Vanja Sikirica, Laure Manuel, Jenny Austin, Arash Mostaghimi

    
• • ·26020 Searching the Holy Grail – Evaluating contact allergens in popular Reddit starter skincare routine

    Page :AB13

    Rob Shaver, Rachit Gupta, Sara Hylwa

    
• • ·26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas

    Page :AB13

    Ramiro Rodriguez, Orlando Martinez-Luna, Rebecca Vasquez

    
• • ·26048 The effect of an educational intervention on cosmetology students’ ability to recognize alopecia

    Page :AB13

    Saniya Shaikh, Claudia I. Vidal, Eric Armbrecht

    
• • ·26053 Improvement in sleep is associated with improved quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a phase 3 trial of baricitinib therapy

    Page :AB14

    Peter Lio, George Han, Edward Lain, Catherine Maari, Susan Ball, Luna Sun, Amy M. DeLozier, Andrew Buchanan, Yuxin Ding, Lawrence F. Eichenfield

    
• • ·26087 Cost discrepancies in sunscreens marketed for adults versus children

    Page :AB14

    Michelle J. Chang, Shari R. Lipner

    
• • ·26129 A systematic review and meta-analysis of prognostic outcomes in cutaneous squamous cell carcinoma with and without perineural invasion

    Page :AB14

    Kristen Clark, Shirleen Cheng, William Guo, Julia Miao, Jocellie Marquez, Marissa Ayasse, Jamie Saragossi, Evan Jones, Jordan Slutsky

    
• • ·26130 Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma: Analysis of a large size retrospective series

    Page :AB14

    Valérie Tremblay-Abel, Marc-Antoine Poulin, Marie-Michèle Blouin, François Parent, Émilie Perron

    
• • ·26139 The growing problem of antifungal resistance in onychomycosis and other superficial mycoses: A case report and review

    Page :AB15

    Aditya K. Gupta, Helen J. Renaud, Emma M. Quinlan, Neil H. Shear, Vincent Piguet

    
• • ·26157 Vitiligo and metabolic syndrome: A systematic review and meta-analysis

    Page :AB15

    Christina Melian, Joyce Xiao, William Guo, Hunya Usmani, Daniel Lozeau

    
• • ·26203 Risk of treatment discontinuation among patients with psoriasis initiated on ustekinumab versus secukinumab in the United States

    Page :AB15

    Amanda Steel Teeple, Dominic Pilon, Timothy Fitzgerald, Maryia Zhdanava, Laura Morrison, Aditi Shah, Patrick Lefebvre

    
• • ·26256 Chinese American perceptions and expectations of dermotologic care

    Page :AB15

    Jia Gao, Abigail Cline, Janet Moy, Bijan Safai

    
• • ·26259 Prurigo nodularis associated pruritus is a systemic process affecting both nodular and interlesional skin

    Page :AB16

    Prachi Aggarwal, Justin Choi, Kyle A. Williams, Amy H. Huang, Youkyung S. Roh, Nishadh Sutaria, Rajeev Chavda, Sylvie Gabriel, Shawn G. Kwatra

    
• • ·26293 Gender, race, and dermatologic history affect knowledge and attitudes towards sunscreen usage

    Page :AB16

    Abigail Cline, Carlos Sarriera, Yasi Mansouri, Marian Russo

    
• • ·26307 Trends and factors associated with dermatology Medicare charges to payment ratios, 2012-2017

    Page :AB16

    Rishabh S. Mazmudar, Raghav Tripathi, Bryan T. Carroll

    
• • ·26331 A systematic review and meta-analysis of cardiovascular events in patients with hidradenitis suppurativa

    Page :AB16

    Renuka Kannappan, Kelly Pellegrino, William Guo, Hunya Usmani, Jocellie Marquez, Marissa Ayasse, Paige Varney, Joann Salvemini, Richard Clark, Tara Kaufmann

    
• • ·26353 Comparative effectiveness of acne scar treatments: A systematic review and network meta-analysis

    Page :AB17

    Sarah A. Ibrahim, Melanie A. Clark, Kelly A. Reynolds, Sanjana Iyengar, Vishnu B. Harikumar, Bianca Y. Kang, Emily Poon, Jonathan I. Silverberg, Murad Alam

    
• • ·26357 Teaching and assessing trichoscopy findings in patients with lichen planopilaris and central centrifugal cicatricial alopecia: An exploration in the incidence and utility in clinical practice

    Page :AB17

    Ashley N. McWilliams, Saniya Shaikh, Eric Armbrecht, Sofia Chaudhry

    
• • ·26382 A systematic review and meta-analysis of systemic lupus erythematosus in patients with alopecia areata

    Page :AB17

    W. Mark Richardson, Hunya Usmani, William Guo, Jocellie Marquez, Marissa Ayasse, Katherine Siamas, Adrienne Haughton, Marcia Tonnesen

    
• • ·26416 Is it really DRESS? A retrospective descriptive study

    Page :AB17

    Erika Watts Oquendo, Gabriel Arias, Luz Figueroa, Julio Sanchez, Rafael Martin

    
• • ·26420 Vulvar pain and pruritus secondary to dermatographism: An underrecognized etiology

    Page :AB18

    Sydney Rivera, Ginat Mirowski

    
• • ·26423 Psychometric properties of patient-reported outcome measures for nail conditions: A systematic review

    Page :AB18

    Rakhshan Kamran, Leah Algu, Cameron F. Leveille, Claire Stewart, Shari R. Lipner, Anne Klassen, Charlene Rae

    
• • ·26440 Alternative uses of ustekinumab for nonindicated dermotologic conditions: A systematic review

    Page :AB18

    Sara Kianian, Sahil Rawal, William Guo, Jocellie Marquez, Marissa Ayasse, Katherine Siamas, Yoojin Lee, Joann Salvemini

    
• • ·26448 Distance to diagnosing dermatology provider as an indicator of number of melanomas

    Page :AB18

    Rose Parisi, John Huppertz, Allison Potolski, Virginia Tracey

    
• • ·26465 Trends in dermatology practice size consolidation in the United States from 2012 to 2020

    Page :AB19

    Grace McNeely, Jordan R. Pollock, Jake S. Hogan, David L. Swanson, Natalia F. Biles, Shawn G. Kwatra

    
• • ·26479 Short term complications of Mohs surgery versus wide local excision in patients with melanoma in situ

    Page :AB19

    Rahul Raiker, Haig Pakhchanian, Vishal Patel

    
• • ·26485 Effectiveness of free screenings in detecting skin cancers: A 4-year comparison to a dermatology clinic

    Page :AB19

    Collin J. O’Bryan, David X. Gao, Joshua B. Kentosh

    
• • ·26519 Patient safety alert: Preventing infection from misuse of medication vials

    Page :AB19

    James S. Taylor, Jay Patel, Elizabeth Otto

    
• • ·26528 Hidradenitis suppurativa disease severity associated with objective markers of inflammation and patient-reported pain

    Page :AB20

    Tyler M. Andriano, Kristen P. Pacific, Kayla M. Babbush, Gabrielle Benesh, H. Dean Hosgood, Steven R. Cohen

    
• • ·26562 Dermatologic disparities amongst persons experiencing homelessness

    Page :AB20

    Taylor E. Woo, Merna Adly, Danya Traboulsi, David Klassen, Jori Hardin

    
• • ·26566 Cutaneous reactions in clinical trials for oncologic drugs: An increasing need for dermatologic involvement

    Page :AB20

    Jason J. Yang, Naomi So, Nolan Maloney, Julia Arzeno, Katherine Clifton, Daniel Bach

    
• • ·26591 Characterization of flares in patients with generalized pustular psoriasis—A population-based study from the French National Health Data System database (SNDS)

    Page :AB20

    Hervé Bachelez, Jacques Massol, Gérard de Pouvourville, Tristan Gloede, Patricia Medina, Dirk Esser, Malek Bentayeb, Katell Le Lay, Christian Thoma, Manuelle Viguier

    
• • ·26592 Characterization of response clusters identified by unsupervised machine learning: A post hoc analysis of the head-to-head ECLIPSE trial of guselkumab and secukinumab in patients with moderate-to-severe psoriasis

    Page :AB21

    Diamant Thaçi, Curdin Conrad, Alexander Egeberg, Andreas Pinter, Kristian Reich, Bethany Hyde, Ye-Jin Eun, Sven Wegner, Maria Jazra, Bülent Öztürk, Knut Schäkel

    
• • ·26602 A systematic review and meta-analysis of prognostic outcomes of cutaneous squamous cell carcinoma with perineural invasion by anatomical location

    Page :AB21

    Shirleen Cheng, Kristen Clark, William Guo, Hunya Usmani, Jocellie Marquez, Marissa Ayasse, Evan Jones, Jordan Slutsky

    
• • ·26603 Real-world health outcomes in US adult patients with mild-to-moderate plaque psoriasis taking topical therapy: Results from a chart review

    Page :AB21

    Tara Nazareth, James Hetherington, James Lucas, Ibrahim Khilfeh, Natalie Nunez-Gomez, David Kaplan

    
• • ·26617 Bias in bias out: A scoping review of skin types represented in machine learning research in dermatology

    Page :AB21

    Lisa N. Guo, Michelle S. Lee, Bina Kassamali, Carol Mita, Vinod E. Nambudiri

    
• • ·26622 The impact of neuropathic itch on patients’ quality of life

    Page :AB22

    Zoe M. Lipman, Gil Yosipovitch

    
• • ·26630 The role of skin barrier in cutaneous adverse drug reactions in oncology therapy and the benefit of topical emollients

    Page :AB22

    Georgios Stamatas, Thomas Ondet, Mario Monshouwer

    
• • ·26633 The role research gap-years play in a successful dermatology match

    Page :AB22

    Collin M. Costello, Jamison A. Harvey, Jake G. Besch-Stokes, Puneet Bhullar, Elisabeth S. Lim, Katie L. Kunze, Megha M. Tollefson, Leila M. Tolaymat, Shari A. Ochoa

    
• • ·26634 Insights into the mechanisms of EGFRi-induced cutaneous adverse drug reactions from functional phospho-proteomic and transcriptomic data

    Page :AB22

    Georgios Stamatas, Thomas Ondet, Mario Monshouwer

    
• • ·26648 Real-world comparison of monotherapy and concomitant medication use with biologic therapies for psoriasis: Ixekizumab versus guselkumab

    Page :AB23

    Andrew Blauvelt, Russel Burge, Bridget Charbonneau, William Malatestinic, Baojin Zhu, Fangyu Wang, Benjamin Lockshin

    
• • ·26670 The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in a baricitinib phase 3 study, BREEZE-AD5

    Page :AB23

    Gil Yosipovitch, Kim Papp, Seth Forman, George Han, Jill Waibel, Maria Jose Rueda, Luna Sun, Yun-Fei Chen, Orin Goldblum, Evangeline Pierce, Jonathan Silverberg

    
• • ·26673 A systematic review and meta-analysis of sexual dysfunction in patients with hidradenitis suppurativa

    Page :AB23

    Paige Varney, Mikayla Brown, William Guo, Hunya Usmani, Jocellie Marquez, Marissa Ayasse, Tara Kaufmann, Adrienne Haughton

    
• • ·26747 Atopic dermatitis inpatient mortality: Analysis of the National Inpatient Sample Database

    Page :AB23

    Ehizogie Edigin, Precious Obehi Eseaton, Hafeez Shaka

    
• • ·26765 Myelin basic protein autoantibodies as a biomarker in morphea

    Page :AB24

    Elise Burger, Heidi Jacobe

    
• • ·26778 Does hidradenitis suppurativa worsen outcomes of patients admitted for heart failure exacerbation?

    Page :AB24

    Ehizogie Edigin, Precious Obehi Eseaton, Hafeez Shaka

    
• • ·26781 Psoriasis does not worsen outcomes of patients admitted for heart failure exacerbation

    Page :AB24

    Ehizogie Edigin, Precious Obehi Eseaton

    
• • ·26785 Atopic dermatitis is associated with increased inpatient mortality in hospitalizations for asthma

    Page :AB24

    Ehizogie Edigin, Precious Obehi Eseaton

    
• • ·26786 Delphi method study in defining surgical site infection following Mohs surgery

    Page :AB25

    Vijaya T. Daniel, Ailish M. Hanley, Bassel H. Mahmoud

    
• • ·26789 Analysis of cutaneous T cell lymphoma hospitalizations in the United States

    Page :AB25

    Ehizogie Edigin, Precious Obehi Eseaton

    
• • ·26841 Alopecia areata and risk of cancer varies based on type of malignancy

    Page :AB25

    Kevin Phan, Saxon D. Smith

    
• • ·26843 Carbon dioxide laser excision for hidradenitis suppurativa patients—Healing, complications, and recurrence in patients with diabetes mellitus and history of smoking

    Page :AB25

    Taylor L. Braunberger, Paras Vakharia, Nneamaka Ezekwe, Cynthia L. Nicholson, Angela Parks-Miller, Iltefat H. Hamzavi

    
• • ·26905 The effect of Polypodium leucotomos extract (Fernblock) on visible light and UV-induced photoaging

    Page :AB26

    Aunna Pourang, Mohsen Dourra, Nneamaka Ezekwe, Indermeet Kohli, Iltefat Hamzavi, Henry W. Lim

    
• • ·26915 Steps towards trustworthy AI: Detecting unsupported lesions

    Page :AB26

    Jonas De Vylder, Tom Kimpe, Laudine Janssen, Sofie Van Kelst, Sofie Mylle, Evelien Verhaeghe, Julie Desmedt, Maria Garmyn, Lieve Brochez

    
• • ·26917 Clinical utility of imaging for evaluation of cellulitis in hospitalized pediatric patients

    Page :AB26

    Sidharth Chand, Renajd Rrapi, Sarah Song, Colleen Gabel, Daniela Kroshinsky

    
• • ·26941 The prognostic value of inositol polyphosphate 5-phosphatase in cutaneous squamous cell carcinoma in a random sampling representative of the general population

    Page :AB26

    Aaron R. Mangold, Meera H. Patel, Caitlin M. Brumfiel, Kevin J. Severson, Richard J. Butterfield, Nan Zhang, Steven A. Nelson, David J. DiCaudo, Mark R. Pittelkow, Aleksander Sekulic

    
• • ·26942 Nasal swabs may effectively guide methicillin-resistant Staphylococcus aureus (MRSA) coverage for pediatric cellulitis: A retrospective study

    Page :AB27

    Sidharth Chand, Renajd Rrapi, Sarah Song, Colleen Gabel, Daniela Kroshinsky

    
• • ·26944 Incidence and outcomes for cutaneous abscess by body area in pediatric patients hospitalized for cellulitis

    Page :AB27

    Sidharth Chand, Renajd Rrapi, Sarah Song, Colleen Gabel, Daniela Kroshinsky

    
• • ·26948 Identifying gaps in global health dermatology: A survey of GLODERM members

    Page :AB27

    Linda Oyesiku, Devon McMahon, L. Claire Fuller, Esther Freeman

    
• • ·26956 Demographic and histopathologic features of cutaneous granulomatous diseases

    Page :AB27

    Aaron R. Mangold, Caitlin M. Brumfiel, Meera H. Patel, Kevin J. Severson, Richard J. Butterfield, Mark R. Pittelkow, Steven A. Nelson

    
• • ·26999 Cancer risk in adult patients with atopic dermatitis: A population-based cohort study in the United Kindgom

    Page :AB28

    Zelma C. Chiesa Fuxench

    
• • ·27005 Proteomics analysis of blister fluid from patients with bullous pemphigoid

    Page :AB28

    Payal Mukesh Patel, Kyle T. Amber, Jing Li, Lei Bao

    
• • ·27024 Demographic and clinical factors associated with patient-reported remission in psoriatic arthritis

    Page :AB28

    George Gondo, Megan Mosca, Julie Hong, Emanual Maverakis, April Armstrong, Joseph F. Merola, Tina Bhutani, Stacie J. Bell, Wilson Liao

    
• • ·27031 Sunscreens designed and validated by consumers to be “invisible on all skin tones”

    Page :AB28

    Frank Sun, Mark Benn, Katrina Bernhardt, Sarah Neadle, Katherine Skinner

    
• • ·27035 Assessment of the natural history of hidradenitis suppurativa (HS) over 4 years: Results from the HS UNITE registry

    Page :AB29

    Alexa B. Kimball, Christopher Sayed, Yinghui Duan, Amy Gamelli, Marilia Oliveira, Jeffrey M. Sobell

    
• • ·27091 Violence in academic dermatology practices across the United States: A cross-sectional survey study

    Page :AB29

    Raghav Tripathi, Angie Y. Wan, Rishabh S. Mazmudar, Jeremy S. Bordeaux, Jeffrey F. Scott

    
• • ·27111 National burden of emergency department visits due to hidradenitis suppurativa

    Page :AB29

    Raghav Tripathi, Neil J. Korman, Harib H. Ezaldein

    
• • ·27132 Lymphomatoid papulosis: A retrospective review of clinical characteristics, symptomatology, treatments, and associated malignancies at a single institution

    Page :AB29

    Joseph Stoll, BTL, Melissa Pulitzer, Alison Moskowitz, Steven Horwitz, Patricia L. Myskowski, Sarah J. Noor

    
• • ·27174 Health-related quality of life (HRQoL) in patients with hidradenitis suppurativa: A single center analysis

    Page :AB30

    David A. Castillo Molina, Paula A. Chacón Jaramillo, Marcela Duran-Torres, Jesus D. Fierro Lozada, Daniela M. Molina Dorado, Maria D. Polania Tovar, Maria J. Carroll-Patiño, Zamira P. Vargas Caycedo, Nelson José Alvis-Zakzuk

    
• • ·27239 Analysis of pyoderma gangrenosum hospitalizations: A report from the National Inpatient Sample database

    Page :AB30

    Ehizogie Edigin, Precious Obehi Eseaton

    
• • ·27260 Depression screening for adolescent acne patients

    Page :AB30

    Michael Lor, Sarah Lonowski, Amy Vandiver, Nirali Patel, Carol E. Cheng

    
• • ·27270 Prurigo nodularis and infectious disease hospitalizations: A national cross-sectional study

    Page :AB30

    Nishadh Sutaria, Justin Choi, Youkyung Sophie Roh, Jordan R. Pollock, Sylvie Gabriel, Rajeev Chavda, Shawn G. Kwatra

    
• • ·27297 Financial burden of atopic dermatitis out-of-pocket health care expenses

    Page :AB31

    Wendy Smith Begolka, Raj Chovatiya, Isabelle J. Thibau, Jonathan I. Silverberg

    
• • ·27310 A single institution retrospective analysis of the use of furosemide in the treatment of chronic venous insufficiency

    Page :AB31

    Jennifer Yuan Sui, Eric Yuan, Caesar Anderson, Amanda F. Marsch

    
• • ·27328 The impact of a dedicated wound clinic on wound healing

    Page :AB31

    Alexandra Kuzyk, Connie Zhang, Laurie Parsons

    
• • ·27340 Taste and smell disturbances induced by terbinafine: A systematic review of the literature

    Page :AB31

    Jose W. Ricardo, Shari R. Lipner

    
• • ·27349 Cutaneous surgery outcomes in patients on EGFR inhibitors

    Page :AB32

    Michelle A. McNally, Anisha B. Patel, Valencia Thomas, Meghan Heberton

    
• • ·27358 Resource stewardship in dermatology: An evidence-based list of recommendations

    Page :AB32

    Linda Zhou

    
• • ·27384 Elevated psoriasis severity in obesity is associated with inadequate adiponectin-mediated regulatory T cell response

    Page :AB32

    Kevin Kwan, Haoming Liu, Grace Yu, Michael S. Bonkowski, Amy S. Paller

    
• • ·27434 Early trends of disease improvement in adult patients with atopic dermatitis treated with dupilumab: Real-world data from the PROSE registry

    Page :AB32

    Jerry Bagel, Gil Yosipovitch, David M. Pariser, Robert Y. Lin, Haixin Zhang, Daniel Richman, Andrew Korotzer, Shikha Bansal

    
• • ·27478 Herpes zoster and immunosuppression among patients with psoriasis or psoriatic arthritis on drug therapy

    Page :AB33

    Alex Jafari, Kyle Owens, Lauren Chen, Katherine Jolin, Andrea Murina, Erin Boh

    
• • ·27479 Does caffeine has positive effect on the prevalence of nonmelanoma skin cancer? Case-control study in Korea

    Page :AB33

    Jong Uk Kim, Ju Eun Seol, Seong Min Hong, Woo Jung Jin, So Hee Park, In Ho Park, Jung Eun Seol, So Young Jung, Hyojin Kim

    
• • ·27497 The administrative burden of prescribing isotretinoin

    Page :AB33

    Nidhi Shah, Elizabeth Smith, Jessica Czermak, Meredith Ferris, A. Yasmine Kirkorian

    
• • ·27510 Dysbiotic skin microbiome network of individual mediated host response to pollution stress

    Page :AB33

    Lu Wang, Yi-Ning Xu, Yabin Chen, Jinsong Zhang, Mingming Pu, Tingyan Mi, Yaping Du, Chandraprabha Doraiswamy, Tao Zeng, Luonan Chen

    
• • ·27513 Treatment of skin picking disorder with N-acetylcysteine: A retrospective review

    Page :AB34

    Angelina S. Hwang, Elliott H. Campbell, Julio C. Sartori-Valinotti

    
• • ·27517 Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma

    Page :AB34

    Justin M. McLawhorn, Thomas Stasko, Lindsey Collins

    
• • ·27518 Retrospective analysis of 578 inpatient dermatology consultations in hematology and bone marrow transplant patients: A 5-year study

    Page :AB34

    Alexander S. Hines, Antonious Hazim, David A. Wetter, Alina G. Bridges, Michael J. Camilleri, Marian T. McEvoy, Rokea A. el-Azhary, Mark D.P. Davis, Julio C. Sartori-Valinotti

    
• • ·27533 Comparative efficacy and safety of systemic therapies used in adult and adolescent moderate-to-severe atopic dermatitis (AD): A systematic literature review (SLR) and network meta-analysis (NMA)

    Page :AB34

    Jonathan I. Silverberg, Jacob P. Thyssen, Kyle Fahrbach, Kristin Mickle, Joseph C. Cappelleri, William Romero, Michael C. Cameron, Daniela E. Myers, Claire Clibborn

    
• • ·27534 Physician-patient knowledge on GoodRx

    Page :AB35

    Ahmed Yousaf, Stephen Davis, Erica Ghareeb, Roxann Powers

    
• • ·27535 Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: 104-week data from a phase 2 study

    Page :AB35

    John E. Harris, Amit G. Pandya, Mark Lebwohl, Pearl Grimes, Alice B. Gottlieb, Howard L. Sofen, Angela Y. Moore, Kathleen Butler, Fiona Kuo, Kang Sun, David Rosmarin

    
• • ·27540 Localized versus generalized granuloma annulare: A retrospective review of 407 patients

    Page :AB35

    Ahmed Yousaf, Osama J. Boustany, Michael Gerbo, Shanawar Waris, Stephen Davis, Roxann Powers

    
• • ·27548 The influence of hair color on alopecia areata

    Page :AB35

    Ahmed Yousaf, Michael S. Kolodney

    
• • ·27555 Incidence of bullous pemphigoid and risk of mortality in the dialysis population

    Page :AB36

    Jenny Liles, Jennifer Waller, Loretta Davis

    
• • ·27568 Maintenance of repigmentation after discontinuation of ruxolitinib cream in patients with vitiligo

    Page :AB36

    David Rosmarin, Amit G. Pandya, Pearl Grimes, Mark Lebwohl, Alice B. Gottlieb, Iltefat Hamzavi, Kathleen Butler, Fiona Kuo, Shaoceng Wei, Beth Rumberger, John E. Harris

    
• • ·27590 Abrocitinib in the treatment of moderate-to-severe atopic dermatitis refractory to dupilumab treatment: An analysis of JADE-EXTEND, a phase 3 long-term extension study

    Page :AB36

    Vivian Shi, Tina Bhutani, Mette Deleuran, Luz Fonacier, Stephen Shumack, Fan Zhang, Michael C. Cameron, Gary Chan, Hernan Valdez, Natalie Yin

    
• • ·27593 Contraception progestin type and female pattern hair loss

    Page :AB36

    Kelly E. Flanagan, James T. Pathoulas, Chloe J. Walker, Laura J. Burns, Isa Pupo Wiss, Maryanne M. Senna

    
• • ·27618 Extensive unguided laboratory testing is of limited value in initial episodes of small vessel vasculitis of the skin

    Page :AB37

    Brian Chu, Andrew C. Walls, Robert G. Micheletti, Arash Mostaghimi

    
• • ·27632 Investigating the utility of point-of-care INR measurements in patients on warfarin prior to Mohs microscopic surgery

    Page :AB37

    Daniel Tinker, Jordan Tanner, Danielle Rinck, Stephen Tinker, Ramona Behshad

    
• • ·27637 Strategies to minimize pain during platelet-rich plasma scalp injections

    Page :AB37

    Susie Suh, Fiore S. Casale, Natasha A. Mesinkovska

    
• • ·27640 Disparities in telemedicine access for Spanish-speaking pediatric patients

    Page :AB37

    Andrew R. Blundell, Elena B. Hawryluk, Shinjita Das

    
• • ·27645 Health-related quality of life and economic burden of prurigo nodularis

    Page :AB38

    Katherine Whang, Thomas Le, Raveena Khanna, Kyle Williams, Youkyung Sophie Roh, Nishadh Sutaria, Justin Choi, Sylvie Gabriel, Rajeev Chavda, Yevgeniy Semenov, Shawn Kwatra

    
• • ·27653 Consumer attitudes and behaviors on medical cannabis in dermatology

    Page :AB38

    Samuel Yeroushalmi, Daniel Rollan Nemirovsky, Dovid Aharon Feldman, Kamaria Nelson, Andrew Sparks, Adam Friedman

    
• • ·27675 Acceptance of patients insured by Medicaid at American dermatology residency training sites

    Page :AB38

    Jazzmin C. Williams, Alexandra E. Maxey, Maria L. Wei, Erin Amerson

    
• • ·27711 Antibiotic prescriptions by dermatologists to Medicare Part D beneficiaries

    Page :AB38

    Angelina S. Hwang, Lanyu Mi, David L. Swanson

    
• • ·27729 Psoriatic disease characteristics by metabolic comorbidities among patients with psoriasis

    Page :AB39

    Clinton Enos, Vanessa Ramos, Tinchi Lin, Robert R. McLean, Nicole Foster, Blessing Dube, Abby S. Van Voorhees

    
• • ·27764 Muffin technique micrographic surgery for nonmelanoma skin cancer

    Page :AB39

    Philip Surmanowicz, Arunima Sivanand, Amy X. Du, Muhammad N. Mahmood, Robert Gniadecki

    
• • ·27803 Soft tissue dermal filler–associated necrosis: A systematic review of the literature

    Page :AB39

    Kathryn Rentfro, Dillon Clarey, Marissa Lobl, Emily Glenn, Ronald Sulewski, Ashley Wysong

    
• • ·27851 Efficacy of guselkumab (GUS) on axial-related endpoints in patients with active psoriatic arthritis (PsA) with imaging-confirmed sacroiliitis: Results through week 52 from DISCOVER-1 and DISCOVER-2

    Page :AB39

    Alice B. Gottlieb, Joseph F. Merola, April W. Armstrong, Laura Savage, Soumya D. Chakravarty, Alexa P. Kollmeier, Bei Zhou, Ya-Wen Yang, Kristen Sweet, Wolf-Henning Boehncke

    
• • ·27924 Screening for coccidioidomycosis prior to immunosuppressive therapy in dermatology patients

    Page :AB40

    Kate Stanfield, Therese Holguin, Aimee C. Smidt, John Durkin

    
• • ·27925 Keloid treatment: A systematic review with a focus on antineoplastic therapies

    Page :AB40

    Evyatar Evron, Niki Nourmohammadi, Scott Worswick

    
• • ·27926 Diagnosis of dermotologic conditions in hispanic skin of color patients by medical students

    Page :AB40

    Shannon Kody, Danika Dorelien, Abigail Cline, Marian Russo

    
• • ·27940 Assessment of treatment maintenance effects of finasteride 1 mg every other month regimen in androgenic alopecia and clinical differences according to treatment response

    Page :AB40

    Min-jeong Kang, Soon-Hyo Kwon, Woo-Young Sim, Bark-Lynn Lew

    
• • ·28008 Examination of health information needs of caregivers of and individuals with burn injuries

    Page :AB41

    Geeta Ahuja, Tammie M. Jones, Ali Weinstein, Alaanah Bhanji, Ramez Bakhtar, Kacey Ferguson

    
• • ·28108 Untargeted metabolomics and steroid signatures in urine of male pattern baldness patients after finasteride treatment for a year

    Page :AB41

    Ji-Hoon Lim, Yu Ra Lee, Eunju Im, Haksoon Kim, Jeongae Lee, Han Bin Oh, Ki Jung Paeng, Min-Jeong Kang, Soon-Hyo Kwon, Woo Young Sim, Bark Lynn Lew

    
• • ·28177 Increasing sun protective behaviors in Hispanic patients: A review of the literature

    Page :AB41

    Natalya Gallaga, Paige Hoyer, Richard F. Wagner

    
• • ·28181 A retrospective review of continuation and discontinuation rates of biologic therapy during the COVID-19 pandemic in a single academic center dermatology practice

    Page :AB41

    Stephanie R. Cohen, David X. Gao, Jared S. Kahn, Anh H. Lam, Kristin Fiumara, David Rosmarin

    
• • ·28226 Aromatase inhibitor-induced dermatologic adverse effects: A systematic review

    Page :AB42

    Sara Behbahani, Amaris Geisler, Genevieve Kaunitz, Miriam K. Pomeranz

    
• • ·28228 Effects of timolol on wound healing: A single-center retrospective study

    Page :AB42

    Angelina S. Hwang, Yul W. Yang, Aaron R. Mangold

    
• • ·28247 Pediatric hospitalizations for atopic dermatitis in the USA: Predictors for developing the atopic triad

    Page :AB42

    Lacey Zimmerman, Carolina Puyana, Maria M. Tsoukas

    
• • ·28248 Medical student perceptions of assessment systems on introductory dermatology clerkships

    Page :AB42

    Jordan T. Said, Jaewon Yoon, Leah L. Thompson, Gabriel E. Molina, Steven T. Chen

    
• • ·28332 UVA vs UVB phototherapy for graft-versus-host disease: A retrospective chart review

    Page :AB43

    Priyanka Kumar, Noori Kim

    
• • ·28336 Outcomes of cosmetic procedures for treatment of morphea: A retrospective cohort study

    Page :AB43

    Laila Abbas, Adrienne Joseph, Denzil Mathew, Christopher Derderian, Heidi Jacobe

    
• • ·28340 Identification of flare triggers in hidradenitis suppurativa

    Page :AB43

    Alyssa M. Thompson, Jennifer M. Fernandez, Aleksi J. Hendricks, Elizabeth M. Mata, Jennifer L. Hsiao, Vivian Y. Shi

    
• • ·28354 Delayed admission to a specialist referral center: Impact on clinical outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis

    Page :AB43

    Abigail E. Clark, Stephanie Fook-Chong, Karen Choo, Choon Chiat Oh, Yi Wei Yeo, Shiu Ming Pang, Haur Yueh Lee

    
• • ·28390 Secondary intention healing in Mohs micrographic surgery—An academic single-center experience

    Page :AB44

    Julián Barrera-Llaurador, Osward Y. Carrasquillo, Marely Santiago-Vázquez, Valeria J. González-Molina, Sheila M. Valentín-Nogueras

    
• • ·28399 Comparing trends in qualifications of allopathic medical students matching into dermatology

    Page :AB44

    Frederick Morgan, Cheryl Bayart

    
• • ·28406 Social media usage by dermatology programs in the first ever virtual residency application cycle

    Page :AB44

    Marielle Jamgochian, Shazli Razi, Babar Rao, Amandeep Kaur

    
• • ·28456 Efficacy and tolerability of oral antibiotics for cetuximab-induced acneiform eruption

    Page :AB44

    YoungHwan Choi, Jaihee Bae Dong Min Shin; Donghwi Jang; Dokyoung Yoon; Jongeun Lee; Se Jin Oh; Hyun Je Kim; Ji-Hye Park

    
• • ·28464 Hidradenitis suppurativa and association with stroke: Systematic review and meta-analysis

    Page :AB45

    Kevin Phan, William Ng, Belinda Lai, Amit Garg, Saxon D. Smith

    
• • ·28470 Dermatology residents’ perspectives on the role of community service and service-learning in dermatology residency training programs: A nationwide survey

    Page :AB45

    Bansri Patel, Victoria Humphrey, Alaina James

    
• • ·28484 A U.S. population–based epidemiologic analysis of head and neck and genital mucosal melanoma from the Surveillance, Epidemiology and End Results (SEER) database

    Page :AB45

    Danyal Tahseen, Ghazal Ghafari, Walter J. Liszewski, Dennis P. West, Beatrice Nardone

    
• • ·28485 A CME virtual patient simulation improves management of adult and pediatric patient with atopic dermatitis

    Page :AB45

    Shari J. Dermer, Piyali Chatterjee-Shin, Pan Chen, Katie S. Lucero

    
• • ·28486 Cause of death after melanoma diagnosis: A US population-based analysis of current SEER data from the National Cancer Institute

    Page :AB46

    Beatrice Nardone, Ghazal Ghafari, Yasmeen Ali, Walter J. Liszewski, Dennis P. West

    
• • ·28487 Extracorporeal photopheresis for early stage cutaneous T-cell lymphoma: Race-based differences in treatment utilization and response

    Page :AB46

    Priyanka Kumar, Amarachi Eseonu, Courtney Johnson, Noori Kim, Sima Rozati

    
• • ·28517 Increasing prevalence of insect venom allergy among adolescents

    Page :AB46

    Yonit Wohl, Batya Davidovici, Jacob Mashiah, Yosefa Bar-Dayan

    
• • ·28546 Sex and ethnic representation in dermotologic fellowships: An examination of national trends 2006-2018

    Page :AB46

    Albert G. Wu, Shari R. Lipner

    
• • ·28568 A detailed characterization of the US dermatology Medicare physician workforce

    Page :AB47

    William Murphy, Vartan Pahalyants, Nicole Gunasekera, Connie Shi, Vinod Nambudiri

    
• • ·28588 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a randomized, double-blind, vehicle-controlled phase 2 study

    Page :AB47

    Matthew Zirwas, Zoe D. Draelos, Janet DuBois, Leon Kircik, Angela Moore, Linda Stein Gold, Robert C. Higham, Lynn Navale, Patrick Burnett, David R. Berk

    
• • ·28609 Pitfalls and best practices in teledermatology at St. Louis University Department of Dermatology

    Page :AB47

    Gabriela Morris, Cory Duprey

    
• • ·28611 Improving African American enrollment in hidradenitis suppurativa clinical trials: A clinical and research staff perspective

    Page :AB47

    Chidubem A.V. Okeke, Mahima Bhayana, Faith C. Simmonds, Uchechukwu J. Okoh, Azure B. Erskine, Jessica D. Perry, William D. Shipman, Janyla A. Seltzer, Jane Otado, Ginette A. Okoye, Angel S. Byrd

    
• • ·28620 The impact of the COVID-19 pandemic on perceived hair loss and stress in a cohort of alopecia areata patients: A cross-sectional study

    Page :AB48

    Chloe J. Walker, Kelly E. Flanagan, James T. Pathoulas, Isabel Pupo Wiss, Abby Ellison, Natasha Mesinkovska, Maryanne M. Senna

    
• • ·28636 Antidrug antibody formation with use of biological agents in psoriasis patients

    Page :AB48

    Jia Gao, Danika Dorelien, Abigail Cline, Bijan Safai

    
• • ·28644 Inpatient training modules increase dermatology resident confidence for hospital consults

    Page :AB48

    Kelsey Wilson, Thomas Jennings

    
• • ·28651 Substance use and psychiatric comorbidity in patients with delusions of infestation

    Page :AB48

    Arsh Patel, Arjun M. Bashyam, Kayla Felix, Steven R. Feldman

    
• • ·28668 Allergic contact dermatitis associated with scalp applied products: A systematic review of topical allergens and alopecia implication

    Page :AB49

    Christine Pham, Margit Juhasz, Jessica Lin, Golara Honari, Natasha Atanaskova Mesinkovska

    
• • ·28693 A retrospective analysis of factors associated with matching into top-tier dermatology programs

    Page :AB49

    Anna Eversman, Jatin Narang, David X. Zheng, Timmie R. Sharma

    
• • ·28694 Survey of patients’ wound care habits following Mohs micrographic surgery

    Page :AB49

    Ailish M. Hanly, Vijaya T. Daniel, Bassel H. Mahmoud

    
• • ·24880 A combination of 89% Vichy volcanic mineralizing water and hyaluronic acid after aggressive laser procedure for skin rejuvenating

    Page :AB50

    Elena Araviiskaia, Martina Kerscher, Julieta Spada, Cecilia Orlandi, Maryna Anifilova, Sonya Abdulla, Catherine Delva, Delphine Kerob, Monika Arenbergerova, Masha Sviatoslav Tuz, Jerry Tan

    
• • ·24899 Ixekizumab sustains high efficacy and a favorable safety profile in burdensome areas in patients with moderate-to-severe psoriasis: 5-year results from UNCOVER-2

    Page :AB50

    Kim Papp, Andrew Blauvelt, Luis Puig, Hany Elmaraghy, Kyoungah See, Missy McKean-Matthews, Heidi Crane, Alyssa Garrelts, Craig Leonardi

    
• • ·24916 Efficacy of ruxolitinib cream in patients with atopic dermatitis who demonstrated partial responses: Pooled analysis from two randomized phase 3 studies

    Page :AB50

    Eric L. Simpson, Leon Kircik, Andrew Blauvelt, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Lawrence F. Eichenfield

    
• • ·24960 Botryomycosis in an immunocompromised adult male

    Page :AB50

    Caroline Zhu, Zachary Gillooly, Sandra Osswald

    
• • ·24982 Evaluation of biopsy management at student-run free clinic

    Page :AB51

    Caroline Zhu, Kavina Patel, Giselle Guerrero, Marie Vu, Jessica Wong, Pavela Bambekova, John Browning

    
• • ·24988 Spectrum of facial angiofibromas in 85 patients with tuberous sclerosis complex in a tertiary hospital. Retrospective study and revision of the literature

    Page :AB51

    Pablo Cobo Rodríguez, Pablo Boixeda De Miquel, Iván Checa Recio, Jaime Martínez Mariscal, Raquel Cabana Navia, María Antonia Pastor Nieto, Esther Jiménez Blázquez, Adriana Martín Fuentes, Patricia González Muñoz, Consuelo Sánchez Herreros, Esther de Eusebio Murillo

    
• • ·25009 Manager of technology

    Page :AB51

    Aixing Fan, Kristina Fabijanic, Angela Meseha, Thomas Boyd

    
• • ·25027 Treatment of epithelioma cuniculatum (plantar verrucous carcinoma): A systematic review of the literature

    Page :AB51

    Samantha Shwe, Surget V. Cox, Christina N. Kraus, Ashley N. Elsensohn

    
• • ·25036 Dermoscopic features of large cell acanthoma

    Page :AB52

    Jong Bin Park, Jang Hwan Jung, Do Ik Kwon, Seol Hwa Seong, Kee Suck Suh, Min Soo Jang

    
• • ·25052 Ustekinumab-induced disseminated verrucosis

    Page :AB52

    Steven A. Svoboda, Patrick S. Rush, Kevin G. Sharghi, Peter L. Rady, Stephen K. Tyring, Joshua D. Eikenberg

    
• • ·25085 Factors associated with the highest and lowest cited research articles in dermatology journals

    Page :AB52

    Meredith E. Thomley, Ana Preda-Naumescu, Isabella Aldana, Carter J. Boyd, Stephanie Bevans

    
• • ·25094 Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

    Page :AB52

    Hidemi Nakagawa, Osamu Nemoto, Atsuyuki Igarashi, Hidehisa Saeki, Kenji Kabashima, Manabu Oda, Takeshi Nagata

    
• • ·25117 Analysis of cutaneous infections in homeless populations at student-run free clinic

    Page :AB53

    Marie Vu, Jessica Wong, Fredy Calderon, Jonathan Luu, Cara Schachter, John Browning

    
• • ·25130 A comprehensive topical antioxidant inhibits oxidative stress induced by blue light exposure and pollution in human skin tissue

    Page :AB53

    Mitchell Wortzman, Diane B. Nelson

    
• • ·25133 A single-center, open-label clinical trial evaluated the efficacy and tolerability of a comprehensive, hydrating topical antioxidant developed specifically for men

    Page :AB53

    Brooke C. Sikora, Jeffrey S. Dover, Mitchell Wortzman, Diane B. Nelson

    
• • ·25135 Safety and efficacy of VP-102 in molluscum contagiosum by age: Pooled results of two phase 3 multicenter, randomized, vehicle-controlled trials

    Page :AB53

    Melissa Olivadoti, Elaine Siegfried, Scott Katz, Pieter d’Arnaud, Melissa Olivadoti

    
• • ·25154 Enhanced topical delivery of salicylic acid from an encapsulated system

    Page :AB54

    Junhong Mao, Aaron Cohen

    
• • ·25178 Disease remission during a short-term treatment phase II study of nomacopan in mild-to-moderate bullous pemphigoid

    Page :AB54

    Miles Nunn, James Fettiplace

    
• • ·25200 Public versus private drug insurance and psoriasis degree of severity in patients with prescribed biologics in Canada: A retrospective cohort study

    Page :AB54

    Laurence Mainville, Paul Fortin

    
• • ·25212 Does a four-week dermatology elective improve visual diagnosis?

    Page :AB54

    Anna Swigert, Mandy Majidian, Erika Elliott, Andrea Murina

    
• • ·25240 Cosentyx (secukinumab) for the treatment of adult onset pityriasis rubra pilaris: A single arm, open-label exploratory study

    Page :AB55

    Jason C. Sluzevich, Meera H. Patel, Thais P. Pincelli, Caitlin M. Brumfiel, Mark R. Pittelkow, Aaron Mangold

    
• • ·25255 Sun protective behaviors in sun-sensitive individuals: Examining for ethnic and racial differences

    Page :AB55

    Nicole Bolick, Linglin Huang, Arash Mostaghimi, Rebecca I. Hartman

    
• • ·25258 Efficacy and safety of ixekizumab in Chinese patients with moderate-to-severe plaque psoriasis: 12-week results from a phase 3 study

    Page :AB55

    Wenlong Rui, Xia Li, Jie Zheng, Weili Pan, Min Zheng, Yan Lu, Fuqiu Li, Yangfeng Ding, Jianzhong Zhang, Hongying Li

    
• • ·25334 Primary cutaneous EBV-positive diffuse large B-cell lymphoma masquerading as periorbital cellulitis

    Page :AB55

    Zaydi Javeed, L. Kevin Heard, Kerry Hennessy, Adel Haque, Vidhi Shah, Lucia Seminario-Vidal, Wei-Shen Chen, Pei-Ling Chen

    
• • ·25338 Solitary sclerotic fibroma of the skin

    Page :AB56

    Samrawit Worku

    
• • ·25357 Malignancies related to study drug and leading to discontinuation through 5 years of tildrakizumab exposure in 2 phase 3 clinical trials

    Page :AB56

    Adam Friedman, Ronald B. Vender, Mital Desai, Alan M. Mendelsohn, Stephen J. Rozzo, Jennifer Cather

    
• • ·25363 Serious infections and infections related to study drug and leading to discontinuation through 5 years of tildrakizumab exposure in 2 phase 3 clinical trials

    Page :AB56

    Kurt Gebauer, Eingun James Song, Alan M. Mendelsohn, Stephen J. Rozzo, Dario Kivelevitch

    
• • ·25385 Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analyses from phase III studies in psoriasis and psoriatic arthritis (PsA)

    Page :AB56

    Kristian Reich, Xenofon Baraliakos, Laura C. Coates, Alice B. Gottlieb, Boni Elewski, Weibin Bao, Torben Kasparek, Corine Gaillez, Effie Pournara, Maher Aassi, Chiara Perella

    
• • ·25399 A 1% colloidal oatmeal OTC cream is clinically effective for the management of mild to moderate atopic dermatitis in African-American children

    Page :AB57

    Toni Anne Lisante, Menas Kizoulis, Paul Zhang, Christopher Nunez

    
• • ·25406 Comparison of biologic initiation and health care costs among patients with psoriasis receiving fixed-dose combination halobetasol-propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion vs calcipotriene 0.005%/ betamethasone dipropionate 0.064% (CAL/BD) foam

    Page :AB57

    Leon Kircik, George Joseph, Patrick Gagnon-Sanschagrin, Brock Bumpass, Elizabeth Serra, Tina Lin, Abby Jacobson, Annie Guérin, Brad P. Glick

    
• • ·25411 The utility of teledermatology in the evaluation of skin lesions

    Page :AB57

    Emily Lynn Clarke, Jason Reichenberg, Ammar M. Ahmed, Brett Keeling, James Custer, Paul J. Rathouz, Anokhi Jambusaria-Pahlajani

    
• • ·25418 Clinical utility of clinical, radiologic and tissue studies of verrucous venous malformation

    Page :AB57

    Alexandria Brown, Thuy Phung

    
• • ·25421 Systemic therapy of children with psoriasis—Need for intensified information and preparation before start

    Page :AB58

    Brigitte Stephan, Franziska Gensel, Matthias Augustin

    
• • ·25423 Improvements in work productivity following baricitinib treatment in patients with moderate-to-severe atopic dermatitis: Results from BREEZE-AD5

    Page :AB58

    Lawrence F. Eichenfield, Emanual Maverakis, Jerry Tan, Lorne Albrecht, Andrew Buchanan, Amy M. DeLozier, Jinglin Zhong, Luna Sun, David Rosmarin

    
• • ·25442 Relationship between topical corticosteroid utilization and atopic dermatitis severity and burden: A population-based cross-sectional study

    Page :AB58

    Alexander Egeberg, Jeanette Halskou Hougaard, Linda Weyler, Philip Sugerman, Jacob P. Thyssen

    
• • ·25444 Ligelizumab further reduced sleep impairment in patients with chronic spontaneous urticaria previously treated with omalizumab

    Page :AB58

    Marcus Maurer, Karl Sitz, Gordon Sussman, Martin Metz, Michihiro Hide, Ana Giménez-Arnau, Nathalie Barbier, Eva Hua, Reinhold Janocha, Maria-Magdalena Balp, Thomas Severin

    
• • ·25447 Baricitinib treatment results in clinically meaningful itch reduction and enhanced quality of life in patients with moderate-to-severe atopic dermatitis: Results from BREEZE-AD5

    Page :AB59

    Shawn Kwatra, Seth Forman, Alma Cruz, Susan Ball, Amy DeLozier, Evangeline Pierce, Andrew Buchanan, Luna Sun, Yuxin Ding, Bruce Strober

    
• • ·25461 The Student Dermatology Clinic for the Underserved: A service-learning model for dermatology residency training programs

    Page :AB59

    Bansri Patel, Victoria Humphrey, Alaina James

    
• • ·25468 Thanatka: A traditional Burmese culture dermatologic tool

    Page :AB59

    Kyaw Zin Htet, Kieron S. Leslie

    
• • ·25482 Secukinumab efficacy and safety profile in pediatric patients with severe chronic plaque psoriasis up to 1 year

    Page :AB59

    Christine Bodemer, Andrzej Kaszuba, Külli Kingo, Athanasios Tsianakas, Akimichi Morita, Enrique Rivas, Philemon Papanastasiou, Manmath Patekar, Charis Papavassilis, Gerard Bruin, Ruquan You

    
• • ·25486 Correlation of the Vitiligo Area Scoring Index with patient- and physician-reported measures of clinical improvement in a randomized, double-blind phase 2 study

    Page :AB60

    Iltefat Hamzavi, David Rosmarin, Kathleen Butler, Fiona Kuo, Zhaoyin Zhu, Kang Sun

    
• • ·25508 Trichodysplasia spinulosa in setting of a pediatric cardiac transplant and immunosuppression

    Page :AB60

    Jose Cervantes, Maya Firsowicz, Lucia Diaz

    
• • ·25511 Effects of upadacitinib on the patient-reported impact of atopic dermatitis: Atopic Dermatitis Impact Scale (ADerm-IS) results from two pivotal phase 3 studies (MEASURE UP 1 and MEASURE UP 2)

    Page :AB60

    Eric L. Simpson, Marjolein S. de Bruin-Weller, Vimal H. Prajapati, Brian M. Calimlim, Henrique D. Teixeira, Jiewei Zeng, Meng Liu, Jonathan I. Silverberg

    
• • ·25525 High-risk behaviors in teenagers: Legislative impact on indoor tanning injuries

    Page :AB60

    Laura Russell, Suman Sahil, An-Lin Cheng, Colleen Reisz

    
• • ·25529 Secukinumab demonstrates a consistent safety profile in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis over long term: Updated pooled safety analyses

    Page :AB61

    Alice Gottlieb, Atul Deodhar, Iain B. McInnes, Xenofon Baraliakos, Kristian Reich, Stefan Schreiber, Weibin Bao, Hanno B. Richards, Luminita Pricop, Philip J. Mease, Mark Lebwohl

    
• • ·25535 The burden of skin disease in the Barekese subdistrict of rural Ghana

    Page :AB61

    Nicholas Flint, Sam Simister, Joshua Webb, Ivan Flint, Ty Dickerson, Zachary Hopkins, Aaron Secrest

    
• • ·25554 An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis treated with ixekizumab from 16 clinical studies

    Page :AB61

    Luis Puig, Andrew Blauvelt, Michael Ramharter, Arnon Cohen, Wen Xu, Himanshu Patel, Christopher Schuster, Elisabeth Riedl

    
• • ·25555 “Stars” paradoxically irritated by lasers

    Page :AB61

    Jasmine Mann, Rabi Nambi

    
• • ·25560 Assessment of patient satisfaction and adverse effects following the use of a commercially available hair fiber filler

    Page :AB62

    Arash Babadjouni, Natasha Mesinkovska, Margit Juhasz, Christine Pham, Aunna Pourang, Ella Csuka, Evyatar Evron, Bobak Hedayati

    
• • ·25561 Patient satisfaction with secukinumab on clearing the skin of psoriasis: Results from US dermatology electronic medical records

    Page :AB62

    April W. Armstrong, Dhaval Patil, Eugenia Levi, Catherine B. McGuiness, Xin Wang, Chi-Chang Chen, Elizabeth Nguyen, Paul S. Yamauchi

    
• • ·25572 Impact of risankizumab on the duration of PASI90 achievement: A post hoc analysis of 4 phase III clinical trials

    Page :AB62

    Mark G. Lebwohl, Ahmed M. Soliman, Hongbo Yang, Jessie Wang, Sarah H. Koenigsberg, Annika Anderson, Bryon Padilla, Andreas Pinter

    
• • ·25597 Improvements in scalp and nail psoriasis with apremilast treatment in patients with moderate to severe plaque psoriasis with and without a history of psoriatic arthritis

    Page :AB62

    Jeffrey Crowley, Melinda Gooderham, Sven Richter, Rebecca Shi, Kristian Reich

    
• • ·25602 Improvements and response achievement in PASI subscale domains for head scaling and erythema in apremilast-treated patients with moderate to severe plaque psoriasis of the scalp: Results from the STYLE study

    Page :AB63

    Kim Papp, Abby Van Voorhees, Linda Stein Gold, Mark Lebwohl, Bruce Strober, Zuoshun Zhang, Yao Wang

    
• • ·25603 Improvement in scalp psoriasis and quality of life with apremilast in patients with moderate to severe scalp psoriasis regardless of prior systemic treatment: Results from the phase 3, randomized STYLE study

    Page :AB63

    Yao Wang, Linda Stein Gold, Mark Lebwohl, Bruce Strober, Zuoshun Zhang, Abby Van Voorhees

    
• • ·25617 Topical formulation with an ingredient blend composed of Rhodiola rosea and Eleutherococcus senticosus (Siberian ginseng) induces stress protective response on human skin against intrinsic and extrinsic stressors

    Page :AB63

    Ganesh Diwakar, Lisa Barnes, Dale Kern, Carlos Olmos

    
• • ·25652 Severe adult-onset Still disease managed with anakinra

    Page :AB63

    Christopher White, Kristin Witfill

    
• • ·25655 Treatment of hidradenitis suppurativa in immunosuppressed transplant patients

    Page :AB64

    Carolyn Ahlers, Lee Wheless

    
• • ·25656 Vulvar discoid lupus erythematosus: An unusual site for cutaneous lupus erythematosus

    Page :AB64

    Samar Sheriff, Janine Malone, Courtney R. Schadt, Jeffrey P. Callen

    
• • ·25662 Squamoid eccrine ductal carcinoma

    Page :AB64

    Peter Sigal, Jessica Ghaferi

    
• • ·25665 Efficacy and safety of mirikizumab in psoriasis: 52-week results from the OASIS-1 randomized controlled trial

    Page :AB64

    Andrew Blauvelt, Alexa B. Kimball, Matthias Augustin, Yukari Okubo, Michael Witte, Claudia Rodriguez Capriles, Angelina Sontag, Vipin Arora, Olawale Osuntokun, Bruce Strober

    
• • ·25668 To biopsy or not to biopsy? Medical student assessment of malignant vs benign skin lesions

    Page :AB65

    Mandy Majidian, Anna Swigert, Kezia Surjanto, Erika Elliott, Laura Williams

    
• • ·25669 Abscess formation of nasal flap area four years after reconstruction, 4 months after new-onset hidradenitis suppurativa

    Page :AB65

    Nirav Shah, Adel Haque, Vidhi Shah, Larry Heard, Nicole Nagrani, Brandon Cardon, Sarah Moore, David Aung-Din, Brooke Baldwin

    
• • ·25671 Nonepidemic variant of Kaposi sarcoma in an immunocompetent HIV-negative male

    Page :AB65

    Hope Barone, David Fivenson, Adam Richardson, Brian Schapiro

    
• • ·25686 Variability in the dosing of PD1 inhibitors used for treatment of nonmelanoma skin cancers

    Page :AB65

    Nader Aboul-Fettouh, Sirunya Silapunt, Michael R. Migden, Leon Chen

    
• • ·25696 Impact of guselkumab on quality of life and work productivity outcomes among patients with moderate-to severe plaque psoriasis in the Corrona Psoriasis Registry

    Page :AB66

    April W. Armstrong, Kristina Callis-Duffin, Timothy Fitzgerald, Amanda Teeple, Jonathan Uy, Mobolaji Olurinde, Katelyn Rowland, Robert R. McLean, Lin Guo, Ying Shan, Abby S. Van Voorhees

    
• • ·25700 Mycobacterium chelonae panniculitis from self-administered medical injections

    Page :AB66

    Madeline Schaeffer, Brian Schapiro, David Fivenson

    
• • ·25706 Cutaneous manifestations and clinical disparities in the homeless population

    Page :AB66

    Marguerite O’Quinn, Christopher Haas, Deborah Hilton

    
• • ·25709 Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results from an open label study evaluating adrenal suppression potential

    Page :AB66

    Vivian Laquer, David Davidson, Andrea Nguyen, Tien Nguyen

    
• • ·25723 Difamilast a topical PDE4 inhibitor: Phase 3 trials in Japanese adult and pediatric patients with atopic dermatitis

    Page :AB67

    Akio Tanaka, Michihiro Hide, Takahiro Tsuchiya, Kensuke Ito

    
• • ·25724 Countering skin aging through DNA repair enhancement: What can we learn from skin of color?

    Page :AB67

    Stephanie Chan, John Koo

    
• • ·25726 Prospective adjuvant therapy trial design using a prognostic 40-gene expression profile (40-GEP) test for high-risk cutaneous squamous cell carcinoma (cSCC) and BWH staging-based risk assessment

    Page :AB67

    Sherrif F. Ibrahim, Sarah T. Arron, Ally-Khan Somani, Sarah J. Kurley, Kyle R. Covington, Alison L. Fitzgerald, Chrysalyne D. Schmults, Ashley Wysong

    
• • ·25734 Migratory panniculitis of the pannus

    Page :AB67

    Eddie A. Kwan, Grant M. Williams, Michael R. Lewin-Smith, Mark S. Lincoln, Abigail J. Lee

    
• • ·25741 Demographic and clinical factors associated with patient-reported remission in psoriasis

    Page :AB68

    George Gondo, Edward Hadeler, Nicholas Brownstone, Emanual Maverakis, Joseph F. Merola, April Armstrong, Tina Bhutani, Stacie J. Bell, Wilson Liao

    
• • ·25742 Evaluation of the active ingredient complex of an anti-hair loss shampoo on the activation of Wnt/betacatenin pathway in human hair follicle dermal papilla cells

    Page :AB68

    Ana Coutinho, Fernanda Chaves Beltrão, Fabio Sanches, Valerie Mengeaud, Camille Mas, Helene Duplan

    
• • ·25746 Testing of a light dosimeter for use in erythropoietic protoporphyria

    Page :AB68

    Haya S. Raef, Lina Rebeiz, Rebecca Karp-Leaf, Irene Kochevar, Amy K. Dickey, Sarina B. Elmariah

    
• • ·25748 Ixekizumab sustained complete clearance, itch resolution, and improved quality of life for moderate-to-severe psoriasis patients who achieved rapid, high skin clearance

    Page :AB68

    David Rosmarin, Melinda Gooderham, Laura Ferris, Kyoungah See, Eric Wolf, Russel Burge, Missy McKean-Matthews, Kristian Reich

    
• • ·25750 Tapinarof cream 1% once daily for plaque psoriasis: Secondary efficacy outcomes from two pivotal phase 3 trials

    Page :AB69

    Linda Stein Gold, Andrew Blauvelt, April Armstrong, Seemal R. Desai, Howard Sofen, Lawrence J. Green, Stephen K. Tyring, Laura K. Ferris, Philip M. Brown, David S. Rubenstein, Stephen C. Piscitelli

    
• • ·25754 Presence of psoriatic arthritis has no impact on the clinical efficacy and safety of secukinumab in patients with psoriasis: Pooled analysis of the phase 3 CLEAR and CLARITY trials

    Page :AB69

    Jerry Bagel, Andrew Blauvelt, Stephen Tyring, Manmath Patekar, Xiangyi Meng, Mark Lebwohl

    
• • ·25773 A randomized, dose-escalating, double-blind study to evaluate abobotulinumtoxinA for the treatment of moderate-to-severe glabellar lines

    Page :AB69

    John Joseph, Amir Moradi, Z. Paul Lorenc, Kyle Coleman, Glynis Ablon, Joely Kaufman-Janette, Sue Ellen Cox, Andrew Campbell, Steven Dayan, Girish Munavalli

    
• • ·25777 Trends in telemedicine utilization and access for dermatologic concerns during the COVID-19 pandemic

    Page :AB69

    Michelle S. Lee, Lisa N. Guo, Vinod E. Nambudiri

    
• • ·25789 Profiling acne sufferers: From acne types and severity to impact in personal and social life

    Page :AB70

    Aurélie Coubart, Matthew Richtmyer, Wendi Gardner, Claudia Montoya, Menas Kizoulis, Gabriela Oana Cula, Nikoleta Batchvarova

    
• • ·25792 Improvements in BSA associate with improvements in itch and quality of life in patients with moderate-to-severe psoriasis treated with ixekizumab or guselkumab through 24 weeks

    Page :AB70

    Alice Gottlieb, Melinda Gooderham, Bruce Konicek, Russel Burge, So Young Park, Andrew Blauvelt

    
• • ·25799 Efficacy and safety of ixekizumab in patients with moderate-to-severe plaque psoriasis with and without psoriatic arthritis at baseline: Results from UNCOVER studies through 5 years

    Page :AB70

    Alice Gottlieb, Kurt de Vlam, Yan Wang, Kyoungah See, Rebecca Bolce, Eric Wolf, Russel Burge, Himanshu Patel, Joseph F. Merola

    
• • ·25800 Bimekizumab for the treatment of moderate to severe psoriasis of the scalp: Post hoc analysis from the BE SURE phase 3 trial

    Page :AB70

    Kristian Reich, Joseph F. Merola, Boni Elewski, Kim A. Papp, Luis Puig, Pheobe Rich, Christopher Cioffi, Eva Cullen, Luke Peterson, Alice B. Gottlieb

    
• • ·25824 Baseline characteristics of psoriasis patients participating in the VALUE multinational postmarketing observational study

    Page :AB71

    Diamant Thaci, Charles Lynde, Julia-Tatjana Maul, Andrea Szegedi, Mamitaro Ohtsuki, Hongwei Wang, Ahmed M. Soliman, Simone Rubant, Kim A. Papp

    
• • ·25842 Basal cell carcinoma–like cutaneous metastases of a breast adenocarcinoma: A case report

    Page :AB71

    Madeleine Lachance, Claire Coulombe, Bernard Delisle

    
• • ·25843 Tapinarof cream 1% once daily for plaque psoriasis: Patient-reported outcomes from two pivotal phase 3 trials

    Page :AB71

    Robert Bissonnette, Bruce Strober, Mark Lebwohl, Jerry Bagel, James Del Rosso, Joseph F. Merola, Neal Bhatia, Paul Yamauchi, Philip M. Brown, David S. Rubenstein, Anna M. Tallman

    
• • ·25846 Broadening the spectrum of cocaine induced neutrophilic dermatoses

    Page :AB71

    Alexander Valiga, Sherry Yang

    
• • ·25851 Efficacy of secukinumab in managing axial manifestations and nail psoriasis in patients with psoriatic arthritis: Results from the MAXIMISE trial

    Page :AB72

    Alice B. Gottlieb, Xenofon Baraliakos, Laura C. Coates, Effie Pournara, Michael Rissler, Dermot Whyms, Chiara Perella, Kristian Reich, Dafna D. Gladman, Maher Aassi

    
• • ·25853 Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open-label extension phase

    Page :AB72

    Elke Weisshaar, Jacek C. Szepietowski, Thomas R. Sciascia, Gil Yosipovitch, Sonja Ständer

    
• • ·25854 Effects on type 2 immunity when specifically targeting the interleukin-13 cytokine with tralokinumab

    Page :AB72

    Emma Guttman-Yassky, Kenji Kabashima, Ana Pavel, Delphine Staumont-Sallé

    
• • ·25861 Gender differences in the geographic distribution of the U.S. dermatologist workforce: A national cross-sectional study

    Page :AB72

    Sepideh Ashrafzadeh, Gregory A. Peters, Elizabeth A. Buzney, Hang Lee, Maryam M. Asgari

    
• • ·25876 Subject satisfaction with two treatments a year (every six months) of abobotulinumtoxinA is high among both previously treated and toxin-naïve cohorts

    Page :AB73

    Joel L. Cohen, Kian Karimi, Ava Shamban, Matthew Meckfessel

    
• • ·25877 Efficacy evaluation of a topical hyaluronic acid serum

    Page :AB73

    Zoe Diana Draelos

    
• • ·25878 Brow shape and height after treatment with abobotulinumtoxinA in the glabellar lines

    Page :AB73

    Joel L. Cohen, Joely Kaufman-Janette, Matthew Meckfessel, Alessandra Nogueira, Sarah Coquis-Knezek

    
• • ·25886 Recurrent basal cell carcinoma of the scalp in a patient on long-term hydroxyurea therapy

    Page :AB73

    Alexandra Rubin, Attiya Haroon, Nadiya Chuchvara, Babar K. Rao, Bahar F. Firoz

    
• • ·25891 The effects of Chinese herbal medicine Rhodiola rosea on preventing photoaging in keratinocytes

    Page :AB74

    Hua-en Lee, Enoch Toh, Jude C. Clapper, Cheng Chang Hsu

    
• • ·25894 CLL-associated cryofibrinogenemia

    Page :AB74

    Eleanor M. Pope, Elizabeth H. Cusick, Kathleen A. Mannava, Molly E. Plovanich

    
• • ·25903 Association of breast and colorectal cancer in patients with central centrifugal cicatricial alopecia: A cross-sectional, pilot study

    Page :AB74

    Jessica Brown-Korsah, Fritzlaine C. Roche, Susan C. Taylor

    
• • ·25904 Skin mottling following provoked deep vein thrombosis

    Page :AB74

    Devor O’Connor, Adam V. Sutton, Tyler D. Evans, Erica B. Lee

    
• • ·25907 Actinic keratosis in Colombia: First approaches

    Page :AB75

    David A. Castillo Molina, Jesus D. Fierro Lozada, Diana Quintero Estupiñan, Maria J. Carroll-Patiño, Mariana Reyes Rey, Paula A. Chacón Jaramillo, Nanis Ramirez Herrera, Paula C. Rubiano Mojica, Nelson José Alvis-Zakzuk, Gabriela Bula Galán, David E. Castillo Saavedra

    
• • ·25912 Multifocal granular cell tumor affecting skin and scrotum in a child

    Page :AB75

    Marcos Oro-Ayude, Laura Mesa-Álvarez, Carlos Álvarez-Álvarez, Carlos Feal, Beatriz González-Sixto, Queila Rodríguez-Jato, Carmen Couselo-Rodríguez, Diego Soto-García, Ángeles Flórez

    
• • ·25913 Interest and exposure of premedical students to dermatology at a historically Black university

    Page :AB75

    Geeta Ahuja, Kamaria Nelson, Nnaemeka Okorie, Ginette Okoye

    
• • ·25925 Travel burden for free dermatologic care in uninsured and homeless populations

    Page :AB75

    Rahul Patel, Marie Vu, Jessica Wong, John Browning

    
• • ·25933 Tirbanibulin ointment 1% for actinic keratosis (AK): Pooled data from two phase 3 studies

    Page :AB76

    Andrew Blauvelt, Steven Kempers, Todd Schleisinger, Edward Lain, Hui Wang, David Cutler, Mark Lebwohl, Jane Fang, Rudolf Kwan

    
• • ·25934 Bimekizumab efficacy for moderate to severe plaque psoriasis across patient subgroups: Pooled results from 3 multicenter, randomized, double-blinded phase 3 trials

    Page :AB76

    Bruce Strober, Richard B. Warren, Peter Foley, Melinda Gooderham, Diamant Thaçi, Eva Cullen, Christopher Cioffi, Luke Peterson, Cynthia Madden, April Armstrong

    
• • ·25935 Phase I maximal use pharmacokinetic study of tirbanibulin ointment 1% in subjects with actinic keratosis (AK)

    Page :AB76

    Regina Yavel, J. Scott Overcash, Jay Zhi, David Cutler, Jane Fang

    
• • ·25942 Dupilumab-associated facial dermatitis: A case series

    Page :AB76

    David Milgraum, Marielle Jamgochian, Cindy Wassef, Amy Pappert

    
• • ·25951 Impact of teledermatology triage on provider workload within a managed care setting

    Page :AB77

    Adam Zakaria, Toby Maurer, Erin Amerson

    
• • ·25959 Clinical and histopathologic evolution of inflammatory linear verrucous epidermal nevus in a pediatric patient

    Page :AB77

    Margaret A. MacGibeny, David M. Milgraum, Nadiya Chuchvara, Babar K. Rao, Cindy Wassef

    
• • ·25971 Schedule frequency of chlormethine gel for patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): A real-world evidence study

    Page :AB77

    Christiane Querfeld, Gary Binder, Marco Turini, Deval Gor, Christina L. Wassel, Chris Pashos

    
• • ·25977 Selected infection topics in adult patients with moderate-to-severe atopic dermatitis treated with baricitinib

    Page :AB77

    Melinda Gooderham, Jamie Weisman, Orin Goldblum, Dennis Brinker, Maher Issa, Kristian Reich

    
• • ·25983 Rates of individual and composite cardiovascular events through 5 years of tildrakizumab exposure in 2 phase 3 clinical trials

    Page :AB78

    Cynthia Trickett, Robert Gniadecki, Darren T. West, Alan M. Mendelsohn, Stephen J. Rozzo, Sunil Dhawan

    
• • ·25984 Gastrointestinal adverse events related to study drug and leading to discontinuation through 5 years of tildrakizumab exposure in 2 phase 3 clinical trials

    Page :AB78

    Jennifer Conner, Boni E. Elewski, Amy Baum-Jones, Alan M. Mendelsohn, Stephen J. Rozzo, Melinda Gooderham

    
• • ·25985 Efficacy of tildrakizumab 100 mg for PASI improvement in patients with moderate to severe plaque psoriasis: Pooled analysis using nonresponder imputation from reSURFACE 1 and 2 through week 52

    Page :AB78

    Mark G. Lebwohl, Richard G.B. Langley, Rodney Sinclair, April W. Armstrong, Alan M. Mendelsohn, Stephen J. Rozzo, Jerry Bagel

    
• • ·25987 A randomized, evaluator-blinded, multicenter study to evaluate safety and effectiveness of a biostimulatory poly-L-lactic acid injectable implant after changes in reconstitution

    Page :AB78

    Melanie Palm, Susan Weinkle, Younghoon Cho, Brenda LaTowsky, Heidi Prather

    
• • ·25988 Acceptability of 20% aminolevulinic acid photodynamic therapy for treatment of actinic keratoses on the upper extremities in a phase 3, randomized, vehicle-controlled trial

    Page :AB79

    Brian Berman, Neal Bhatia, Daniel Piacquadio, Anna Houlihan, David Davidson, Daniel Siegel

    
• • ·25989 Effects of age, weight, or sex on the pharmacokinetics of a novel low-dose micronized-isotretinoin 32-mg formulation and lidose-isotretinoin 40 mg

    Page :AB79

    Sumit Madan, Sudershan Kumar, David Davidson

    
• • ·25991 Application of the statistical method to convert published PASI 50/75/90/100 into absolute PASI response rate in patients with moderate-to-severe plaque psoriasis treated with tildrakizumab based on data from two pivotal phase 3 studies (reSURFACE 1/2)

    Page :AB79

    Igor Dykukha, Andreu Schoenenberger, Ismail Kasujee, Ulrich Mrowietz, Reinhard Vonthein

    
• • ·25992 Long-term efficacy of tildrakizumab 100 mg by PASI 75/90/100 and PGA in a pooled analysis of reSURFACE 1 and reSURFACE 2 through up to 4 years of treatment

    Page :AB79

    J. Mark Jackson, Andrew Alexis, Kristine Kucera, Alan M. Mendelsohn, Stephen J. Rozzo, Joseph Gorelick

    
• • ·25993 Efficacy of long-term tildrakizumab for plaque psoriasis: PASI 50/75/90/100 and PGA for up to 5 years of treatment in reSURFACE 2

    Page :AB80

    Heather Roebuck, Aaron S. Farberg, Sameh Hanna, Alan M. Mendelsohn, Stephen J. Rozzo

    
• • ·25995 5-year efficacy of tildrakizumab 100 and 200 mg by PASI 50/75/90/100 and PGA in reSURFACE 1

    Page :AB80

    Andrew Blauvelt, Rodney Sinclair, Akihiko Asahina, Atsuyuki Igarashi, Alan M. Mendelsohn, Stephen J. Rozzo, Kimberly Eads, Scott Guenthner, Lyn Guenther

    
• • ·25996 Safety of tildrakizumab 100 mg and 200 mg through 5 years of exposure in reSURFACE 2

    Page :AB80

    Lorne Albrecht, George Han, Wendy Cantrell, Andrea Nguyen, Alan Mendelsohn, Stephen Rozzo

    
• • ·25997 Safety of tildrakizumab 100 mg and 200 mg through 5 years of exposure in reSURFACE 1

    Page :AB80

    Pablo Fernández-Peñas, Akihiko Asahina, Atsuyuki Igarashi, Jayme Heim, Alan Mendelsohn, Stephen Rozzo, Neal Bhatia

    
• • ·26003 An objective, quantitative assessment of flexible hyaluronic acid fillers in lip and perioral enhancement

    Page :AB81

    Vince Bertucci, Nowell Solish, Andreas Nikolis

    
• • ·26012 Clinicopathologic characteristics of melanoma in Parkinson disease patients

    Page :AB81

    Surya Ravichandran, Seth Flynn, Camille Robinson, Beiyu Liu, Cindy Green, Michelle Pavlis

    
• • ·26016 Combined modality therapies adjunctive to hedgehog inhibitors in the management of basal cell carcinoma: A systematic review and pooled-analysis

    Page :AB81

    Arsh Patel, Meenal Kheterpal, Jane Kim, Jason Liss, Lauren Howard, Sin-Ho Jung

    
• • ·26030 The impact of allergic sensitization and smoking on the association between urinary polycyclic aromatic hydrocarbons and the symptoms of atopic triad in the US population

    Page :AB81

    Sooyoung Kim, Kathryn A. Carson, Anna L. Chien

    
• • ·26032 Sustained and rapid improvements in patient reported outcomes for moderate-to-severe psoriasis patients with moderate and high BSA treated with ixekizumab: Side-by-side results from UNCOVER-3 and IXORA-S

    Page :AB82

    Jerry Bagel, Alice B. Gottlieb, Russel Burge, Kyoungah See, Alyssa Garrelts, Missy McKean-Matthews, Kim Papp

    
• • ·26033 Exacerbation and appearance of dermatosis during COVID-19 quarantine period in Bogotá, Colombia: A descriptive study of the psychological impairments

    Page :AB82

    David A. Castillo Molina, Jesus D. Fierro Lozada, Luisa F. Camacho-Lazaro, Mariana Reyes Rey, Daniela M. Molina Dorado, Maria Daniela Polania Tovar, Paula Andrea Chacon Jaramillo, Maria Juliana Sanchez Zapata, Nelson José Alvis-Zakzuk, Diana P. Cantillo

    
• • ·26043 In vitro evaluation of anti-inflammatory properties of a multifunctional sunscreen

    Page :AB82

    Francine Papaiordanou, Gabriela Pacheco de Oliveira, Jéssica Parolina Salvador, Flavia Cardoso Males, Antonio Carlos Amedeo Vatimo, Douglas Costa Morais, Stevin Zung

    
• • ·26071 Extensive Hailey-Hailey disease effectively treated with apremilast

    Page :AB82

    Shiva Kheradmand, Alex Harrison, Richard Miller

    
• • ·26085 Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial

    Page :AB83

    Kristina Callis Duffin, Linda Stein Gold, Craig Leonardi, David Pariser, Lawrence Green, Howard Sofen, Bruce Strober, Mindy Chen, Amgen Inc;Yao Wang, Kim Papp

    
• • ·26086 Gender-based stereotyping and cost discrepancies for razors

    Page :AB83

    Michelle J. Chang, Shari R. Lipner

    
• • ·26090 Clinical efficacy of a novel topical treatment for neck rejuvenation: A randomized, double-blind, regimen-controlled study

    Page :AB83

    Elizabeth T. Makino, Rahul C. Mehta

    
• • ·26094 A randomized, evaluator-blinded, comparator-controlled, study to evaluate safety and effectiveness of HARC for cheek augmentation and correction of midface contour deficiencies

    Page :AB83

    Derek Jones, Leslie Baumann, Amir Moradi, Sachin Shridharani, Melanie Palm, Craig Teller, Mark Taylor, Theda Kontis, Anne Chapas, Michael S. Kaminer, David Bank

    
• • ·26103 A randomized, evaluator-blinded, no-treatment controlled study to evaluate safety and effectiveness of LGP-HAL for correction of midface volume deficit/contour deficiency

    Page :AB84

    Alessandra Noguiera, Xiaojun Wang, Yan Wu, Bi Li, Xiongzheng Mu, Li Li

    
• • ·26118 Cutaneous Crohn masquerading as hidradenitis suppurativa

    Page :AB84

    Jacob Subash

    
• • ·26121 A case of light chain amyloidosis presenting as hair loss

    Page :AB84

    Ilana D. Breen, Meera H. Patel, Caitlin M. Brumfiel, Steven A. Nelson, Jeremy T. Larsen, Aaron R. Mangold

    
• • ·26138 Clinical utility and reliability of buccal mucosal biopsies for the diagnosis of ocular cicatricial pemphigoid in patients with isolated ocular disease

    Page :AB84

    Samantha Lopez, Jennifer Cao, Arturo Dominguez

    
• • ·26141 The risk of Mohs surgery complications in patients with preoperative beta-blocker use

    Page :AB85

    Rahul Raiker, Haig Pakhchanian, Min Deng

    
• • ·26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study

    Page :AB85

    Maryanne M. Senna, Amy J. McMichael, Tiffany T. Mayo, Julian Mackay-Wiggan, Marc Glashofer, Luna Sun, Guanglei Yu, Fabio P. Nunes, Jill S. McCollam, Wen-Shuo Wu, Brett King

    
• • ·26147 Beyond skin deep: Electronic case-based learning modules to teach multidisciplinary care in dermatology among clerkship students

    Page :AB85

    Chaocheng Liu, Vivienne Beard, Marlene Dytoc

    
• • ·26155 A lesser-known presentation of acute systemic lupus erythematosus

    Page :AB85

    Leïla Reguigui, Noreen Walsh, Kerri Purdy

    
• • ·26158 The patient-reported burden of alopecia areata by current severity: A real-world study in the US

    Page :AB86

    Russel Thomas Burge, Peter Anderson, Jennifer Austin, James Piercy, Laure Manuel, Emily Edson-Heredia, Jill Shwed McCollam, Maryanne Senna

    
• • ·26163 Risankizumab to treat psoriasis in a patient with hepatitis B and hepatitis C

    Page :AB86

    Ruby Lee, Yolanka Lobo, Lynda Spelman

    
• • ·26186 Efficacy and safety of continuous risankizumab every 12 weeks beyond 3 years of follow-up: An interim analysis of the LIMMitless open-label extension trial

    Page :AB86

    Kim A. Papp, Mark G. Lebwohl, Lluís Puig, Jiewei Zeng, Simone Rubant, Ranjeeta Sinvhal, Yiwei Zhao, Gabriela Alperovich, Craig Leonardi

    
• • ·26187 Clinical evaluation of skin uniformization and calming properties of a multifunctional sunscreen

    Page :AB86

    Francine Papaiordanou, Gabriela Pacheco de Oliveira, Jessica Parrolina Salvador, Antonio Carlos Amedeo Vatimo, Douglas Costa Morais, Stevin Zung

    
• • ·26188 Recurrence status, perineural invasion, lymphovascular invasion, and hypothyroidism are independently associated with lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck: A matched case-control study

    Page :AB87

    Marissa Lobl, Heng Jiang, Joshua Abels, Shera Feinstein, Shauna Higgins, Omeed Ahadiat, Erica Lee, Makenzie Hawkins, Myles Cockburn, Adam Sutton, Ashley Wysong

    
• • ·26189 Patient Satisfaction with Teledermatology during the Covid-19 Pandemic

    Page :AB87

    Judy Hamad, Amy W. Fox, Maria S. Kammire, Alison N. Hollis, Saif Khairat

    
• • ·26191 Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study

    Page :AB87

    Aaron S. Farberg, Karl Lewis, Meenal Kheterpal, Kurt Gebauer, Alexander Guminski, Carmen Loquai, Nicholas Squittieri, Ralf Gutzmer

    
• • ·26197 Efficacy and safety of risankizumab vs methotrexate in patients with moderate-to-severe plaque psoriasis: Results from the 28-week randomized, double-blind period of an ongoing phase 3 study in Brazil

    Page :AB88

    Tania F. Cestari, Cacilda daSilva Souza, Luna Azulay-Abulafia, Ricardo Romiti, André V.E. Carvalho, Caio César Silva de Castro, Silvio Alencar Marques, João Roberto Antonio, Lincoln Fabrício, Jasmina Kalabic, Luiza Keiko Oyafuso

    
• • ·26198 Evaluating patient outcomes in the BOLT 42-month trial using modified Response Evaluation Criteria in Solid Tumors methodology: Results from a preplanned analysis

    Page :AB88

    Reinhard Dummer, Aaron S. Farberg, James Spencer, Felix Kiecker, Alexander Guminski, Kurt Gebauer, Carmen Loquai, Caroline Robert, Nicholas Squittieri, Michael Migden

    
• • ·26200 Tumor burden in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma following treatment with sonidegib: Results of the 42-month BOLT study

    Page :AB89

    Michael Migden, Aaron S. Farberg, James Spencer, Felix Kiecker, Alexander Guminski, Kurt Gebauer, Carmen Loquai, Caroline Robert, Nicholas Squittieri, Reinhard Dummer

    
• • ·26202 Antineoplastic therapy after discontinuation of sonidegib 200 mg in patients with advanced basal cell carcinoma: Results from the 42-month, randomized, double-blind BOLT study

    Page :AB89

    Ralf Gutzmer, Alexander Guminski, Peter Foley, Anne Lynn S. Chang, Karl Lewis, Nicholas Squittieri, Carmen Loquai

    
• • ·26204 Hematology laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study

    Page :AB89

    Michael Migden, Karl Lewis, Alexander Guminski, Ralf Gutzmer, Carmen Loquai, Nicholas Squittieri, Peter Foley

    
• • ·26206 Effect of sonidegib on secondary tumor size endpoints through 12 weeks of treatment in patients with nevoid basal cell carcinoma syndrome

    Page :AB90

    John Lear, Axel Hauschild, Nicholas Squittieri, Nicole Basset-Seguin, Reinhard Dummer

    
• • ·26207 Data extraction accuracy in stage III melanoma from a clinical data warehouse

    Page :AB90

    Sandy François, Colin H. Adler, Nyla I. Flowers, Kendra B. Little, Michael C. Lowe, Suephy C. Chen, Howa Yeung

    
• • ·26211 Pharmacokinetics of sonidegib in patients with nevoid basal cell carcinoma syndrome

    Page :AB90

    John Lear, Axel Hauschild, Nicholas Squittieri, Nicole Basset-Seguin, Reinhard Dummer

    
• • ·26218 Skin cancer and sun protection practices in Fanconi anemia patients

    Page :AB90

    Jenna Ruggiero, Christina Boull

    
• • ·26229 Use of dupilumab for atopic dermatitis in young post-transplant patients: A case series of 2 patients

    Page :AB91

    Rachit Gupta, Sheilagh Maguiness, Christina Boull

    
• • ·26232 Cutaneous metastatic breast cancer in zosteriform distribution

    Page :AB91

    Baydon Hilton, Elizabeth Demaree, David Cleaver, Lloyd Cleaver

    
• • ·26237 Baricitinib, an oral, reversible Janus kinase-1 and -2 inhibitor, for atopic dermatitis: Head and neck response from BREEZE-AD5

    Page :AB91

    Robert Bissonnette, Neil Korman, Benjamin Lockshin, Na Lu, Yun-Fei Chen, Orin Goldblum, José Rueda, Yves Poulin

    
• • ·26245 Gastrointestinal Kohlmeier-Degos disease: What a dermatologist needs to know

    Page :AB91

    Samantha Sattler, Lee Shapiro

    
• • ·26248 Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study

    Page :AB92

    Alice B. Gottlieb, Joseph F. Merola, Kristian Reich, Frank Behrens, Weibin Bao, Pascale Pellet, Luminita Pricop, Iain B. McInnes

    
• • ·26260 Long-term treatment of plaque psoriasis with Cal/BD foam was locally well tolerated and not associated with skin atrophy

    Page :AB92

    Leon Kircik, Marie Holst Mørch, Bibi Petersen, Monika Liljedahl, Andreas Wollenberg

    
• • ·26262 M89, a dermocosmetic combining 89% Vichy volcanic mineralizing water and hyaluronic acid applied once daily for 4 weeks was effective and well tolerated after peeling procedures

    Page :AB92

    Elena Araviiskaia, Martina Kerscher, Julieta Spada, Cecilia Orlandi, Maryna Anfilova, Sonya Abdulla, Catherine Delva, Delphine Kerob, Monika Arenbergerova, Masha Sviatoslav Tuz, Jerry Tan

    
• • ·26266 M89: A combination of 89% Vichy volcanic mineralizing water and hyaluronic acid applied once daily for 4 weeks improves signs and symptoms of rosacea

    Page :AB93

    Jerry Tan, Julieta Spada, Cecilia Orlandi, Martina Kerscher, Maryna Anfilova, Sonya Abdulla, Anita Altmeyer, Catherine Delva, Delphine Kerob, Elena Araviiskaia

    
• • ·26268 M89, a combination of 89% of Vichy volcanic mineralizing water and hyaluronic acid improves signs and symptoms of subjects with rosacea/sensitive/reactive skin: Results from an open-label, observational, international study

    Page :AB93

    Jerry Tan, Julieta Spada, Martina Kerscher, Maryna Anfilova, Sonya Abdulla, Anita Altmeyer, Catherine Delva, Delphine Kerob, Elena Araviiskaia

    
• • ·26271 M89, a combination of 89% Vichy volcanic mineralizing water and hyaluronic acid, is an effective adjunct to skin care in management of rosacea

    Page :AB93

    Enzo Berardesca, Adriana Bonfigli, Bernard Cribier, Frederic Flament, Marco Vicic, Magali Breisse, Emilie Raynaud, Ingrid Durand, Sebastien Grégoire, Delphine Kerob, Jerry Tan

    
• • ·26274 A dermocosmetic used in combination with the fixed combination adapalene 0.1% and benzoylperoxide 5% helps to protect the skin barrier in mild to moderate acne

    Page :AB94

    Brigitte Dréno, Amir Khammari, Karine Duhamelle

    
• • ·26276 “Google investigates” sudden onset of skin darkening leading to the detection of a gastrointestinal cancer

    Page :AB94

    Aswatha Rabindranathnambi, Jasmine Mann, Bernard Norton

    
• • ·26279 In vitro efficacy of a topical formulation containing peptides and vitamin C developed for skin ageing

    Page :AB94

    Sergio Escobar, Noelia Sánchez-Marzo, Martín-Martínez Almudena, Audrey Valois, Marion Nielsen, Delphine Kerob

    
• • ·26284 The effect of vitamin D supplementation in atopic dermatitis: A systematic review and meta-analysis of randomized controlled clinical trials

    Page :AB94

    Andressa Lumi Akabane, Hirotada Kobayashi, Mohamedraed Soliman Elshami, Ugochukwu Uzoeghelu, SiQin Chen, Elie Massaad

    
• • ·26285 A rare case of congenital erythropoietic porphyria presenting with pulse oximeter–induced blisters

    Page :AB95

    Suzel Fournier, Isabelle Auger

    
• • ·26286 Familial multiple lipomatosis: A reported case and brief review of similar diagnoses characterized by multiple lipomas

    Page :AB95

    Hassie Cooper, Yasmin Hadian, Richard Miller

    
• • ·26290 Skin care & emPowerment for All: Wellness for women experiencing homelessness

    Page :AB95

    Haya S. Raef, Diana W. Bartenstein, Nicole M. Golbari, Zoe Burns, Lindsay McCormack, Jolie Jean, Jennifer K. Tan

    
• • ·26291 Rapid skin improvement with ixekizumab treatment for pediatric patients with psoriasis: Results from IXORA-peds

    Page :AB95

    Elizabeth Swanson, Lawrence Eichenfield, Claudia Rodriguez Capriles, Lingnan Li, Terri Ridenour, Alyssa Garrelts, Perla Lansang

    
• • ·26292 Rapid improvement in skin pain, and its impact on quality of life, in adult patients with moderate-to-severe atopic dermatitis from a double-blind, placebo-controlled baricitinib phase 3 study

    Page :AB96

    David Rosmarin, Scott Fretzin, Lindsay Strowd, Marta Casillas, Amy DeLozier, Zach Dawson, Sherry Chen, Na Lu, Jacob P. Thyssen

    
• • ·26294 Successful treatment of refractory plantar wart with duct tape

    Page :AB96

    Samantha Shwe, Aditi A. Sharma, Patrick K. Lee

    
• • ·26299 A case report of bullous pemphigoid in infancy

    Page :AB96

    Seth Thomas Howell, Ariana Eginli, Lindsay Strowd, Christine Ahn

    
• • ·26301 Pharmacokinetic analyses show limited systemic exposure with topical glycopyrronium tosylate

    Page :AB96

    D.M. Pariser, E.L. Lain, R. Mamelok, B. Aurora, D.R. Mould

    
• • ·26304 Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis with and without comorbid allergies or asthma

    Page :AB97

    Peter A. Lio, Jonathan M. Spergel, Michael J. Cork, Michael S. Blaiss, Aharon Kessel, Wendy C. Cantrell, John L. Werth, Michael A. O’Connell, Chuanbo Zang, Liza Takiya

    
• • ·26312 Lichen sclerosus associated with morphea in a patient treated with adalimumab

    Page :AB97

    Joshua M. Smith, Jonathan Jeter

    
• • ·26313 Efficacy and safety of dupilumab for up to 1 year in a phase 3 open-label extension (OLE) trial (LIBERTY AD PED-OLE) in adolescents with uncontrolled, moderate-to-severe atopic dermatitis (AD)

    Page :AB97

    Andrew Blauvelt, Emma Guttman-Yassky, Amy S. Paller, Eric L. Simpson, John Browning, Zhen Chen, Dimittri Delevry, Puneet Mahajan, John T. O’Malley, Ashish Bansal

    
• • ·26324 Association between nicotinamide use and perceived skin cancer reduction

    Page :AB97

    Mandy Majidian, Ronald Moy

    
• • ·26335 A retrospective case series of intravenous rituximab in Thai pemphigus patients

    Page :AB98

    Tanaporn Anuntrangsee, Kumutnart Chanprapaph, Silada Kanokrungsee, Kunlawat Thadanipon

    
• • ·26344 Recurrent reactive infectious mucocutaneous eruption (RIME) caused by human metapneumovirus

    Page :AB98

    Joyce Y. Kim, Shivani Reddy, Valentina B. Sosa, Lindsey Bennett

    
• • ·26355 Alopecia areata: A rare side effect of prazosin

    Page :AB98

    Varitsara Mangkorntongsaku, Chinthuran Thilagarajan, Fatemeh Arianejad, Vicki Howard, Saxon D. Smith, Simon D. Roger

    
• • ·26362 Cutaneous polyclonal plasmacytosis presenting with rhinophymatous change in an adult caucasian male treated with carbon dioxide laser

    Page :AB98

    Jacob G. Dodd, Cynthia Giraldo, David Myers, Allen Holmes, Brittany Lenz, Wendi Wohltmann, Chad Hivnor

    
• • ·26380 A case of cutaneous T-cell pseudolymphoma within a tattoo

    Page :AB99

    Esther Kim, Oluwakemi Onajin

    
• • ·26399 Evaluation of appropriateness of teledermatology triage decisions at a large safety-net hospital

    Page :AB99

    Adam Zakaria, Toby Maurer, Erin Amerson

    
• • ·26414 An uncommon presentation of Sweet syndrome

    Page :AB99

    Erika Watts, Valeria Gonzalez Molina, Deyson Lorenzo, Francisco Colón Fontanez, Julio Sanchez, Rafael Martin

    
• • ·26415 Regulation of postinflammatory hyperpigmentation by niacinamide through potential modulation of the protease inhibitor, SERPINB3

    Page :AB99

    Nirmala Nair, Maitreyee Dutta, Johnson Karu, Fei-Ling Lim, Anita Damodaran, Paul-Van-Der Logt

    
• • ·26419 Rainfall associated with increased melanoma among non-Hispanic whites

    Page :AB100

    Richard F. Wagner

    
• • ·26426 Comparison between risankizumab and guselkumab in rapidity of reporting significant clinical improvement and quality of life (as early as week 4) in severe bionaive psoriasis patients

    Page :AB100

    Ahmed Ameen

    
• • ·26432 A case of bullous porokeratosis–like eruption in the setting of Ehrlichia infection

    Page :AB100

    Amy Zavell, Kara Braudis

    
• • ·26433 Interventions for skin wellbeing clinics in for health care staff during the SARS-CoV2 outbreak: A perspective from London (UK)

    Page :AB100

    Nav Paul, Monika Saha, Marie-Louise Daly, Luigi Citarella, Antonia D’Cruz, Athina Fonia, Rachel Healy, Ljubomir Novakovic, Alison Shanks, Kavitha Sundararaj

    
• • ·26441 Palisaded and neutrophilic granulomatous dermatitis in a child

    Page :AB101

    Ayezel Munoz, Sarah Kesaria, Lindy Ross, Anthony Linfante

    
• • ·26452 Impact of COVID-19 on patient willingness to seek in-person dermatologic care

    Page :AB101

    Rima I. Ghamrawi, Esther A. Balogh, Matthew L. Hrin, Quan Pham, Jacob J. Subash, William W. Huang, Steven R. Feldman

    
• • ·26453 Squamoid eccrine ductal carcinoma of the nose requiring extensive resection and reconstruction

    Page :AB101

    Kristen T. Garvie, Wendi E. Wohltmann, Emily B. Wong

    
• • ·26474 The impact of adalimumab on the intimacy of hidradenitis suppurativa patients: Experience of a dermatology unit in Portugal

    Page :AB101

    Regina Caldas, Filipa Tavares Almeida, Maria José Guimarães, Ana Gabriela Lopes, Teresa Pereira, Celeste Brito

    
• • ·26480 Clinicopathologic correlation of perineurioma, including in a pediatric patient with unusual staining pattern

    Page :AB102

    Rachael Saporito, Brooke Burgess, Palak Parekh

    
• • ·26481 Sensory mononeuritis multiplex: A rare sequela of leukocytoclastic vasculitis

    Page :AB102

    Tanveer Singh Chohan, Sunita Odedra, Alena Salim, BMedSci

    
• • ·26486 Determining the risk of postoperative complications in substance use disorder patients undergoing Mohs surgery

    Page :AB102

    Haig Pakhchanian, Rahul Raiker, Vishal Patel

    
• • ·26495 Prognostic factors stratified by gender in desmoplastic melanoma: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database

    Page :AB102

    Joanne S. Jacob, Harry Dao

    
• • ·26503 Efficacy of combined hedgehog inhibitors with and without adjunctive therapy in the treatment of locally advanced basal cell carcinoma

    Page :AB103

    Akash D. Patel, Surya Ravichandran, Meenal Kheterpal

    
• • ·26508 Blastic plasmacytoid dendritic cell neoplasm

    Page :AB103

    Taylor Gray, Jesse Dewey, John Moesch, Raymond Knisley, George Gibbons, Richard Miller

    
• • ·26509 Interleukin-23 inhibitors for the treatment of psoriasis in the UK: Early experience of a single secondary care department

    Page :AB103

    Amy Livesey, Hywel Cooper

    
• • ·26514 Cutaneous leishmaniasis by nonnative species in Brazil

    Page :AB103

    Cindy Tiemi Matsumoto, Marília Marufuji Ogawa, Mílvia Maria Simões e Silva Enokihara, Samira Yarak

    
• • ·26537 Immunohistochemical pitfalls in poorly differentiated spindle-cell neoplasms

    Page :AB104

    Alvaro J. Ramos-Rodriguez, Camila Villa-Ruiz, Rafael F. Martín, Julio Sánchez-Pont

    
• • ·26540 Quality of life and willingness to pay in patients with seborrheic dermatitis attending an outpatient clinic in South Florida

    Page :AB104

    Flavia Valdes, Stephanie McNamara, David Castillo, Katlein França, Jonette Keri

    
• • ·26544 Acne and use of cosmetics: Results of questionnaire study

    Page :AB104

    Hwa Jung Ryu, Dong-Hye Suh, Hyun Joo Kim, Haneul Oh, Jae Yeong Jeong, Sang Jun Lee

    
• • ·26546 Allopurinol induced Stevens–Johnson syndrome/DRESS overlap: A rare manifestation

    Page :AB104

    José Cuesta Camuñas, Marely Santiago-Vázquez, Erika Watts, Osward Y. Carrasquillo, Julio E. Sánchez, Rafael F. Martín

    
• • ·26548 DaxibotulinumtoxinA for injection (DAXI) demonstrates consistent efficacy, duration, and safety in females independent of age: Subgroup analysis from a large, phase 3 program

    Page :AB105

    Glynis Ablon, Ava Shamban, Susan Weinkle, Susan H. Weinkle, Jessica Brown, Yan Liu

    
• • ·26549 Risk of malignancy associated with medication use in elderly patients with psoriasis

    Page :AB105

    Alexandra Finstad, S. Dresden Glockler-Lauf, Nouf Almuhanna, Refik Saskin, Raed Alhusayen

    
• • ·26550 DaxibotulinumtoxinA for injection (DAXI)–treated subjects show progressive improvement in static glabellar lines with repeated treatment

    Page :AB105

    Richard Glogau, Theda Kontis, Yan Liu, Conor J. Gallagher

    
• • ·26551 Photothermal therapy using gold nanoparticles on the acne in Asians: Preliminary study

    Page :AB105

    Hwa Jung Ryu, Dong-Hye Suh, Hyun Joo Kim, Tae Jun Park, Jae Yeong Jeong, Sang Jun Lee, Ko Eun Kim, Jong Heon Park

    
• • ·26555 Characterizing the skin and fecal microbiome in solid organ transplant recipients

    Page :AB106

    Megan V. Ha, Iman Salem, Mahmoud Ghannoum, Bryan T. Carroll

    
• • ·26558 Anxiety, depression, and quality of life in patients with chronic skin diseases

    Page :AB106

    Pasita Palakornkitti, Prinpat Pinyowiwat, Natta Rajatanavin

    
• • ·26565 The safety profile of thread lifts on the face and neck: An evidence-based systematic review

    Page :AB106

    Christine Pham, Sherman Chu, Delila Pouldar Foulad, Natasha Atanaskova Mesinkovska

    
• • ·26572 Effect of bilastine on chronic spontaneous urticaria (CSU) refractory to fexofenadine: Real world experience from India

    Page :AB106

    Dhiraj Dhoot, Hanmant Barkate, Gaurav Deshmukh

    
• • ·26573 Maintenance of response after guselkumab withdrawal in patients with moderate-to-severe psoriasis: A post hoc analysis of the VOYAGE 2 trial

    Page :AB107

    Curdin Conrad, Andreas Körber, Knut Schäkel, Diamant Thaçi, Gero Joks, Maria Jazra, Sven Wegner, Robert Wapenaar, Carle Paul

    
• • ·26574 Acne consultations: Recommendations for optimizing patient-centred care

    Page :AB107

    Alison M. Layton, Jerry Tan

    
• • ·26580 Efficacy of treatment with brodalumab after treatment failure of previous interleukin 17A inhibitors in patients with psoriasis

    Page :AB107

    Nikolai Loft, Anne Bregnhøj, Simon Fage, Claus Henrik Nielsen, Christian Enevold, Claus Zachariae, Lars Iversen, Lone Skov

    
• • ·26581 Maintenance of complete skin clearance throughout 3 years of continuous guselkumab treatment in patients with moderate-to-severe psoriasis: A post hoc analysis of 5-year data from the VOYAGE 1 trial

    Page :AB108

    Antonio Costanzo, Curdin Conrad, Talia Gramiccia, Maria Jazra, Elke M.G. J. de Jong, Lars Iversen, Bülent Öztürk, Robert Wapenaar, Sven Wegner, Tiago Torres, Luis Puig

    
• • ·26585 Baricitinib for the treatment of pediatric patients with moderate-to-severe atopic dermatitis

    Page :AB108

    Amy Paller, Chia-Yu Chu, Chin-Yi Yang, Jonathan Janes, Apurva Prakash, Maria Jose Rueda, Sarah Stanley, Wen-Shuo Wu, Xin Zhang, Lawrence Eichenfield

    
• • ·26588 Patient-reported outcomes from a large, North American-based cohort, highlight a greater disease burden for generalized pustular psoriasis vs plaque psoriasis: Real-world evidence from the Corrona Psoriasis Registry

    Page :AB108

    Bruce Strober, Nirali Kotowsky, Rose A. Medeiros, Nicole Foster, Judson Janak, Wendell C. Valdecantos, Mary Flack, Amanda K. Golembesky, Mark Lebwohl

    
• • ·26589 Spesolimab, an IL-36R inhibitor, may reduce symptoms of pain in patients with palmoplantar pustulosis – Results from a small pilot study

    Page :AB108

    Andreas Pinter, Christian Boisvert-Huneault, A. David Burden, Kristian Reich, Knut Schäkel, Hongjie Deng, Tristan Gloede, Frank Baehner, Robert Bissonnette, Ulrich Mrowietz

    
• • ·26590 Design and rationale of Effisayil 1, a Phase II, multicenter, randomized, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis with an acute flare

    Page :AB109

    Siew Eng Choon, Mark G. Lebwohl, Slaheddine Marrakchi, A. David Burden, Tsen-Fang Tsai, Akimichi Morita, Alexander A. Navarini, Hongjie Deng, Christian Thoma, Hervé Bachelez

    
• • ·26604 Clinical evaluation of the efficacy of a topical product containing sarcosine on subjects with normal to oily skin types residing in warm and humid environments

    Page :AB109

    Ana Du, Diana M. Gonzalez, Valerie Robert, Margarita Yatskayer

    
• • ·26607 Proactive management using Cal/BD foam in patients with plaque psoriasis prolongs time with a health-related quality of life improvement, compared with reactive management

    Page :AB109

    Linda Stein Gold, Ahmad Jalili, Dominique Lons Danic, Nanna Nyholm, Henrik Thoning, Piergiacomo Calzavara-Pinton

    
• • ·26611 Apremilast in the management of generalized granuloma annulare: A case series

    Page :AB109

    Jazmine Nesvik, David Cleaver, Jonathan Cleaver, Lloyd Cleaver, Leslie Marshall

    
• • ·26616 A comparison of case definitions for infant atopic dermatitis in a large multicenter study

    Page :AB110

    David X. Zheng, Ruth J. Geller, Lacey B. Robinson, Markus D. Boos, Carlos A. Camargo

    
• • ·26619 Appropriateness of a novel low ph 2% poly hydroxy acid-containing facial cleanser for patients with dry and sensitive Skin

    Page :AB110

    Rabab Hussain, Diana Friscia, Wen-Hwa Li, Ramine Parsa, Dara Miller, Thomas Shyr

    
• • ·26638 Risk stratification of patients with stage I cutaneous melanoma (CM) using 31-gene expression profiling (GEP)

    Page :AB110

    Ann Quick, Brian Martin, Christine Bailey, Kyle Covington, Robert Cook

    
• • ·26639 The utility of full thickness skin grafts in nasal reconstruction

    Page :AB110

    Joyce Chen, Nikita Gupta, Collin M. Costello, Carolyn Mead-Harvey, Katie L. Kunze, Juan C. Martinez, Shari A. Ochoa

    
• • ·26652 Patient and caregiver perspectives on treatment attributes for atopic dermatitis

    Page :AB111

    Joshua Zeichner, Steven R. Feldman, Claire Ervin, Rebecca Crawford, Emily Evans, Michael A. Zielinski, Joseph C. Cappelleri, Marco DiBonaventura, Liza Takiya, Daniela E. Myers

    
• • ·26653 Can ?-arrestin isoforms control response of melanoma cells to chemotherapy?

    Page :AB111

    Ada Girnita, Caitrin Crudden, Naida Suleymanova, Leonard Girnita

    
• • ·26654 Ixekizumab demonstrates greater medication adherence, persistence, and longer monotherapy duration than secukinumab, adalimumab, ustekinumab, and etanercept up to 3 years in the treatment of psoriasis: Real-world results

    Page :AB111

    Andrew Blauvelt, Baojin Zhu, Mwangi Murage, Jiaying Guo, Terri Ridenour, Mingyang Shan, Russel Burge

    
• • ·26667 Symmetrical intertriginous and flexural exanthema (baboon syndrome) induced by alcohol deterrent drug

    Page :AB111

    Alin Laurentiu Tatu, Diana Sabina Radaschin, Florin Ciprian Bujoreanu, Elena Niculet, Alin Laurentiu Tatu

    
• • ·26669 Addressing diversity in dermatology: How to be an ally

    Page :AB112

    Xavier Rice, Bianca Uzoma, Paige Hoyer, Lindy Ross

    
• • ·26677 Case of nodular amyloidosis in a type II diabetic

    Page :AB112

    Andrea Francis, Andrew M. Armenta, Nikoleta Brankov, Brent C. Kelly, Michael G. Wilkerson

    
• • ·26681 Noninvasive evaluation of density and diameter of dermal papillae in psoriatic and healthy skin: An intrapatient controlled study

    Page :AB112

    Francesco Lacarrubba, Anna Elisa Verzì, Davide Francesco Puglisi, Beatrice Nardone, Maria Letizia Musumeci, Giuseppe Micali

    
• • ·26682 Socioeconomic factors associated with receipt of sentinel lymph node biopsy for melanoma

    Page :AB112

    David X. Zheng, Melissa A. Levoska, Raghav Tripathi, Jeremy S. Bordeaux, Jeffrey F. Scott

    
• • ·26685 Transient bullous dermolysis of the newborn: An extremely rare entity presenting in two brothers

    Page :AB113

    Joseph Saad Aleshaki, Raminder Grover

    
• • ·26691 Rapid and concurrent improvements in the signs and symptoms of atopic dermatitis with baricitinib in the phase 3 study, BREEZE-AD5

    Page :AB113

    Peter Lio, Jennifer Soung, Jennifer Cather, Marta Casillas, Yuxin Ding, Amy M. De Lozier, Yun-Fei Chen, Eric Simpson

    
• • ·26698 Characteristics and disease burden in patients with mild to moderate vs severe plaque psoriasis in real-world settings: Results from the Corrona Psoriasis Registry

    Page :AB113

    Bruce Strober, Angel Cronin, Tin-chi Lin, Jaqueline O’Brien, Kelechi Emeanuru, Hyung-Joo Kang, Natalie Nunez Gomez, Ibrahim Khilfeh, Mark Lebwohl

    
• • ·26711 Impact of biopsy and provider training on diagnostic accuracy of cutaneous immune-related adverse events

    Page :AB113

    Jordan T. Said, Leah L. Thompson, Edward B. Li, Jaewon Yoon, Nira A. Krasnow, Gabriel E. Molina, Nicole J. Polyakov, Ruth K. Foreman, R. LeBoeuf, Steven T. Chen

    
• • ·26717 A randomized, no-treatment controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of HARD in the chin for augmentation and correction of chin retrusion

    Page :AB114

    Lisa Donofrio, Anne Chapas, Keith Marcus, Joely Kaufman, Glynis Ablon, Amir Moradi, Rebecca Kazin, Alexander Rivkin, Rod Rohrich, Robert Weiss, Rosalyn George

    
• • ·26718 Comparison of long-term treatment patterns between ixekizumab and secukinumab users among biologic-experienced psoriasis patients

    Page :AB114

    Andrew Blauvelt, Nianwen Shi, Russel Burge, Terri L. Ridenour, Najwa Somani, Baojin Zhu, Bilal Atiya, Carolyn R. Lew, Scott A. Kern, Nicole M. Zimmerman, Mwangi J. Murage

    
• • ·26726 A case of transient reactive papulotranslucent acrokeratoderma: Exploring the role of epidermal barrier dysfunction during the COVID-19 pandemic

    Page :AB114

    Victoria McCarver, Risa Ross, Richard Miller

    
• • ·26732 Efficacy and tolerability of a combination regimen with diamond tip dermabrasion and topical skincare in subjects with dry, hyperpigmented, photodamaged or acne/oily facial skin

    Page :AB114

    Lisa Goberdhan, MSHS, Katie Schneider, Elizabeth Makino, Rahul C. Mehta

    
• • ·26735 Lupus or leprosy? A tale of two diseases

    Page :AB115

    Cici Zhou, Kara Reardon, Pamela Allen

    
• • ·26738 Assessing the cosmetic changes in the facial skin using noninvasive RCM and OCT in vivo skin imaging instrumentation after use of a topical retinoid product in subjects with moderate to severe photodamage

    Page :AB115

    Lisa T. Goberdhan, Giovanni Pellacani, Marco Ardigo, Katie Schneider, Elizabeth T. Makino, Rahul C. Mehta

    
• • ·26750 Cumulative clinical benefits of biologic treatments for psoriasis over 1 year

    Page :AB115

    Andrew Blauvelt, Melinda Gooderham, Christopher E.M. Griffiths, Baojin Zhu, Russel Burge, Gaia Gallo, Jiaying Guo, Alyssa Garrelts, Mark Lebwohl

    
• • ·26772 Impact of receptivity to profoundness and intuition on treatment preferences in atopic dermatitis

    Page :AB115

    Quan Duc Minh Pham, Matthew L. Hrin, Rima I. Ghamrawi, Alan B. Fleischer, Steven R. Feldman

    
• • ·26775 Vancomycin-associated drug-induced hypersensitivity syndrome after IV therapy with vancomycin and implantation of a vancomycin-eluting spacer and absorbable beads

    Page :AB116

    Reid Oldenburg, Andrew Choi, Jeremy Schneider

    
• • ·26777 HPV vaccination status and resolution of verruca in pediatric patients

    Page :AB116

    Anuk Burli, Sarah Hancock, Yu Zhao, Deborah Paul, Maria Cordisco

    
• • ·26780 Patient experiences with teledermatology during the COVID-19 pandemic: A survey

    Page :AB116

    Samuel Yeroushalmi, Sarah Hannah Millan, Kamaria Nelson, Andrew Sparks, Adam Friedman

    
• • ·26808 A “mite-y” rash in a neonate

    Page :AB116

    Jaclyn Smith, Zachary Hopkins, Jessica Forbes, Carlos Nousari

    
• • ·26827 Reflectance confocal microscopy as a diagnostic tool of onychomycosis—Comparison of direct smear and culture methods in 60 patients

    Page :AB117

    Yejin Lee, Hye-Jin Ahn, Ki-Heon Jeong, Mu-Hyoung Lee, Min Kyung Shin

    
• • ·26828 Exaggerated arthropod assault in a child with sickle cell anemia: A novel association

    Page :AB117

    Jaclyn Smith, Bernice Baroudi, Jessica Forbes, Carlos Nousari

    
• • ·26834 Secukinumab demonstrated sustained effectiveness in moderate-to-severe plaque psoriasis across weight categories: 36-month data from PURE

    Page :AB117

    Kim Papp, Melinda Gooderham, Wei-Jing Loo, Hermenio Lima, Mark Lomaga, Vincent Ho, Jaggi Rao, Irina Turchin, Adriana Leticia LopezTello Santillan, Antonio Vieira, Lenka Rihakova

    
• • ·26838 Long-term proactive treatment of plaque psoriasis vulgaris with Cal/BD foam was associated with prolonged time in remission and reduced number of relapses

    Page :AB117

    Richard B. Warren, Kim A. Papp, Marie H. Mørch

    
• • ·26839 Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks

    Page :AB118

    Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham, David M. Pariser, Eric L. Simpson, Takafumi Etoh, Zhen Chen, Brad Shumel

    
• • ·26842 Long-term proactive management with Cal/BD foam is beneficial for all patients with psoriasis irrespective of baseline characteristics

    Page :AB118

    Mark Lebwohl, Marie Holst Mørch

    
• • ·26845 Toward novel depigmenting agents through repurposing existing drugs

    Page :AB118

    Juris Germanas, Kyonghee Kim, Tomas Germanas

    
• • ·26856 Proliferative nodule resembling angiomatoid Spitz with pronounced degenerative atypia arising within a giant congenital nevus

    Page :AB118

    Taylor L. Braunberger, Madeline Adelman, Tor A. Shwayder, Loren E. Clarke, Ben J. Friedman

    
• • ·26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

    Page :AB119

    Nina Magnolo, Külli Kingo, Vivian Laquer, John Browning, Adam Reich, Jacek C. Szepietowski, Deborah Keefe, Rafal Mazur, Prayashi Ghelani, Pascal Forrer, Manmath Patekar

    
• • ·26863 Porphyria cutanea tarda in a hemodialysis patient

    Page :AB119

    Margaret L. Snyder, Stephen P. Brady, Christine Kannler

    
• • ·26869 Atenolol as treatment for systemic hemangiomatosis in a premature infant

    Page :AB119

    Samuel Der Sarkissian, BMED, Ludi Ge, Helen Yiling Sun, Deshan Sebaratnam

    
• • ·26874 Long-term efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who were partial responders or nonresponders to etanercept: Post hoc analysis through 5 years from the reSURFACE 2 phase 3 trial

    Page :AB119

    Diamant Thaçi, Christopher E.M. Griffiths, Lars Iversen, Andrea Peserico, Ignasi Pau-Charles, Andrew Blauvelt, Kristian Reich

    
• • ·26875 52-week laboratory safety findings from an open-label extension (OLE) study of dupilumab in adolescent patients with atopic dermatitis (LIBERTY AD PED-OLE)

    Page :AB120

    Michael J. Cork, Benjamin Lockshin, Andrew Blauvelt, Zhen Chen, Faisal A. Khokhar, Ashish Bansal, Randy Prescilla

    
• • ·26876 Prevalence of scars: Results of the first international study

    Page :AB120

    Jean Michel Amici, Sophie Seitè, Caroline LeFloch, Charles Taïeb

    
• • ·26880 Long-term efficacy and safety data for dupilumab in a phase 3, open-label extension trial (LIBERTY AD PED-OLE) in patients aged ?6 to <12 years with uncontrolled, moderate-to-severe atopic dermatitis (AD)

    Page :AB120

    Michael J. Cork, Diamant Thaçi, Lawrence Eichenfield, Peter D. Arkwright, Zhen Chen, Dimittri Delevry, John T. O’Malley, Ashish Bansal

    
• • ·26881 Correlations between progesterone intrauterine device usage and dermatologic conditions

    Page :AB120

    Ananya Munjal, Patrick Ten Eyck, Chaorong Wu, Stephanie Radke, Jennifer Powers

    
• • ·26884 Ruxolitinib cream rapidly decreases pruritus in atopic dermatitis: Pooled results from two phase 3 studies

    Page :AB121

    Andrew Blauvelt, Jacek C. Szepietowski, Kim Papp, Eric L. Simpson, Jonathan I. Silverberg, Brian S. Kim, Shawn G. Kwatra, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Leon Kircik

    
• • ·26887 Effect of ruxolitinib cream on sleep disturbance and sleep impairment: Pooled analysis from two randomized phase 3 studies

    Page :AB121

    Eric L. Simpson, Mark Boguniewicz, Diamant Thaçi, Laurent Misery, Jonathan I. Silverberg, Lisa A. Beck, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Jacek C. Szepietowski

    
• • ·26892 Secondary cutaneous follicular center lymphoma presenting after use of topical fluorouracil for actinic keratosis

    Page :AB121

    Tyler Geers, Jeffrey P. Callen

    
• • ·26900 A phase 2b trial evaluating the efficacy of delgocitinib cream for the treatment of chronic hand eczema (CHE) using and validating the Hand Eczema Severity Index (HECSI)

    Page :AB121

    Per Soerensen, Per Soerensen, Philip Griffiths, Thor Schüett Svane Nielsen, Lotte Seiding Larsen, Katarina Resen, Tove Agner Prof

    
• • ·26901 The genetics of early-stage melanoma in a veteran population

    Page :AB122

    Kevin Cheung, Aaron D. Bossler, Sarah L. Mott, Megan Aadland, Julie McKillip, Brian L. Swick, Jennifer G. Powers

    
• • ·26908 The safety of isotretinoin treatment in patients with peanut or cashew allergies—A case series

    Page :AB122

    Noelle Lemons, Ahmed Yousaf, Zachary Zinn

    
• • ·26914 Ustekinumab-induced myositis: A case series

    Page :AB122

    Nneamaka Ezekwe, Josee Smith, Aunna Pourang, Iltefat Hamzavi

    
• • ·26916 Effectiveness of guselkumab among patients with moderate-to-severe plaque psoriasis in the Corrona Psoriasis Registry

    Page :AB122

    April W. Armstrong, Kristina Callis-Duffin, Timothy Fitzgerald, Amanda Teeple, Jonathan Uy, Mobolaji Olurinde, Katelyn Rowland, Robert R. McLean, Lin Guo, Ying Shan, Abby S. Van Voorhees

    
• • ·26918 Describing real-world pediatric psoriasis patients in the US and EU5

    Page :AB123

    Nadine Chapman-Rothe, Craig Richardson, Amie Scott, Haijun Tian, Fetske Van Der Meulen, Teresa Bachhuber, Steve Lobosco, James Lucas, Sophie Meakin, James Hetherington, James Piercy

    
• • ·26940 Microbiology and prescribing patterns of pediatric cellulitis by purulence and abscess presentation

    Page :AB123

    Sidharth Chand, Renajd Rrapi, Sarah Song, Colleen Gabel, Daniela Kroshinsky

    
• • ·26945 Purpuric pressure ulcers in hospitalized patients with COVID-19: A case series

    Page :AB123

    Sidharth Chand, Renajd Rrapi, Jennifer Lo, Sarah Song, Colleen Gabel, Niyati Desai, Mai Hoang, Daniela Kroshinsky

    
• • ·26955 Reporting on race and ethnicity in published onychomycosis clinical trials

    Page :AB123

    Michelle J. Chang, Shari R. Lipner

    
• • ·26957 A study of dermoscopic features in relation to vitiligo activity

    Page :AB124

    Jae-Ho Lee, Ji-An Uh, Joong-Ho Kim, Ho-Young Kim, Soo-Kyung Lee, Myoung-Shin Kim, Un-Ha Lee

    
• • ·26960 Economic burden of comorbidities in PsO patients

    Page :AB124

    Vardhaman Patel, Lauren Seigel, Anuj Jain, Greeta Jobson, Manasi Suryavanshi

    
• • ·26966 Tofacitinib treats unresponsive vitiligo and elevated thyroid peroxidase antibodies

    Page :AB124

    Angela Yen Moore, Samanna Maberry

    
• • ·26977 Synergistic blend of green tea and lotus protects against blue light-induced free radicals

    Page :AB124

    Hemali Gunt, Stanley B. Levy

    
• • ·26985 Infantile myofibromatosis: A rare case presenting on the chin of a 13-week-old boy

    Page :AB125

    Katelin Harrell, Summer Clark, Henry Haskell, Pamela Allen

    
• • ·26991 A decade to diagnose, a lifetime to treat: The time burden associated with basal cell carcinoma in patients with Gorlin syndrome

    Page :AB125

    Julie Breneiser, Alix Alderman, Srikanth Pendyala, Søren Holm

    
• • ·26993 Efficacy and safety of crisaborole by body region in infants with mild-to-moderate atopic dermatitis

    Page :AB125

    Joel Schlessinger, Julie S. Shepard, Douglass W. Forsha, Andrea L. Zaenglein, John L. Werth, Chuanbo Zang, Amy Cha, Liza Takiya

    
• • ·27000 The real-world burden of atopic dermatitis—Initial results from a multicountry study

    Page :AB125

    Kilian Eyerich, Philip Sugerman, Meijing Wu, Björn Fritz, Alan D. Irvine

    
• • ·27001 Practices and policies of skin cancer screening throughout history

    Page :AB126

    Milbrey Parke, Yuangao Liu, C. Helen Malone, Ikue Shimizu, Ida Orengo, Rajani Katta

    
• • ·27004 Evaluating the impact of risankizumab treatment withdrawal on predicted health-related quality of life in patients with moderate-to-severe plaque psoriasis using a machine learning model

    Page :AB126

    Kim A. Papp, Ahmed M. Soliman, Nicolae Done, Christopher Carley, Esteban Lemus Wirtz, Lluís Puig

    
• • ·27011 Dupilumab for treatment of atopic dermatitis in patients living with HIV

    Page :AB126

    Kelsey Nusbaum, Benjamin Kaffenberger, Michela Paradiso, Jennifer Sopkovich, Hala Daou, Lucia Seminario-Vidal, John Trinidad

    
• • ·27027 Mitigation of damage induced by environmental pollution by feverfew extract

    Page :AB126

    Frank Sun, Mark Benn, Katrina Bernhardt, Wen-Hwa Li, Fang Liu-Walsh, Anne Yuqing Yang

    
• • ·27030 Extended safety analysis of baricitinib 2-mg in adult patients with atopic dermatitis: An integrated analysis from 8 randomized clinical trials

    Page :AB127

    Brett King, Catherine Maari, Edward Lain, Jonathan I. Silverberg, Maher Issa, Katrin Holzwarth, Dennis Brinker, Tracy Cardillo, Fabio P. Nunes, Eric L. Simpson

    
• • ·27038 Efficacy of guselkumab using composite endpoints in patients with active psoriatic arthritis: Domain-specific efficacy from DISCOVER-1 and DISCOVER-2 phase 3 trials

    Page :AB127

    Laura C. Coates, Christopher T. Ritchlin, Laure Gossec, Philip S. Helliwell, Proton Rahman, Alexa P. Kollmeier, Chetan Karyekar, Shihong Sheng, Prasheen Agarwal, Philip J. Mease

    
• • ·27039 Is increased time to performing biopsies for melanoma associated with poorer outcomes? A single-institution, cohort study

    Page :AB127

    Sairekha Ravichandran, Isaac Briskin, Joshua Arbesman

    
• • ·27043 Achieving and maintaining long-term optimal improvements in patient-reported symptoms, signs, and quality of life among patients with moderate-to-severe psoriasis treated with guselkumab: 5-year data from VOYAGE 1

    Page :AB127

    Christopher E.M. Griffiths, Andrew Blauvelt, Chenglong Han, Pablo Fernandez-Penas, David N. Adam, Sandra Philipp, Michael Song, Megan Miller, Yin You, Richard G. Langley

    
• • ·27050 Efficacy of baricitinib 2-mg stratified by baseline body surface area in adults with moderate-to-severe atopic dermatitis

    Page :AB128

    Jonathan I. Silverberg, Mark Boguniewicz, Jill Waibel, Jamie Weisman, Lindsey Strowd, Luna Sun, Yuxin Ding, Orin Goldblum, Fabio P. Nunes, Eric L. Simpson

    
• • ·27062 Necrobiotic xanthogranulomas: 2 cases highlighting the refractoriness of this condition to treatment

    Page :AB128

    Marianne Rousseau-Théberge, Maude Lagacé, Hélène Veillette

    
• • ·27066 Angiosarcoma of the scalp and paraneoplastic encephalopathy: Multidisciplinary approach to diagnosis and treatment

    Page :AB128

    Joohee Han, Noah Goldfarb, Jonathan Koffel, Zhiyi Sha, Keith Skubitz, H. Brent Clark, Maria Hordinsky, Monica Rani, Elisabeth Hurliman

    
• • ·27078 Mediation analysis of independent treatment effect of guselkumab on health-related quality of life in patients with moderate to severe plaque-type psoriasis: Results from 2 phase 3 studies VOYAGE-1&2

    Page :AB128

    April W. Armstrong, Yan Liu, Nan Li, Kristian Reich, Peter Foley, Shu Li, Michael Song, Steven Fakharzadeh, Kim A. Papp, Chenglong Han

    
• • ·27081 Clinical characteristics of patients with psoriasis who initiated risankizumab and other biologics in the United States

    Page :AB129

    Huifang Liang, Xiaomeng (Gloria) Yue, Huifang Liang, Dongmu Zhang, Ranjeeta Sinvhal, Michelle Longcore, Ryan Kilpatrick

    
• • ·27082 Upadacitinib in moderate-to-severe atopic dermatitis: Combined safety analysis of phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)

    Page :AB129

    Emma Guttman-Yassky, Alan D. Irvine, Jonathan I. Silverberg, Kim A. Papp, Amy S. Paller, Brian Waterhouse, Allan R. Tenorio, Barry Ladizinski, Alvina D. Chu, John Liu, Kristian Reich

    
• • ·27099 Actinomyces infection within red pigment of a tattoo

    Page :AB129

    Angela Jiang, Holly Kerr

    
• • ·27101 Trends in utilization of palliative care for stage IV Merkel cell carcinoma in the United States

    Page :AB129

    Raghav Tripathi, Jeffrey F. Scott

    
• • ·27113 The importance of clinical trial knowledge and decision-making factors in eczema clinical trial participation

    Page :AB130

    Isabelle J.C. Thibau, Wendy Smith Begolka

    
• • ·27124 Impact of body mass index (BMI) on the efficacy and safety of halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion in patients with plaque psoriasis

    Page :AB130

    Mark G. Lebwohl, James Q. Del Rosso, Javier Alonso-Llamazares, Mark Lattouf, Abby Jacobson

    
• • ·27128 An atypical presentation of lymphomatoid papulosis in a child

    Page :AB130

    Victor Teran, Renat Ahatov, Antonio Jimenez, Bernard Gibson

    
• • ·27141 Patient-reported psoriasis symptoms stratified by sex and level of skin clearance in clinical trials of brodalumab

    Page :AB130

    Adelaide Hebert, Alice Gottlieb, Roger Ho, Abby Jacobson

    
• • ·27143 Cryotherapy as an adjuvant in the treatment with vismodegib for local advanced nonsurgical basal cell carcinoma: A report of 8 cases

    Page :AB131

    David A. Castillo Molina, Jesus D. Fierro Lozada, Ana María García C, Manuela A. Molano Pérez, Melissa Cantillo Avilez, Laura Guerrero-Roncancio, Sara Muñoz-Ordoñez, Isabella Campo Slebi, Nelson José Alvis-Zakzuk, David E. Castillo Saavedra, Diego M. Martinez Zuñiga

    
• • ·27144 Patient expectations and willingness with teledermatology

    Page :AB131

    Carey Kim, Abigail Cline, Yasaman Mansouri, Carlos Sarriera, Marian Russo

    
• • ·27147 Antimalarials as pre-exposure prophylaxis for COVID-19: A retrospective matched cohort study

    Page :AB131

    Nikolai Klebanov, Vartan Pahalyants, William S. Murphy, Jordan T. Said, Nicholas Theodosakis, Stacey Duey, R. Monina Klevens, Evelyn Lilly, Maryam Asgari, Yevgeniy R. Semenov

    
• • ·27154 Lichen planus pemphigoides in a patient recently started on lisinopril

    Page :AB131

    Robert Spaulding, Kristin Donovan, Soon Bahrami, Jeffrey P. Callen

    
• • ·27155 Analysis of the publication rate of abstracts presented at the Annual American Academy of Dermatology meeting in 2017

    Page :AB132

    Quoc-Bao Nguyen, Kyle Lauck, Caroline Starling, Anisha Patel

    
• • ·27165 Virtual teledermatopathology clinicopathologic correlation rounds for inpatient skin biopsies: A quality improvement project

    Page :AB132

    Zachary Wolner, Harrison Nguyen, Ha Eun Kong, Adam J. Perricone, Benjamin K. Stoff, Justin T. Cheeley

    
• • ·27169 Stretch marks gone wrong

    Page :AB132

    Mahima Bhayana, Becky Li, Ginette Okoye

    
• • ·27194 Lifetime history of total body skin examinations in patients with disabilities: Examining for differences in skin cancer screening

    Page :AB132

    Michael S. Chang, Linglin Huang, Arash Mostaghimi, Rebecca I. Hartman

    
• • ·27203 Psoriasis Area and Severity Index component scores in clinical trials of brodalumab

    Page :AB133

    Mark Lebwohl, Lawrence Green, G. Scott Drew, Abby Jacobson

    
• • ·27208 Achievement of body surface area treatment targets in clinical trials of brodalumab

    Page :AB133

    Bruce Strober, Erin Boh, Abby S. Van Voorhees, George Han, Nicole Rawnsley, Abby Jacobson

    
• • ·27237 Effect of abrocitinib vs dupilumab and placebo on patient-reported outcomes (PROs) in moderate-to-severe atopic dermatitis (AD) in JADE COMPARE

    Page :AB133

    Gil Yosipovitch, Jacob P. Thyssen, Carle Paul, Shawn G. Kwatra, Chia-Yu Chu, Ricardo Rojo, Hernan Valdez, Claire Feeney, Fan Zhang, Daniela E. Myers, Marco DiBonaventura

    
• • ·27250 A recurrent, painful, and vesicular rash in a dermatomal distribution

    Page :AB133

    Alfredo Siller, Joseph Jebain, Mojahed M.K. Shalabi, Nader Aboul-Fettouh, Stephen K. Tyring

    
• • ·27259 Cutaneous leishmaniasis in a recreational cave diver after travel to Mexico

    Page :AB134

    Alfredo Siller, Joseph Jebain, Benjamin Garcia, Evan J. Kipp, Melinda Hergert, Michael A. Lee, Stephen K. Tyring

    
• • ·27268 Progesterone-induced pseudoherpetic Grover disease

    Page :AB134

    Neda Shahriari, Katalin Ferenczi, Campbell Stewart

    
• • ·27275 Atopic dermatitis treated safely with dupilumab during pregnancy: A case report and review of the literature

    Page :AB134

    Yolanka Lobo, Ruby Lee, Lynda Spelman

    
• • ·27284 The effect of combined therapy of topical anesthesia and capsaicin ointment in prurigo nodularis management

    Page :AB134

    Naoko Hitosugi, Mohamed Abdelhakim, Daiya Ozaki

    
• • ·27291 Cryoglobulinemic vasculitis associated with Epstein–Barr virus infection: A case report

    Page :AB135

    Justina Guirguis, Fatemeh Jafarian

    
• • ·27300 Analysis of hidradenitis suppurativa hospitalizations by hospital teaching status

    Page :AB135

    Ehizogie Edigin, Precious Obehi Eseaton

    
• • ·27311 Regression of Merkel cell carcinoma after biopsy

    Page :AB135

    Michael Fong, Dustin Wilkes, Lloyd Cleaver

    
• • ·27313 The effect of the COVID-19 pandemic on patients’ perceptions of teledermatology

    Page :AB135

    Sophia Ly, Caroline Porter, Steven R. Feldman

    
• • ·27337 Perceived touch deprivation is associated with more cutaneous sensory symptoms in a nondermatologic sample

    Page :AB136

    Madhulika A. Gupta, Aditya K. Gupta

    
• • ·27346 Efficacy and safety from a phase II study of AUR101, a ROR? inhibitor in moderate-to-severe psoriasis (INDUS-2)

    Page :AB136

    Divyesh Mandavia, Sushil Pande, Suneel Vartak, Shyamal Balki, Shilendra Pandey, Sanjeev Giri, Murali Ramachandra

    
• • ·27350 Dupilumab improves Eczema Area and Severity Index regional scores across all anatomical regions in children aged 6–11 years with severe atopic dermatitis (AD)

    Page :AB136

    Amy S. Paller, Michael J. Cork, Danielle Marcoux, Andreas Wollenberg, Randy Prescilla, Zhen Chen, Ana B. Rossi, Brad Shumel

    
• • ·27362 High rate of complete response achieved with ligelizumab in patients with moderate to severe chronic spontaneous urticaria throughout the phase 2b core study

    Page :AB137

    Jonathan A. Bernstein, Marcus Maurer, Ana Giménez-Arnau, Weily Soong, Karl Sitz, Eva Hua, Nathalie Barbier, Avantika Barve, Thomas Severin, Reinhold Janocha

    
• • ·27366 LEKTI domain 6 reduces an inflammatory response induced by KLK5 in reconstructed skin and dendritic cells

    Page :AB137

    Pascal Canbolat, Sabine Kaessmeyer, Mark Sampson, Hans-Jürgen Mägert, Wolfgang Bäumer

    
• • ·27368 Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the BE VIVID bimekizumab in moderate to severe plaque psoriasis phase 3 trial

    Page :AB137

    Richard B. Warren, Richard G. Langley, Akihiko Asahina, Matthias Augustin, Joseph F. Merola, Alice B. Gottlieb, Valerie Ciaravino, Christopher Cioffi, Luke Peterson, Mark Lebwohl

    
• • ·27372 Meclozine, a novel anti-inflammatory therapeutic in C acnes–induced inflammation in vitro and in vivo

    Page :AB138

    Philippe Alain Grange, Guillaume Ollagnier, Carole Nicco, Philippe Morand, Anne-Geneviève Marcelin, Vincent Calvez, Nicolas Dupin

    
• • ·27373 Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the BE SURE bimekizumab in moderate to severe plaque psoriasis phase 3 trial

    Page :AB138

    Richard B. Warren, Matthias Augustin, Alice B. Gottlieb, Kristina Callis Duffin, Valerie Ciaravino, Christopher Cioffi, Luke Peterson, Andrew Blauvelt

    
• • ·27374 Bimekizumab efficacy in patients with moderate to severe plaque psoriasis receiving continuous bimekizumab or switching from adalimumab: Results from the phase 3 BE SURE trial

    Page :AB138

    Bruce E. Strober, Andreas Pinter, Richard B. Warren, Andrew Blauvelt, Michael Sebastian, Dirk De Cuyper, Veerle Vanvoorden, Maggie Wang, Cynthia Madden, Melinda Gooderham

    
• • ·27375 Dupilumab provides early and sustained improvement of sleep disturbance in children ? 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD

    Page :AB139

    Amy S. Paller, Eric L. Simpson, Lisa A. Beck, H. Chih-ho Hong, Danielle Marcoux, Zhen Chen, Brad Shumel, Ashish Bansal, Ana B. Rossi, Jingdong Chao

    
• • ·27376 Speed of clinical response and improvement in psoriasis with bimekizumab: Pooled results from the multicenter, randomized, double-blinded phase 3 BE VIVID, BE READY and BE SURE trials

    Page :AB139

    Mark Lebwohl, Philip Hampton, Akimichi Morita, Kristian Reich, Jo Lambert, Eva Cullen, Christopher Cioffi, Maggie Wang, Cynthia Madden, Richard Langley

    
• • ·27379 High resolution, dynamic imaging of collagen in skin cells using a bright reporter molecule

    Page :AB139

    Max Brown, Eleanor R. Casey, Olivia V. Kent, Boguslaw Obara, Michael J. Flagler, Matt Ehrman, Arto Maatta, Adam M. Benham, Tim J. Hawkins

    
• • ·27380 Bimekizumab efficacy in patients with moderate to severe plaque psoriasis during the randomized withdrawal and retreatment phase of BE READY, a phase 3 trial

    Page :AB139

    Andrew Blauvelt, Jashin J. Wu, Kristian Reich, Melinda Gooderham, Mark Lebwohl, Katy White, Nancy Cross, Christopher Cioffi, Kim A. Papp

    
• • ·27381 Phase III, randomized trial comparing clinical outcomes between patients with moderate-to-severe chronic plaque psoriasis receiving adalimumab reference product (RP) continuously vs those who switched between BI 695501 and adalimumab RP

    Page :AB140

    Alan Menter, Dorothy McCabe, Benjamin Lang, Jennifer Schaible, Sravan Kumar Eduru

    
• • ·27383 Bimekizumab response maintenance up to 1 year in patients with moderate to severe plaque psoriasis: Pooled results from three phase 3 trials

    Page :AB140

    Andrew Blauvelt, Yayoi Tada, Lars Iversen, Ulrich Mrowietz, Mark Lebwohl, Maggie Wang, Veerle Vanvoorden, Eva Cullen, Fabienne Staelens, Kim A. Papp

    
• • ·27389 Rapid and sustained improvement in itch in children aged 6–11 years with severe atopic dermatitis (AD) treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial

    Page :AB140

    Amy S. Paller, Elaine C. Siegfried, Gil Yosipovitch, Jonathan I. Silverberg, Jashin J. Wu, Zhen Chen, Randy Prescilla, Ana B. Rossi, Dimittri Delevry

    
• • ·27394 Dupilumab provides clinically meaningful improvement in atopic dermatitis (AD) signs, symptoms, and quality of life in children with severe AD: Results from the LIBERTY AD PEDS phase 3 clinical trial

    Page :AB141

    Amy S. Paller, Stephan Weidinger, Michael J. Cork, Danielle Marcoux, Norito Katoh, Haixin Zhang, Ana B. Rossi, Brad Shumel, Annie Zhang, Randy Prescilla, Jingdong Chao

    
• • ·27395 ANCA-positive hemorrhagic vasculitis with severe myositis—Atypical presentation of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

    Page :AB141

    Jette Hooper, Jun Lu

    
• • ·27403 Use of convolutional neural networks in skin lesion analysis using real world image and nonimage data

    Page :AB141

    Samantha Wong, Christine Park, Meng Xia, William Ratliff, Ricardo Henao, Meenal Kheterpal

    
• • ·27406 Dupilumab improves signs and symptoms of severe atopic dermatitis in children aged 6–11 years with and without comorbid asthma

    Page :AB141

    Mark Boguniewicz, Lawrence Sher, Amy S. Paller, Elaine C. Siegfried, Weily Soong, Zhen Chen, Randy Prescilla, Brad Shumel

    
• • ·27409 Tissue ulceration and necrosis secondary to extravasation of mitomycin chemotherapy

    Page :AB142

    Karolina Mieczkowska, Parth Patel, Bijal Amin, Adnan Mir, Rachel Blasiak, Ranon E. Mann, Shalom Kalnicki, Yevgeniy Balagula, Beth N. McLellan

    
• • ·27411 Investigation into the unique protection and correction potential of tinted moisturizing sunscreens for hyperpigmented and photodamaged facial skin

    Page :AB142

    Alisar S. Zahr, Thu Q. Nguyen, Tatiana Kononov

    
• • ·27414 A novel blend of neuromodulating peptides and gamma aminobutyric acid to regulate the release of acetylcholine

    Page :AB142

    Alisar S. Zahr, John Koch, Thu Q. Nguyen, Tatiana Kononov

    
• • ·27419 Laboratory safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: Results from an open-label extension (OLE) study

    Page :AB142

    Andrew Blauvelt, Andreas Wollenberg, Lisa A. Beck, Zhen Chen, Meng Zhang, Faisal A. Khokhar

    
• • ·27421 Analysis of differences in clinical features and diagnostic accuracy depending on location of poroma: Retrospective, multicenter study

    Page :AB143

    Seong Min Hong, Jong Uk Kim, Woo Jung Jin, So Hee Park, Un Ha Lee, Hai Jin Park, In Ho Park, So Young Jung, Jung Eun Seol, Hyojin Kim

    
• • ·27424 Infections in adults with moderate-to-severe atopic dermatitis treated with dupilumab: long-term data from an open-label extension (OLE) study

    Page :AB143

    Andrew Blauvelt, Andreas Wollenberg, Lawrence Eichenfield, Zhen Chen, Debra Sierka, Faisal A. Khokhar, Brad Shumel, Sonya L. Cyr

    
• • ·27426 A young man with an impressive ulcer on the chest

    Page :AB143

    Ethan Sagher, Anna Axelson

    
• • ·27430 Worldwide survey shows that atopic dermatitis is associated with a high disease burden in children

    Page :AB143

    Stephan Weidinger, Eric L. Simpson, Jonathan I. Silverberg, Sébastien Barbarot, Ana B. Rossi, Lysel Brignoli, Grece Saba, Sébastien Auziere, Dimittri Delevry, Laurent Eckert, Puneet Mahajan

    
• • ·27431 Dupilumab treatment improves health-related quality of life in children aged ?6 to <12 years with severe atopic dermatitis

    Page :AB144

    Alan Irvine, Mette Deleuran, Amy Praestgaard, Dimittri Delevry, Randy Prescilla, Ana B. Rossi

    
• • ·27437 Disseminated Candida tropicalis in an immunocompromised pediatric patient

    Page :AB144

    Tyler M. Andriano, Tagai Musaev, Holly Kanavy, Jack Jacob, Bijal Amin

    
• • ·27439 Expression of skin barrier-related genes and long-lasting moisturization by a natural hydration complex

    Page :AB144

    Hemali Gunt, Stanley B. Levy

    
• • ·27454 Efficacy and safety of long-term risankizumab re-treatment following drug withdrawal: IMMhance trial

    Page :AB144

    Richard G. Langley, Stephen K. Tyring, Atsuyuki Igarashi, Sandra Philipp, Jiewei Zeng, Christian Kaufmann, Andrew Blauvelt

    
• • ·27457 Secukinumab helps achieving clear/almost clear skin and improve quality of life in psoriasis over 36 months of treatment: PURE study

    Page :AB145

    Kim Papp, Melinda Gooderham, Michael Robern, Michael Shaffelburg, Dusan Sajic, Juan C. Garcia-Rodriguez, Carmen Taveras, Simon Nigen, Victoria Taraska, Antonio Vieira, Lenka Rihakova

    
• • ·27459 Protection potential of echinochrome A on UV damaged skin

    Page :AB145

    Seong Min Hong, Sang Woo Ahn, Jong Uk Kim, Gyeong Je Cho, Woo Jung Jin, So Hee Park, Jin Han, Hyojin Kim, Jung Eun Seol

    
• • ·27460 Teledermatology vs in-person dermatology consultations in the emergency department: A retrospective study of the Mayo Clinic experience from 2015-2019

    Page :AB145

    Alexander S. Hines, Jacqueline Zayas, David A. Wetter, Alina G. Bridges, Michael J. Camilleri, Marian T. McEvoy, Rokea A. el-Azhary, Mark.D.P. Davis, Julio C. Sartori-Valinotti

    
• • ·27462 Ex vivo efficacy of dermocosmetic containing peptides, salicylic acid, glycolic acid and vichy volcanic water in procollagen type I production

    Page :AB145

    Claudia Marçal, Priscila Correia, José Euzébio Gonçalves Junior, Beatriz Sant’Anna, Delphine Kerob

    
• • ·27464 Bimekizumab vs adalimumab in plaque psoriasis: Higher efficacy translates into improvements in quality of life in the BE SURE multicenter, randomized, double-blinded phase 3 trial

    Page :AB146

    Andrew Blauvelt, Diamant Thaçi, Kim A. Papp, Joseph F. Merola, Eva Cullen, Veerle Vanvoorden, Valerie Ciaravino, Luke Peterson, Kenneth Gordon

    
• • ·27468 Bimekizumab short-term and longer-term infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from eight phase 2/3 clinical trials

    Page :AB146

    Kristian Reich, Yukari Okubo, Kenneth B. Gordon, Andrew Blauvelt, April Armstrong, Dirk De Cuyper, Christopher Cioffi, Luke Peterson, Mark Lebwohl

    
• • ·27469 Accuracy of self-reported acne severity in a small study of 16 adolescents

    Page :AB146

    Peyton Morss-Walton, Jean S. McGee, Monica Rosales Santillan, Anthony Cukras, Martina L. Porter

    
• • ·27472 Onychomycosis: Patterns of systemic antifungal medication in practice

    Page :AB146

    Jong Uk Kim, Sang Woo Ahn, Seong Min Hong, Gyeong Je Cho, Woo Jung Jin, So Hee Park, Jung Eun Seol, Hyojin Kim

    
• • ·27473 Worldwide survey shows that atopic dermatitis in children is associated with a negative impact on their families

    Page :AB147

    Sébastien Barbarot, Jonathan I. Silverberg, Eric L. Simpson, Stephan Weidinger, Ashish Bansal, Ana B. Rossi, Lysel Brignoli, Tarek Mnif, Grece Saba, Dimittri Delevry, Puneet Mahajan

    
• • ·27475 Efficacy of the BIIB059 monoclonal antibody against BDCA2 in active cutaneous lupus erythematosus (CLE): Subgroup analyses of participants with or without systemic LE (SLE) and with different levels of disease activity

    Page :AB147

    Victoria P. Werth, Richard A. Furie, Filippa Nyberg, Howard Sofen, Benjamin F. Chong, Xiaobi Huang, Hua Carroll, Adam Meyers, Catherine Barbey, Cristina Musselli, Nathalie Franchimont

    
• • ·27476 Increased benefit of secukinumab vs ustekinumab in patients with psoriasis regardless of previous systemic psoriasis therapy: Pooled analysis of the phase 3 CLEAR and CLARITY trials

    Page :AB147

    Andrew Blauvelt, Stephen Tyring, Jerry Bagel, Elizabeth Nguyen, Xiangyi Meng, Torben Kasparek, Mark Lebwohl

    
• • ·27480 Effect of apremilast on quality of life, pruritus, and psoriasis in special areas after 52 weeks of therapy in biologic-naive patients with moderate plaque psoriasis who did not achieve a PASI-75 response: Real-world, prospective study in Greece –APRAISAL

    Page :AB148

    Markos Papakonstantis, Elizabeth Lazaridou, Ourania Neofotistou, Georgios Anastasiadis, Christina Kalinou, Panteleimon Aronis, Anastasia Protopapa, Ioanna Lefaki, Konstantinos Krasagakis, Theofanis Spiliopoulos

    
• • ·27482 Efficacy of ruxolitinib cream among patients with atopic dermatitis based on previous medication history: Pooled results from two phase 3 studies

    Page :AB148

    Andrew Blauvelt, Lawrence F. Eichenfield, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Jonathan I. Silverberg

    
• • ·27483 Evaluating the economic burden of iPLEDGE on female patients

    Page :AB148

    Nidhi Shah, Morgan Byrne, A. Yasmine Kirkorian

    
• • ·27489 Depth of response to abrocitinib in adults with moderate-to-severe atopic dermatitis (AD): Pooled analysis of monotherapy studies

    Page :AB148

    Sonja Ständer, Neal Bhatia, Melinda J. Gooderham, Jonathan I. Silverberg, Jacob P. Thyssen, Pinaki Biswas, Marco DiBonaventura, William Romero, Saleem A. Farooqui

    
• • ·27494 Novel high emollient hand sanitizers improve skin condition without compromising antiseptic efficacy

    Page :AB149

    Jane Tazzioli, Ashley Macguire-Flanagan, Carol Vincent, Toral Patel, Stacy Hawkins, Amy Qualls, Teanoosh Moaddel, Gabriella Frey, Lei Huang

    
• • ·27496 Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline patient demographics: Pooled subgroup analysis from two randomized phase 3 studies

    Page :AB149

    Kim Papp, Jacek C. Szepietowski, Leon Kircik, Darryl Toth, Lawrence F. Eichenfield, Seth B. Forman, April W. Armstrong, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Eric L. Simpson

    
• • ·27501 Comparing patient satisfaction between virtual and outpatient evaluation of hair disorders

    Page :AB149

    James T. Pathoulas, Mack T. Su, Kelly E. Flanagan, Chloe J. Walker, Isabel Pupo Wiss, Maryanne M. Senna

    
• • ·27505 Bimekizumab short-term and longer-term anxiety, depression, and suicidal ideation/behavior in patients with moderate to severe plaque psoriasis: Analysis of pooled data from eight phase 2/3 clinical trials

    Page :AB149

    Bruce Strober, Kim A. Papp, Andrew Blauvelt, Mark Lebwohl, Jashin J. Wu, Delphine Deherder, Cynthia Madden, Krista Wixted, Maggie Wang, Matthias Augustin

    
• • ·27506 Quality of life and pruritus over 52 weeks of apremilast treatment in biologic-naive patients with moderate plaque psoriasis: Results of a real-world, multicenter, prospective study in Greece (APRAISAL)

    Page :AB150

    Dimitrios Ioannides, Eleftheria Tampouratzi, Dimitrios Rigopoulos, Alexandros Drosos, Evangelia Rovithi, Evangelia Papadavid, Marina Papageorgiou, Ioannis Bassukas, Efterpi Zafiriou, Pantelis Panagakis

    
• • ·27516 Moving the needle with virtual education: Impact of chronic idiopathic urticarial education on patients and health care providers

    Page :AB150

    Carole Drexel, Wendy Turell, Allen P. Kaplan, Sanaz Eftekhari

    
• • ·27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis

    Page :AB150

    Bardur Sigurgeirsson, Knut Schäkel, Chih-Ho Hong, Isaak Effendy, Waldemar Placek, Phoebe Rich, Gerard Bruin, Pascal Charef, Rong Fu, Isabelle Hampele, Manmath Patekar

    
• • ·27523 Integrated safety analysis of abrocitinib for the treatment of moderate-to-severe atopic dermatitis (AD) from the phase 2 and phase 3 clinical trial program

    Page :AB150

    Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Min Zhang, Saleem A. Farooqui, Susan Johnson, Andrew Thorpe, Ricardo Rojo

    
• • ·27528 Safety and durability of collagenase Clostridium histolyticum-aaes treatment of cellulite in women: 6-month results of a 5-year phase 3b open-label extension study

    Page :AB151

    Michael H. Gold, Michael P. McLane, Saji Vijayan, Qinfang Xiang, Joely Kaufman-Janette

    
• • ·27529 Safety of guselkumab in patients with psoriatic arthritis through 1 year: Pooled findings from DISCOVER-1 and DISCOVER-2 phase 3 trials

    Page :AB151

    Christopher T. Ritchlin, Proton Rahman, Philip S. Helliwell, Wolf-Henning Boehncke, Iain McInnes, Alice B. Gottlieb, Alexa P. Kollmeier, May Shawi, Bei Zhou, Philip J. Mease

    
• • ·27538 Characteristics of patients with psoriasis differ by obesity status and history of metabolic comorbidities

    Page :AB151

    Clinton Enos, Vanessa Ramos, Tinchi Lin, Robert R. McLean, Nicole Foster, Blessing Dube, Abby S. Van Voorhees

    
• • ·27550 Durability of response to abrocitinib in patients with moderate-to-severe atopic dermatitis (AD) after treatment discontinuation in a phase 2b trial

    Page :AB151

    Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, Gary Chan

    
• • ·27551 Environmental impact of virtual isotretinoin monitoring

    Page :AB152

    Justin Lee, Ahmed Yousaf, Samantha Jenkins, Mohammed Tamim Zaki, Omar Abdul-Aziz, Zachary Zinn

    
• • ·27560 Interpreting the relationship between pruritus, sleep, and work productivity: Results from JADE MONO-2

    Page :AB152

    Melinda J. Gooderham, Sonja Ständer, Jacek C. Szepietowski, Giampiero Girolomoni, Andrew G. Bushmakin, Joseph C. Cappelleri, Pinaki Biswas, Claire Feeney, Gary Chan, Marco DiBonaventura, Daniela E. Myers

    
• • ·27567 Clinical management of ocular events with topical glycopyrronium tosylate in the treatment of primary axillary hyperhidrosis

    Page :AB152

    D.A. Glaser, R. Gopalan, N.C. Visitacion

    
• • ·27571 Dupilumab provides clinically meaningful responses in adults with moderate-to-severe atopic dermatitis (AD): Results from LIBERTY AD CHRONOS study

    Page :AB152

    Jonathan I. Silverberg, Eric L. Simpson, Marjolein de Bruin&, Peter Foley, Yoko Kataoka, Zhen Chen, Brad Shumel, Ana B. Rossi, Debra Sierka, Jingdong Chao

    
• • ·27582 Abrocitinib improves work productivity through improvement in pruritus and sleep: Results from the JADE MONO-2 study in patients with moderate-to-severe atopic dermatitis (AD)

    Page :AB153

    Gil Yosipovitch, Mette Deleuran, John Su, Luz Fonacier, Andrew G. Bushmakin, Joseph C. Cappelleri, Claire Feeney, Andrew Thorpe, Ricardo Rojo, Hernan Valdez, Daniela E. Myers

    
• • ·27586 Beyond digital pathology: A portable microscope for painless, real-time examination of skin histopathology without biopsy

    Page :AB153

    Gabriel Sanchez, Piyush Arora, Kate Montgomery

    
• • ·27591 Quantification of the area of affection and inflammation of hidradenitis suppurativa using a dedicated mobile app

    Page :AB153

    Jose Ramirez-GarciaLuna, Sheila C. Wang, Justin Allport, David Croitoru, Rashie Brar, Afsaneh Alavi

    
• • ·27594 Impact of guselkumab on fatigue and mediation analysis of independent treatment effect of guselkumab on fatigue in patients with active psoriatic arthritis: Results from DISCOVER-1&2

    Page :AB153

    Proton Rahman, Philip S. Helliwell, Atul Deodhar, Alexa P. Kollmeier, Elizabeth Hsia, Bei Zhou, Xiwu Lin, Chenglong Han, Ya-Wen Yang, Philip J. Mease

    
• • ·27595 Neurokinin-1 receptor antagonist tradipitant improves itch associated with mild atopic dermatitis: Results from EPIONE, a randomized clinical trial

    Page :AB154

    Jennifer L. Brzezynski, Alyssa R. Kaden, Michael A. Mohrman, Jingyuan Wang, Sandra P. Smieszek, Bartlomiej Przychodzen, Changfu Xiao, Christos Polymeropoulos, Gunther Birznieks, Mihael H. Polymeropoulos

    
• • ·27596 Improvement in absolute psoriasis area and severity index through 5 years of continuous treatment with guselkumab in the VOYAGE 1 trial

    Page :AB154

    Luis Puig, Bruce Strober, Tsen-Fang Tsai, Diamant Thaçi, Melinda Gooderham, Megan Miller, Ya-Wen Yang, Yin You, Yaung-Kaung Shen, Andrew Blauvelt

    
• • ·27599 Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE

    Page :AB154

    Bardur Sigurgeirsson, John Browning, Stephen Tyring, Jacek C. Szepietowski, Raquel Rivera-Díaz, Isaak Effendy, Gerard Bruin, Bertrand Paguet, Rong Fu, Isabelle Hampele, Manmath Patekar

    
• • ·27601 Delivering nutrient benefits from cleansers to the skin through enhanced ceramide production and continuous nourishment

    Page :AB154

    Galina Yarova, Kevin Hermanson, William Lathrop, Dawn Mihalov, John Bajor, Stacy Hawkins, Bivash Dasgupta

    
• • ·27602 Long-term efficacy and safety of once-daily topical efinaconazole 10% topical solution (Jublia) for dermatophyte toenail onychomycosis: An interim analysis

    Page :AB155

    Aditya K. Gupta, Elizabeth A. Cooper

    
• • ·27603 Rapid itch relief with abrocitinib predicts later skin clearance: A post hoc analysis vs dupilumab and placebo in JADE COMPARE

    Page :AB155

    Sonja Ständer, Gil Yosipovitch, Eric L. Simpson, Shawn G. Kwatra, Jacob P. Thyssen, Hernan Valdez, Ricardo Rojo, Marco DiBonaventura, Fan Zhang, Michael Cameron, Claire Feeney

    
• • ·27604 Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial

    Page :AB155

    Justin Ko, Janet Roberts, Maria Hordinsky, Susan Taylor, Arash Mostaghimi, Chiara Chiasserini, Yuxin Ding, Yun-Fei Chen, Wen-Shuo Wu, Yves Dutronc

    
• • ·27605 Annular atrophic lichen planus: A rarity seen in pediatric dermatology

    Page :AB155

    Samantha M. Sears, Patricia S. Todd, Andrea S. Burch

    
• • ·27608 A new subset of Kaposi sarcoma in immunocompetent, HIV-negative Latin Americans

    Page :AB156

    Connor Stonesifer, Megan Trager, Alexandra Coromilas, Mark Strom, Dawn Queen

    
• • ·27611 Fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion for the treatment of plaque psoriasis in patients with 3-5% body surface area (BSA) and poor quality of life (QoL)

    Page :AB156

    Linda Stein Gold, Edward Lain, Jerry Bagel, Abby Jacobson

    
• • ·27615 Impact of body mass index (BMI) on efficacy of three topical acne treatments in patients with moderate-to-severe acne

    Page :AB156

    Fran Cook-Bolden, Fran E. Cook-Bolden, Lawrence Green, Jonette Keri, Leon Kircik, Hilary Baldwin, William P. Wershchler, Eric Guenin, Varsha Bhatt, Radhakrishnan Pillai

    
• • ·27619 Hemifacial hyperhidrosis as the presenting sign of thoracic disc herniation

    Page :AB156

    Daniel Tinker, Daniel ODonoghue, Erin Petersen, Dee Anna Glaser

    
• • ·27620 Effects of ruxolitinib cream in patients with atopic dermatitis with baseline body surface area ?10% and Eczema Area and Severity Index score ?16: Pooled results from two phase 3 studies

    Page :AB157

    Eric L. Simpson, Leon Kircik, Andrew Blauvelt, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Lawrence F. Eichenfield

    
• • ·27624 U.S. academic dermatologists’ attitudes and perceptions toward chaperone use during genital examinations

    Page :AB157

    Jalal Maghfour, Lauren Chen, Justin Olson, Catherine Roach, Andrea Murina

    
• • ·27629 Malignancy rates through 4 years of follow-up in guselkumab-treated moderate to severe psoriasis patients from the VOYAGE 1 and 2 trials and comparisons to the general United States population

    Page :AB157

    Kim A. Papp, Kristian Reich, Kenneth B. Gordon, Mark Lebwohl, Michael Song, Megan Miller, Paraneedharan Ramachandran, Yaung-Kaung Shen, Connie B. Lin, Andrew Blauvelt

    
• • ·27630 Assessing signs and symptoms of hidradenitis suppurativa from the patient perspective

    Page :AB157

    Afsaneh Alavi, Iltefat H. Hamzavi, Sarah Baradaran, Susan D. Mathias, Hilary H. Colwell, Michael Song, Chenglong Han

    
• • ·27633 Efficacy and safety of ruxolitinib cream among adolescents with atopic dermatitis: Pooled Results from two phase 3 studies

    Page :AB158

    Lawrence F. Eichenfield, Eric L. Simpson, Elaine C. Siegfried, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Amy S. Paller

    
• • ·27636 Addition of narrow-band ultraviolet light B phototherapy to ruxolitinib cream in patients with vitiligo

    Page :AB158

    Amit G. Pandya, John E. Harris, Mark Lebwohl, Iltefat Hamzavi, Kathleen Butler, Fiona Kuo, Shaoceng Wei, David Rosmarin

    
• • ·27641 Achieving remission of relapsing polychondritis: A case series observing diagnostic and therapeutic approaches

    Page :AB158

    Kayla Hitarra Felix, Rechelle Z. Tull, Emily R. Shealy, Leah Cardwell, Joseph Jorizzo, William Huang

    
• • ·27646 Hypocomplementemic urticarial vasculitis presenting with angioedema

    Page :AB158

    Dianne Carrasquillo-Bonilla, Karina Cancel-Artau, Rocio Cardona-Muñoz, Rafael F. Martin-Garcia, Julio E. Sanchez

    
• • ·27660 Parasite infection in a patient with a CD30 clonal T-cell lymphocytic variant of hypereosinophilic syndrome: Cause or coincidence

    Page :AB159

    Daniel Ramos-Rodriguez, Joan Garcias-Ladaria, María Nuñez Sanchez, María Peñaranda, Antonio Gutierrez, Juan Escalas Taberner

    
• • ·27662 National estimates and predictors of emergency department utilization for impetigo among the United States pediatric population

    Page :AB159

    Emma R. Russell, Raghav Tripathi, Bryan T. Carroll

    
• • ·27697 Long-term efficacy, safety, and adherence to tralokinumab treatment in moderate-to-severe atopic dermatitis for up to 3 years: Interim readout of ECZTEND, a phase 3, long-term extension trial

    Page :AB159

    Andrew Blauvelt, Jean-Philippe Lacour, Darryl Toth, Vivian Laquer, Stefan Beissert, Andreas Wollenberg, Pedro Herranz, Andrew Pink, Ketty Peris, Hidehisa Saeki

    
• • ·27701 Clinical recommendations to address dermatologic healthcare disparities in HIV-positive lesbian, gay, bisexual, and transgender (LGBT) patients

    Page :AB159

    Antonio Jimenez, Paige Hoyer, Claire Culbertson, Lindy Ross

    
• • ·27702 Crosstalk between HIF-1? and SIRT-1 is bolstered by the natural ingredient bakuchiol but not retinol

    Page :AB160

    Hemali Gunt, Manpreet Randhawa, Krzysztof Bojanowski, Ratan K. Chaudhuri

    
• • ·27716 Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies

    Page :AB160

    Kim Papp, Jacek C. Szepietowski, Leon Kircik, Darryl Toth, Lawrence F. Eichenfield, Seth B. Forman, Diamant Thaçi, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Eric L. Simpson

    
• • ·27722 Biologic initiation rates in psoriasis after first-line systemic use of apremilast vs methotrexate

    Page :AB160

    Ibrahim Khilfeh, Jessie Yan, Eunice Chang, Michael S. Broder, Natalie Nunez-Gomez, David L. Kaplan

    
• • ·27736 Painful retiform purpura with cutaneous necrosis

    Page :AB160

    Alfredo Siller, Joseph Jebain, Yomna Amer, Christopher T. Haley, Leon Chen, Stephen K. Tyring

    
• • ·27737 The clinical spectrum of primary cutaneous CD4 + small/medium-sized pleomorphic T-cell lymphoproliferative disorder: An updated systematic literature review and case series

    Page :AB161

    Philip Surmanowicz, Sean Doherty, Arunima Sivanand, Nikoo Parvinnejad, Jean Deschenes, Michelle Schneider, Robert Gniadecki

    
• • ·27742 From the inside-out: A more effective way of delivering ceramides to the stratum corneum – an in silico simulation study

    Page :AB161

    Nandou Lu

    
• • ·27777 Examining the risk of postoperative Mohs surgery complications in patients with history of glucocorticoid use

    Page :AB161

    Haig Pakhchanian, Rahul Raiker, Min Deng

    
• • ·27782 Retrospective chart review of dermatologic disorders in an underserved New York City population

    Page :AB161

    Jose W. Ricardo, Jonas A. Adalsteinsson, Jonathan Ungar

    
• • ·27804 A cross-sectional study on the association between COVID-19 infection and hospitalization in patients with alopecia areata

    Page :AB162

    Niki Nourmohammadi, Fiore Casale, Katerina Yale, Alessandro Ghigi, Kai Zheng, Natasha Mesinkovska

    
• • ·27817 Dermatomyositis mimicking hypertrophic lichen planus

    Page :AB162

    Lorin Bibb, Kristin Torre, Jun Lu

    
• • ·27826 Cervicofacial actinomycosis: A unique diagnostic challenge in a middle-aged male.

    Page :AB162

    Brett Brazen, Lisa Fronek, Richard Miller

    
• • ·27828 Oxygen-enriched operating rooms and surgical fires: An underestimated risk of ambulatory dermatologic surgery

    Page :AB162

    Antonio Jimenez, Paige Hoyer, Julie Croley, Richard F. Wagner

    
• • ·27832 Impact of facial and truncal acne on quality of life (QoL) in female adults: A multicountry population-based survey

    Page :AB163

    Brigitte Dréno, Stefan Beissert, Fran E. Cook-Bolden, Rajeev Chavda, Julie C. Harper, Adelaide A. Hebert, Edward Lain, Alison Layton, Marco Rocha, Jonathan S. Weiss, Jerry K.L. Tan

    
• • ·27833 Impact of facial atrophic acne scars on quality of life (QoL) in female adults: A multicountry population-based survey

    Page :AB163

    Brigitte Dréno, Stefan Beissert, Fran E. Cook-Bolden, Rajeev Chavda, Julie C. Harper, Adelaide A. Hebert, Edward Lain, Alison Layton, Marco Rocha, Jonathan S. Weiss, Jerry K.L. Tan

    
• • ·27847 Guselkumab (GUS) efficACy in TNF-inhibitor-experienced and TNF-inhibitor-naïve patients with active psoriatic arthritis (PsA): Results of a phase 3, randomized, controlled study

    Page :AB163

    Christopher T. Ritchlin, Atul Deodhar, Wolf-Henning Boehncke, Enrique R. Soriano, Alexa P. Kollmeier, May Shawi, Ya-Wen Yang, Shihong Sheng, Prasheen Agarwal, Philip S. Helliwell

    
• • ·27859 Maintenance of response through up to 5-years of continuous guselkumab treatment of psoriasis in the VOYAGE 2 phase 3 trial

    Page :AB163

    Kristian Reich, April W. Armstrong, Richard Langley, Ron Vender, Peter Foley, Michael Song, Yin You, Yaung-Kaung Shen, Kenneth B. Gordon

    
• • ·27862 Trifarotene transcriptomics analysis and acne-related gene expression

    Page :AB164

    Jayendra Kumar Krishnaswamy, Jean Philippe York, Rajeev Chavda, Sandrine Blanchet-Réthoré, Brigitte Dréno

    
• • ·27874 Correlation of itch response to roflumilast cream with disease severity and patient-reported outcomes in patients with chronic plaque psoriasis

    Page :AB164

    Linda Stein Gold, Javier Alonso-Llamazares, Zoe D. Draelos, Melinda J. Gooderham, Steven E. Kempers, Mark G. Lebwohl, Darryl P. Toth, Gil Yosipovitch, Robert C. Higham, Lynn Navale, David R. Berk

    
• • ·27876 The PASI-HD improved precision in measuring disease severity in subjects with mild to moderate plaque psoriasis treated with roflumilast cream, a phosphodiesterase-4 inhibitor

    Page :AB164

    Kim A. Papp, Mark G. Lebwohl, Leon Kircik, David Pariser, Bruce Strober, Gerald Krueger, David R. Berk, Lynn Navale, Robert C. Higham

    
• • ·27880 Differences in pediatric vs adult clinical trial designs for atopic dermatitis

    Page :AB164

    Gaurav Agnihotri, Peter A. Lio, Kachiu C. Lee

    
• • ·27884 A multicenter clinical study to evaluate the efficacy and tolerance of a benzoyl peroxide and retinol regimen in the treatment of mild to moderate acne vulgaris

    Page :AB165

    Gabby Kosmoski, Dara Miller, Heather Smith, Evren Atillasoy, Catherine Coret

    
• • ·27885 An optimized formulation of retinol with a specific sensory profile upregulates antiaging biomarkers for both prevention and rejuvenation of the skin

    Page :AB165

    Daphne Meza, Ruchi Patel, Anisa Rahim, Melissa Tang, Jasmine Tan, Wen Ni Tan, Josh Zhang, Ramine Parsa

    
• • ·27886 Optimized delivery of a novel acetyl dipeptide provides clinical and consumer perceivable benefits to antiaging attributes of the lower face, including firming and jawline contour

    Page :AB165

    Brenda L. Edison, Neena K. Tierney, Heather A. Smith, Allison Rush, Derrick Chua, Marisa Dufort, Barbara A. Green, Clara Milikowski, Patricia Farris

    
• • ·27887 Skin exfoliation with low concentrations of alpha hydroxy acids and poly hydroxy acids when incorporated into wash-off or leave-on products using a novel abbreviated model to measure cell turnover rate

    Page :AB165

    Brenda L. Edison, Heather A. Smith, Barbara A. Green, Neena K. Tierney

    
• • ·27890 Chelation properties demonstrated by a novel analytical method help elucidate polyhydroxy acids benefits for environmental oxidative stress and pigmentation

    Page :AB166

    Marisa Dufort, Hong Li, Fa Zhang, Fang Liu-Walsh, Brenda L. Edison, Neena K. Tierney

    
• • ·27891 Safety and efficacy of an Avena sativa (oat) skin care regimen for therapy-related xerosis and pruritus in adult oncology patients undergoing systemic cancer treatments

    Page :AB166

    Judith Nebus, Adegboyega Adenaike, Tony McGuire, Toni Anne Lisante, Lisa Caratelli, Neena K. Tierney, Oluwaseun Kukoyi, Thomas Brinkman, Kwami Ketosugbo, Sarah Noor, Mario E. Lacouture

    
• • ·27892 Tolerance and effectiveness of a gel cream containing oat and feverfew on capsaicin sting positive dry sensitive skin

    Page :AB166

    Cecelia Li, Xiaojing Gu, Daisy Xiong

    
• • ·27893 An advanced oil composition containing stabilized retinol with enhanced bioactivity using neocitrate

    Page :AB166

    Daphne Meza, Michael Chang, Ruchi Patel, Star Walsh, Anne-Sophie Brillouet, Ramine Parsa

    
• • ·27900 Maintaining long-term improvements in patient-reported symptoms, signs, and quality of life among patients with moderate to severe plaque psoriasis treated with guselkumab: VOYAGE 2, 5-year data

    Page :AB167

    April W. Armstrong, Kenneth B. Gordon, Lynda Spelman, Kim A. Papp, Chenglong Han, Michael Song, Yin You, Luis Puig, Laura K. Ferris, Kristian Reich

    
• • ·27905 Factors affecting outcomes with Mohs surgery for rare tumors of the skin

    Page :AB167

    Bianca Y. Kang, Ketan Jain-Poster, Vishnu Harikumar, Kelly A. Reynolds, Sarah A. Ibrahim, Emily Poon, Murad Alam

    
• • ·27910 A sporotrichoid rash in a landscaper and fish owner

    Page :AB167

    Paige Seeker, Alexandra Montgomery, Tracy Biediger

    
• • ·27915 Rapid skin improvement with upadacitinib with or without topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)

    Page :AB167

    Eric L. Simpson, Richard B. Warren, Lawrence F. Eichenfield, Norito Katoh, Xiaofei Hu, Jiewei Zeng, Brian M. Calimlim, Allan R. Tenorio, Henrique D. Teixeira, Marjolein De Bruin-Weller

    
• • ·27917 A hairy situation

    Page :AB168

    Heidi McDonald, Giselle Guerrero

    
• • ·27933 A rare case of familial generalized multiple glomangiomas in an 11-year-old boy

    Page :AB168

    Elise Weisert, Frank Winsett, Sharon Raimer, Brandon Goodwin

    
• • ·27934 Unpaid insurance claims associated with the treatment of alopecia areata and lichen planopilaris

    Page :AB168

    Molly Kitley, Hadley Johnson, Adam Spooner, Maria Hordinsky, Ronda Farah

    
• • ·27945 Biologics-resistant areas in Korean patients with moderate to severe psoriasis

    Page :AB168

    Sang-Hyeon Won, Bong Seok Shin, Dae-Lyong Ha, Jin-Hwa Son, Jungsoo Lee, Kihyuk Shin, Hoon-Soo Kim, Hyun-Chang Ko, Moon-Bum Kim, Kyunghyung Seo, Byung-Soo Kim

    
• • ·27949 Treatment of glabellar lines with onabotulinumtoxinA results in improved clinical outcomes and long-lasting patient satisfaction

    Page :AB169

    Joel L. Cohen, Jean Carruthers, Sue Ellen Cox, Koenraad De Boulle, Steven Fagien, Patricia Ogilvie, Julie Garcia, Nazanin Ashourian

    
• • ·27965 Cryosurgery as a novel treatment for Sweet syndrome: A case report

    Page :AB169

    Jessica L. Jones, Jonathan Cleaver, David Cleaver, Nathan Cleaver, Lloyd Cleaver

    
• • ·27969 Good night, sleep tight, don’t let the Cimex bite

    Page :AB169

    Lawangeen Zeb, Andrew Stein, Emily Haltigan, Nila Radhakrishnan

    
• • ·27971 Single institution experience with a dermatology hospitalist service

    Page :AB169

    Keegan O’Hern, Alicia Dagrosa, Dylan J. Badin, Emily Shaughnessy

    
• • ·27978 Psoriasis and methotrexate: A systematic review and meta-analysis of nonmelanoma skin cancer risk

    Page :AB170

    Margaret E. Lang, Jacob Stewart, Patricia J. Erwin, Jerry D. Brewer

    
• • ·27989 An unusual presentation of acute generalized exanthematous pustulosis (AGEP) in pregnancy

    Page :AB170

    Tanya Henry, Taryn Murray, Michelle Bain, Iris Aronson

    
• • ·27993 Cardiac autonomic dysfunction in psoriasis patients with and without metabolic syndrome

    Page :AB170

    Elias S. Siraj, Carolina M. Casellini, Henri K. Parson, Taylor M. Dyson, Abby S. Van Voorhees

    
• • ·27995 Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors

    Page :AB170

    Michael Sander, Igor Stukalin, Isabelle A. Vallerand, Siddhartha Goutam, Benjamin W. Ewanchuk, Daniel E. Meyers, Aliyah Pabani, Don Morris, Daniel Y.C. Heng, Tina Cheng

    
• • ·28022 Three concurrent morphologic presentations of eosinophilic granulomatosis with polyangiitis in a patient

    Page :AB171

    Benjamin Lui Liang Jun, Wong Soon Boon Justin, Ellie Choi Ci-En

    
• • ·28032 Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)

    Page :AB171

    Andrew Blauvelt, Michael R. Ardern-Jones, Thomas Bieber, Chih-ho Hong, Chia-Yu Chu, Meng Liu, Yang Yang, Barry Ladizinski, Henrique D. Teixeira, Brian M. Calimlim, Jacob P. Thyssen

    
• • ·28036 Phase 2 randomized, placebo-controlled, dose-ranging study to evaluate the safety and efficacy of onabotulinumtoxina for the treatment of platysma prominence

    Page :AB171

    Rodney Rohrich, David E. Bank, Vince Bertucci, Brian S. Biesman, Steven Dayan, Shannon Humphrey, Derek Jones, Joely Kaufman-Janette, Channy Y. Muhn, Jason K. Rivers, Warren Tong

    
• • ·28043 Roflumilast cream significantly improves chronic plaque psoriasis in patients with steroid-sensitive area involvement

    Page :AB171

    Zoe D. Draelos, Mark G. Lebwohl, Charles W. Lynde, Walter K. Nahm, Kim A. Papp, David M. Pariser, Linda Stein Gold, Daniel Stewart, Robert C. Higham, Lynn Navale, David R. Berk

    
• • ·28044 Seasonal variation, climate factors and squamous cell carcinoma: A regional analysis of Rhode Island

    Page :AB172

    Erica Lin, Rachel Lim, Navya Baranwal, Isabelle Moseley, Tiffany Libby, Abrar Qureshi, Eunyoung Cho

    
• • ·28064 The study about clinical characteristics and prognosis of alopecia totalis

    Page :AB172

    Min-Jeong Kang, Bark-Lynn Lew, Woo-Young Sim

    
• • ·28073 Evaluation of the impact of hyaluronic acid (HA) filler manufacturing technologies on HA chain degradation

    Page :AB172

    Jay Mashburn, Jimmy Faivre

    
• • ·28076 Patient perceptions of aesthetic benefit: Comparing benign lesion clearance to other common aesthetic procedures

    Page :AB172

    Thomas E. Rohrer, Girish S. Munavalli, Anita Crompton

    
• • ·28079 Serum proteases upregulate significantly between 20 and 40 years of age: Impact for dermal matrix regulation

    Page :AB173

    Deborah Finlay, Bradley Jarrold, Makio Tamura, Michael Flagler

    
• • ·28081 Strategies to improve quality of atopic dermatitis care in North America: Results from the Atopic Dermatitis Quality of Care (ADQoC) initiative

    Page :AB173

    Peter Lio, Lawrence Eichenfield, Emma Guttman, Vincent Piguet, Eric Simpson

    
• • ·28086 Statin use may be a predictor of larger and more aggressive tumor characteristics in squamous cell carcinoma

    Page :AB173

    Erica B. Lee, Heng Jiang, Marissa B. Lobl, Ashley Wysong

    
• • ·28094 Neoadjuvant pembrozilumab inducing dramatic regression of locally advanced merkel cell carcinoma

    Page :AB173

    Suraj Venna, Kelly McCoy, Chelsea Stahl, Alexandra Magee, Kirit Bhatt, Gordon Hafner, Sekwon Jang, Suraj Venna

    
• • ·28095 Long-term safety of guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials with up to 5 years of treatment

    Page :AB174

    Andrew Blauvelt, Kenneth B. Gordon, Christopher E.M. Griffiths, Kim A. Papp, Peter Foley, Michael Song, Megan Miller, Yaung-Kaung Shen, Yin You, Paraneedharan Ramachandran, Kristian Reich

    
• • ·28096 Sustained improvement in general health-related quality of life and work productivity in patients with moderate to severe psoriasis treated with guselkumab: 5-year data from clinical trial VOYAGE 2

    Page :AB174

    Kristian Reich, Kenneth B. Gordon, Peter Foley, Mark Lomaga, Chenglong Han, Megan Miller, Yin You, Marc Alexander Radtke, Jashin J. Wu, April W. Armstrong

    
• • ·28115 Cost analysis of rosacea treatments in a dermatologic center in Bogotá, Colombia

    Page :AB174

    David A. Castillo Molina, Diego M. Martinez Zúñiga, Jesús E. Jaimes Silva, Luisa Fernanda Camacho-Lázaro, María Juliana Sánchez Zapata, María José Centeno, Nelson J. Alvis-Zak, Gabriela Bula Galan, Jennipher A. Blanco Gómez, David E. Castillo Saavedra

    
• • ·28127 Rare development of telangiectasias secondary to trastuzumab use

    Page :AB174

    Ramakrishna Viswa Bysani, Brianna Castillo, Emily Smith

    
• • ·28131 Hashimoto thyroiditis associated with unilateral Graves ophthalmopathy

    Page :AB175

    Dianne Carrasquillo-Bonilla, Karina Cancel-Artau, Andrea Medina-Gonzalez, Rafael F. Martin-Garcia

    
• • ·28137 Pediatric pemphigus foliaceus and rituximab treatment

    Page :AB175

    Cyrelle R. Fermin, Aimee C. Smidt

    
• • ·28139 A case of IgA vasculitis associated with underlying cytomegalovirus colitis

    Page :AB175

    Katelyn Mariko Kim, Ben Friedman

    
• • ·28140 How a lotion with prebiotic yeast extract regulates the environmental aggressors impact on the skin microbiome

    Page :AB175

    Cecilia Li, Yueming Jiang, Dan-Qi Wang

    
• • ·28144 Cobblestoned skin on neck: The differential

    Page :AB176

    Brianna Castillo, Susan Zurowski, Kara Braudis

    
• • ·28154 Endocrine mucin-producing sweat gland carcinoma in a patient with metastatic melanoma

    Page :AB176

    Mary Elizabeth Reed Shenk, Emily Hoffman Smith

    
• • ·28157 Rare case of symmetric extragenital lichen sclerosus et atrophicus on joints of all four extensor extremities in an adolescent female

    Page :AB176

    Araya Zaesim, Kari Lyn Martin

    
• • ·28158 Multiple cutaneous neoplasms and uveal melanoma in a patient with Muir-Torre syndrome

    Page :AB176

    Cameron M.B. Zachary, Paige K. Dekker, Emily L. Guo, Sanna Ronkainen

    
• • ·28163 Exposure of fine particulate matter air pollution and incident atopic dermatitis in the general population: A national population-based retrospective cohort study

    Page :AB177

    Hyun Min Seo, Se Kwang Park, Ki Yeon Kim, Ju Wang Jang, Hyung Kwon Park, Joung Soo Kim

    
• • ·28169 Psoriasis in routine clinical care: Complete skin clearance rates with guselkumab increase through week 52—Results from the real-life PERSIST study

    Page :AB177

    Matthias Hoffmann, Michael Sticherling, Bernhard Korge, Dariusch Mortazawi, Yvonne Personke, Mario Gomez, Sven Wegner, Sascha Gerdes

    
• • ·28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis

    Page :AB177

    Thomas Bieber, Lisa A. Beck, Andrew Pink, Hidehisa Saeki, Lawrence Eichenfield, Thomas Werfel, Anders Rosholm, Mads Røpke, Amy Paller

    
• • ·28171 Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: Combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2)

    Page :AB177

    Andrew Blauvelt, Andreas Wollenberg, Andrew Pink, Ketty Peris, April Armstrong, Lynda Spelman, Hidehisa Saeki, Charles Lynde, Pedro Herranz, Sebastien Barbarot, Eric Simpson

    
• • ·28179 Effectiveness of a skincare product on relieving the symptoms of neonatal and infantile acne and its impact on QoL

    Page :AB178

    Sophie Seite

    
• • ·28185 Treatment of hyperpigmented labial lentigines using Q-switched Nd:YAG laser in a preadolescent patient with Peutz-Jeughers syndrome

    Page :AB178

    Eric Grisham, Max Vale, Deepti Gupta

    
• • ·28186 Efficacy and safety of tralokinumab monotherapy in North American adult patients with moderate-to-severe atopic dermatitis: A subanalysis of the ECZTRA 2 trial

    Page :AB178

    Marni Wiseman, April W. Armstrong, Jennifer Soung, Lorne Albrecht, Mark Lomaga, Kim A. Papp

    
• • ·28194 Patient-reported outcomes of ruxolitinib cream for the treatment of atopic dermatitis: Pooled results from two phase 3 studies

    Page :AB178

    Eric L. Simpson, Matthias Augustin, Diamant Thaçi, Laurent Misery, Jonathan I. Silverberg, April W. Armstrong, Zelma C. Chiesa Fuxench, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Kim Papp

    
• • ·28200 Effects of ruxolitinib cream on work productivity and activity impairment in patients with atopic dermatitis: Pooled results from two phase 3 studies

    Page :AB179

    Lawrence F. Eichenfield, Jonathan I. Silverberg, Michael E. Kuligowski, May E. Venturanza, Kang Sun, Matthias Augustin

    
• • ·28206 Disseminated gonococcal infection manifesting as embolic septic vasculitis

    Page :AB179

    Vignesh Ramachandran, Sasank Konda

    
• • ·28216 Visualizing the elimination of glabellar lines following treatment with daxibotulinumtoxinA for injection (DAXI)

    Page :AB179

    Shannon Humphrey, Sabrina Fabi, Derek Jones, Todd Gross, Yan Liu, Roman Rubio

    
• • ·28218 Recurrent purpuric pigmented papules following botulinum A toxin treatments

    Page :AB179

    Mark J. Siegel, Cathy Massoud, Carter Ellis

    
• • ·28229 Perinatal chikungunya-induced scalded skin syndrome

    Page :AB180

    Ritu N. Swali, Joseph Jebain, Alfredo Siller, Ravi R. Patel, Jennifer Adams, Omar Lupi, Stephen K. Tyring

    
• • ·28231 The use of lifestyle medicine in dermatology: Level of evidence in intervention studies

    Page :AB180

    Rebecca L. Quinonez, Anita O. Oladunni, Kiyanna Williams, Heather Woolery-Lloyd

    
• • ·28251 Quantification of erythema associated with continuous nylon, polyglactin-910, and fast absorbing gut sutures in facial surgery repair: A randomized prospective study

    Page :AB180

    Ali MajdZadeh, Catherine Lim, David Zloty

    
• • ·28254 Correlation of HLA-Cw6 positivity with clinical characteristics including treatment efficacy in Korean patients with psoriasis

    Page :AB180

    Eun-So Lee, So Min Kim

    
• • ·28273 Prevalence of prurigo nodularis in the regional area of Brittany (France): Estimation by matching two databases

    Page :AB181

    Laurent Misery, Emilie Brenaut, Elodie Torreton, Juliette Bonté, Stéphane Bouée

    
• • ·28275 The conundrum of transected spindle tumors: To Mohs or not to Mohs?

    Page :AB181

    Dan Wenzel, Riley McLean-Mandell, Patrick ODonnell

    
• • ·28276 Acrodermatitis enteropathica

    Page :AB181

    Kristyna Cleminson

    
• • ·28283 Efficacy and tolerability of early initiation of sirolimus for kaposiform hemangioendothelioma in an extreme premature infant

    Page :AB181

    Mary E. Logue, Hillary Elwood, Emily Altman, Aimee Smidt

    
• • ·28284 Subcutaneous hinge flaps: A great choice, especially in the setting of COVID

    Page :AB182

    Dan Wenzel, Riley McLean-Mandell

    
• • ·28285 Interactive online case-based education significantly improved dermatologists’ knowledge and competence in managing the full spectrum of psoriasis

    Page :AB182

    Elaine Bell, Marinella Calle, Kilian Eyerich

    
• • ·28310 Bibliometric analysis of the 50 most cited publications in hidradenitis suppurativa

    Page :AB182

    Justine Seivright, Alyssa Thompson, Natalie Villa, Vivian Shi, Jennifer Hsiao

    
• • ·28321 Cutaneous endometriosis of the umbilicus

    Page :AB182

    Angela Yen Moore, Kara Hurley

    
• • ·28323 Cutaneous leiomyosarcoma in scope of practice for dermatologists

    Page :AB183

    Angela Yen Moore, Samuel R. Shing

    
• • ·28325 Artificial intelligence (AI) in dermatology: An application in sub-Saharan Africa

    Page :AB183

    Christophe Hsu, Philippe Gottfrois, Yi Xiao, Daudi Mavura, Hafidh Hassan, Fahafantsoa Rapelanoro Rabenja, Herizo Andriambololoniaina, Zhao Shuang, Chen Xiang, Alexander Navarini

    
• • ·28326 Achieving fidelity and consistency in billing among Saint Louis University dermatology providers

    Page :AB183

    Kara Signorelli, Peter Boor, Aditya Nellore, Eric Ambrecht, Daniel West

    
• • ·28327 The growth of direct-to-consumer telemedicine: A review and outlook for the future

    Page :AB183

    Varun Ranpariya, Jules B. Lipoff

    
• • ·28330 Bibliometric analysis of original research in four high-impact dermatology journals

    Page :AB184

    Justine Seivright, Melodyanne Y. Cheng, Natalie M. Villa, Vivian Y. Shi, Jennifer L. Hsiao

    
• • ·28331 Time intervals until the first return office visit for dermatologists compared with other specialties

    Page :AB184

    Varun Ranpariya, Suraj Muddasani, Steven R. Feldman

    
• • ·28353 Hemorrhagic cellulitis secondary to vibrio fluvialis infection

    Page :AB184

    Harleen Arora, Chauncey McHargue

    
• • ·28356 Efficacy of topical serum containing high and low molecular weight of hyaluronic acid as anti-aging in Brazilian skin

    Page :AB184

    Alessandra Romiti, Priscila Correia, José Euzébio Gonçalves Junior, Beatriz Sant’Anna, Caroline Le Floc

    
• • ·28362 Black widow spider bite: A common creature in an uncommon geographic location

    Page :AB185

    Marely Santiago Vazquez, Osward Y. Carrasquillo, Natalia M. Pelet del Toro, Francisco Colón Fontanez

    
• • ·28364 Efficacy of deep cleansing gel containing 2% salicylic acid, 0.2% zinc gluconate, and 0.05% lipohydroxyacid as monotherapy to treat mild to moderate facial acne vulgaris

    Page :AB185

    Loan Towersey, Clarice Caixeta, Roderick James Hay, Brigitte Drenó, Sophie Seité, Priscila Correia, José Euzébio Gonçalves Junior, Beatriz Sant’Anna

    
• • ·28365 Adult female acne: A cross-sectional study of diet, family history, body mass index, and premenstrual flare as risk factors and contributors to severity

    Page :AB185

    Ehiaghe Anaba

    
• • ·28367 A case of chronic prurigo nodularis, angiolymphoid hyperplasia with eosinophilia, and reactive lymphadenopathy: Intersection of multiple processes, or a novel clinical entity?

    Page :AB185

    Elena Kurland, Bridget Myers, Ben Friedman, Pranita Rambhatla

    
• • ·28379 Case report of effect of a topical antioxidant serum containing vitamin C, ferulic acid, and phloretin after Q-switched laser for treatment of melasma

    Page :AB186

    Valeria Campos

    
• • ·28383 The effectiveness of thread-embedding therapy for treating scarring and nonscarring alopecia

    Page :AB186

    Susie Suh, Katerina L. Yale, Natasha A. Mesinkovska

    
• • ·28395 5-fluorouracil-induced hand-foot syndrome mimicking Gottron papules

    Page :AB186

    Kelley Sharp, Reid Waldman

    
• • ·28400 Retrospective analysis of dermatology residency applicant’s research output from 2007-2018

    Page :AB186

    Jatin Narang, Anna Eversman, Mehak Kalra, Frederick Morgan, Elizabeth Obi, Emma R. Russell, Angela H. Wei, David X. Zheng, Wilhemina Osei-Koomson, Bryan T. Carroll, Timmie R. Sharma

    
• • ·28412 A rare association of Sweet syndrome with autoimmune thyroiditis: Case report and review of literature

    Page :AB187

    Kristyna Gleghorn, Natalya Gallaga, Brent Kelly

    
• • ·28414 Recurrent melanoma treated with talimogene laherparepvec in combination with radiation therapy: A case report

    Page :AB187

    Eliana Figueredo Zamora, Laura Taylor, Jae Y. Jung

    
• • ·28420 Predictors of postresidency publication quantity and quality in dermatologists

    Page :AB187

    Jatin Narang, Mehak Kalra, David X. Zheng, Emma R. Russell, Elizabeth Obi, Bryan T. Carroll, Timmie R. Sharma

    
• • ·WITHDRAWN: Epidemiologic characteristics of primary psychodermatologic conditions: A systematic review

    Page :AB187

    
• • ·28422 Fibroepithelioma of Pinkus as an indicator of internal malignancy

    Page :AB188

    Joseph Kim, Curtis Lamar Hardy, Nicholas Logemann, Hugh Lyford, Andrea McGlynn, James Walsh, Aaron Cantor

    
• • ·28423 Treatment of cutaneous lesions in patient with blue rubber bleb nevus with diode laser

    Page :AB188

    Vien The Tran, Phung Kim Thi Ngo, Minh Van Hoang, Anh Quynh Ngoc Phan, Tri Cao Le, Giang Huong Tran, Quy Thanh To

    
• • ·28426 Diagnosis of basal cell carcinoma using a portable handheld multiphoton microscope

    Page :AB188

    Roberto Novoa, Sarah T. Arron, Sarah Arron, Jeffrey North, Richard Caligaris, Kate L. Montgomery, Piyush Arora, Clara Brechtel, Gabriel N. Sanchez

    
• • ·28435 Sex steroids percutaneous penetration in vivo in man: Relationship to mathematical predictive model

    Page :AB188

    Anuk Burli, Rebecca M. Law, Howard I. Maibach

    
• • ·28440 Cutaneous lymphoma in a single tertiary institution of Korea classified by the 2018 update of the WHO-EORTC classification

    Page :AB189

    Jaihee Bae

    
• • ·28442 Cutaneous metastases from different cancers: Characteristics and survival analysis

    Page :AB189

    Dong Min Shin

    
• • ·28444 Punch elevation for resistant acne scar

    Page :AB189

    Dong Min Shin

    
• • ·28445 Clinical, dermoscopic, and pathologic features of Onychopapilloma

    Page :AB189

    Donghwi Jang

    
• • ·28447 Effect of photobiomodulation therapy on radiodermatitis in a mouse model

    Page :AB190

    Donghwi Jang

    
• • ·28448 Reconstitution human skin with spatial transcriptomics

    Page :AB190

    Donghwi Jang

    
• • ·28449 A comparative study on effects of particular matter between high- and low-particulate matter periods on healthy skin

    Page :AB190

    Dokyoung Yoon

    
• • ·28450 Longitudinal brush pigmentation: A dermoscopic feature on hyponychium in 3 cases of melanocytic nevi in children

    Page :AB190

    Jongeun Lee

    
• • ·28452 A case of ecthyma in patients with bevacizumab

    Page :AB191

    Jae Yeon Ryu, Jin Woo Park, Ji Hyun Lee

    
• • ·28455 A novel active complex reduces neuromediated cutaneous inflammation to optimize hydration of dry, dehydrated sensitive skin

    Page :AB191

    Nicolas Joly-Tonetti, Ali Tfayli, Alice Randon, Virginie Le Noel, Nadège Lachmann

    
• • ·28457 Visualization of penetration of topical antifungal drug substances through mycosis-infected nails by matrix assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI)

    Page :AB191

    Nicolas Joly-Tonetti, Fernanda Endringer Pinto, Charlotte Bagger, Hanan Osman-Ponchet, Christian Janfelt

    
• • ·28461 A systematic review of gender differences in sexual health impairment in hidradenitis suppurativa

    Page :AB191

    Danielle Yee, Erin K. Collier, Swetha Atluri, Joanna Jaros, Vivian Y. Shi, Jennifer L. Hsiao

    
• • ·28463 Aprelimast and psoriasis: Significant hemoglobin A1c reduction and improved insulin resistance independent of changes in body mass index

    Page :AB192

    Joseph Tadros, Kristen Fernandez

    
• • ·28478 Risk for depression after diagnosis for vitiligo in dermatology patients: Real-world evidence from a large, urban, Midwestern US, dermatology patient population study

    Page :AB192

    Amber Randolph, Yasmeen Ali, Roopal V. Kundu, Dennis P. West, Beatrice Nardone

    
• • ·28481 Risk for nonmelanoma second primary malignancy in malignant melanoma survivors: A nationwide report from the National Cancer Institute Surveillance, Epidemiology, and End Results program

    Page :AB192

    Ghazal Ghafari, Yasmeen Ali, Danyal Tahseen, Walter J. Liszewski, Dennis P. West, Beatrice Nardone

    
• • ·28489 Virtual simulation-based CME improves treating to target in psoriasis

    Page :AB192

    Shari J. Dermer, Piyali Chatterjee-Shin, Katie S. Lucero

    
• • ·28492 Doxycycline pigmentation in a patient with vandetanib-induced acne

    Page :AB193

    Suraj Venna, Roxana Shirazi, Jeff Harvell, Suraj Venna

    
• • ·28496 Comprehensive national analysis of geographic distribution of cutaneous melanoma and nonmelanoma skin cancer in Russia

    Page :AB193

    Anastasiya Muntyanu, Vladimir Nechaev, Andrei Zubarev, Ivan V. Litvinov

    
• • ·28498 Evaluation of clinical photography on patients’ perception of hair loss severity

    Page :AB193

    James T. Pathoulas, Kelly E. Flanagan, Chloe J. Walker, Isabel Pupo Wiss, Maryanne M. Senna

    
• • ·28505 Reporting of subgroup analysis in randomized controlled trials published in the highest impact factor dermatology journals

    Page :AB193

    Eli Raneses, Meagan M. Simpson, Thomas Barlow

    
• • ·28506 Umbilical cutaneous noneczematous diseases: A clinical and histopathologic study

    Page :AB194

    Jiehyun Jeon, Ji Yun Seo, Anna Kim, Yoo Sang Baek

    
• • ·28518 Differential diagnosis of scalp folliculitis and acne vulgaris affecting the scalp using polarized light dermatoscopy

    Page :AB194

    Stefana Cretu, Carmen Maria Salavastru

    
• • ·28521 Frequency of procedural and medical treatments for actinic keratosis

    Page :AB194

    Varun Ranpariya, Suraj Muddasani, Steven R. Feldman

    
• • ·28522 The impact of the SARS-CoV-2 pandemic on phototherapy utilization

    Page :AB194

    Aunna Pourang, Hailey Olds, Nneamaka Ezekwe, Henry W. Lim, Iltefat Hamzavi

    
• • ·28523 Evaluation of a facial serum containing 3% TXA on resistant hyperpigmentation in darker skin types

    Page :AB195

    Hina Choudhary, Stephen Lynch, Uchenna Okereke, Valerie Callender

    
• • ·28525 Artificial intelligence and deep learning analysis of half a million individuals with European origin reveals specific skin aging process

    Page :AB195

    Frederic Flament, Laurie Jacquet, Marion Nielsen, Delphine Kerob, Ruowei Jiang, Yuze Zhang, Thierry Passeron

    
• • ·28527 A Canada wide survey of access to patch testing

    Page :AB195

    J. D. Matthew Hughes, Isabelle Vallerand, Ryan Lewinson, Laurie Parsons

    
• • ·28532 Unna boot efficacy in dermatologic diseases

    Page :AB195

    Gabriella Santa Lucia, Alan Snyder, John Plante, Alexandra Ritter, Dirk Elston

    
• • ·28533 Vitiligo following intense pulsed light (IPL) for hair removal in the face and axilla

    Page :AB196

    Celso Lopes

    
• • ·28534 Erythema multiforme DRESSed up

    Page :AB196

    Anusha Panthagani, Jasmine Mann, Robert Berg, Rabi Nambi

    
• • ·28537 Disparities in access to apremilast for psoriasis: A spatial and statistical analysis of the distribution of medicare apremilast providers in the United States in 2017

    Page :AB196

    Emmanuella Ngozi Asabor, Shayan Cheraglou, Jeffrey Cohen

    
• • ·28544 Satisfaction and willingness to incorporate telemedicine for hidradenitis suppurativa

    Page :AB196

    Tyler M. Andriano, Kayla M. Babbush, Avigdor Nosrati, Gabrielle Benesh, H. Dean Hosgood, Steven R. Cohen

    
• • ·28545 A man with halo nevi and premature hair graying

    Page :AB197

    Alexis B. Lyons, Olabola Awosika, Henry W. Lim

    
• • ·28547 Retrospective review of patients with dupilumab facial and neck redness treated with itraconazole at a single academic medical center

    Page :AB197

    Sarah Song, David Gao, Kristin Fiumara, David Rosmarin

    
• • ·28551 IMAPSORS project: A multicenter validation study to assess the accuracy of an artificial intelligence solution to quantify psoriasis severity

    Page :AB197

    Antonio Martorell, Eduardo Ibor Crespo, Victor Gisbert Climent, Salvador Arias, Ricardo Ruiz-Villaverde, Rosa Taberner, Antonio Sahuquillo, Maria Luisa Fernandez-Diaz

    
• • ·28554 Analysis of advanced cutaneous squamous cell carcinoma of the head and neck in a largely rural population

    Page :AB197

    Halie N. Mechels, Jordan L. Bormann, Marcus L. Frohm, William C. Spanos

    
• • ·28560 A survey of UVA protection levels of SPF 50+ dermocosmetic face sunscreens on the European market

    Page :AB198

    Veronique Delvigne

    
• • ·28561 The impact of telemedicine on the delivery of dermatologic care during the COVID-19 pandemic

    Page :AB198

    Vartan Pahalyants, William Murphy, Nicole Gunasekera, Daniela Kroshinsky

    
• • ·28563 Risankizumab as an efficient therapy for psoriatic patients in long term: Analysis of 3 cases with a maintenance dose every 16 weeks.

    Page :AB198

    Antonio Martorell, Maria Solera, Virginia Sanz-Motilva, Maria Luisa Garcia-Melgares, Luis Hueso, Jose Luis Rueda, Gema Ochando, Cristina Pelufo, Marta Borras, Alberto Alfaro

    
• • ·28574 Thalidomide treatment for seronegative oral erosive disorders: A case series

    Page :AB198

    Tian Ran Zhu, Emily Nadelmann, Steven R. Cohen

    
• • ·28575 Caring for skin during a pandemic: Acute facial skin changes following mask-wearing

    Page :AB199

    Rachel Elsanadi, Fiore Casale, Niki Nourmohammadi, Katerina Yale, Cristina Nguyen, Vardit Eckhouse, Yoav Cohen, Natasha Atanaskova Mesinkovska

    
• • ·28576 Pseudoxanthoma elasticum-like changes in panniculitides: A case series

    Page :AB199

    Katie B. Homan, Hannah Pederson, Allie Preston, Peter Nguyen, Elyssa Berg, Palak Parekh

    
• • ·28580 Diffuse capillary malformation with overgrowth and phakomatosis pigmentovascularis type II in a newborn

    Page :AB199

    Antonio Jimenez, Anthony Linfante, Erica Kelly

    
• • ·28581 Vulvar mammary-like adenocarcinoma with overlying extramammary Paget disease

    Page :AB199

    Betty Nguyen, Lauren Michelle, Cyrus Nguyen, Larisa Lehmer, Bruce D. Ragsdale

    
• • ·28585 A topical antioxidant serum containing silymarin prevents sebum peroxidation in oily, blemish-prone skin

    Page :AB200

    Stephen Lynch, Ashleigh Murtaugh, DesTenee Green, Brittany Lee, Hina Choudhary

    
• • ·28587 A multicenter assessment of medical student experiences in virtual dermatology clinical electives

    Page :AB200

    Danny W. Linggonegoro, Danny W. Linggonegoro, Sepideh Ashrafzadeh, Vinod Nambudiri, Elizabeth Buzney

    
• • ·28590 The impact of genital psoriasis among psoriatic patients

    Page :AB200

    Pavane L. Gorrepati, Yahya Argobi, Maria Alora, Gideon P. Smith

    
• • ·28596 Efficacy of laser CO2 treatment for lymphedema secondary to gynecologic cancer therapy

    Page :AB200

    Shenara Musthaq, Britney Wilson, Anthony Rossi

    
• • ·28618 Postexcision outcomes after skin cancer removal

    Page :AB201

    Jennifer Powers, Julie McKillip, Amanda Steahr, Trenton Greif

    
• • ·28623 Omalizumab in the management of atopic dermatitis

    Page :AB201

    Julia Balbi de Castro, Sarina B. Elmariah

    
• • ·28628 An atypical presentation of neurofibromatosis: Late-onset segmental type with deep involvement

    Page :AB201

    James S. Petit, Silas Money, Mario Maruthur

    
• • ·28629 Virtual group visits for reducing psychosocial distress in pediatric vitiligo and alopecia areata patients and caregivers

    Page :AB201

    Adena Rosenblatt, Natalia Khosla

    
• • ·28630 Use of systemic immunosuppressive treatment is not related to COVID-19 positivity in a retrospective review of patients in Massachusetts

    Page :AB202

    William Murphy, Nikolai Klebanov, Vartan Pahalyants, Nicholas Theodosakis, Kevin Patel, R. Monina Klevens, Evelyn Lilly, Yevgeniy R. Semenov

    
• • ·28634 Robotic 1064-nm laser with a precision-controlled, motorized, arm for non-contact abdominal lipolysis: An FDA device clearance clinical trial

    Page :AB202

    Michael Abrouk, Jill S. Waibel, Suzanne Kilmer, Thomas Fiala

    
• • ·28635 New onset exanthem in a 32-year-old with Hodgkin’s lymphoma

    Page :AB202

    Britney Wilson, Shenara T. Musthaq, Anthony Rossi

    
• • ·28645 IgG lambda monoclonal gammopathy, scleromyxedema, and sensorimotor neuropathy

    Page :AB202

    Sunita Odedra, Tanveer Chohan, Alena Salim

    
• • ·28646 Stress due to facial/body hair excess or scalp hair loss in transgender ethnic groups

    Page :AB203

    Chloe J. Walker, Dustin H. Marks, James T. Pathoulas, Kelly E. Flanagan, Isa Pupo Wiss, Maryanne M. Senna

    
• • ·28647 Rice products in hair growth

    Page :AB203

    Kiana Hashemi, Christine Pham, Aunna Pourang, Tiana Mamaghani, Margit Juhasz, Natasha Atanaskova Mesinkovska

    
• • ·28654 A case of panniculitis and polyarthritis revealing an underlying malignancy

    Page :AB203

    Kimberly Shao, Frank Santoro

    
• • ·28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19

    Page :AB203

    Tiffany J. Garcia-Saleem, Connor J. Stonesifer, Larisa J. Geskin

    
• • ·28666 Global initiatives in dermatology and education

    Page :AB204

    Ciara Grayson, Olabola Awosika, Ellen Pritchett

    
• • ·28675 A case of systemic amyloidosis diagnosed by dermatologic consult

    Page :AB204

    Alison Huber, Dr. Emily Smith

    
• • ·28677 Perineural sclerosis in invasive squamous cell carcinoma

    Page :AB204

    Allison Sindle, Kara Braudis, Nicholas Golda

    
• • ·28684 Vitiligo following ablative laser for melasma

    Page :AB204

    Celso Lopes

    
• • ·28697 Generalized granuloma annulare-like eruption induced by recombinant varicella zoster virus vaccination

    Page :AB205

    Jessica G. Collins, Thomas A. Dutra, Michael W. Peterson

    
• • ·28698 Case series of plaque parapsoriasis and homeopathic therapy

    Page :AB205

    Lawrence Chukwudi Nwabudike

    
• • ·28700 Chromate-induced allergic contact dermatitis treated with dupilumab

    Page :AB205

    Britney N. Wilson, Esther A. Balogh, David J. Rayhan, Daniel J. Yousefzadeh, Steven R. Feldman

    
• • ·28701 CME improves dermatologists’ knowledge and competence related to therapies for minimizing acne scarring

    Page :AB205

    Shari J. Dermer, John Maeglin, Heather Lewin, Jerry Tan

    
• • ·28713 Dermoscopic changes observed in acute UV radiation

    Page :AB206

    James Keith Parker, James Keith Parker, Emily Smith

    
• • ·28714 Primary cutaneous Fusarium infection in an immunocompetent host

    Page :AB206

    Gabrielle Robinson, Ben Friedman, Chauncey McHargue

    
• • ·28725 Alternating weekly treatment schedule for superficial radiotherapy for nonmelanoma skin cancers

    Page :AB206

    Tom Kim, Ingrid Freeny, William Ting

    
• • ·Disclosure of relevant financial relationships

    Page :AB207

    Plan Plan
• • ·26823 A giant facial plexiform neurofibromatosis is driven by RAF1 gain mutation

    Page :AB302

    Minh Van Hoang, Phung Kim Thi Ngo, Anh Quynh Ngoc Phan, Bao Chi Bui, Dung Tu Phan Nguyen, Vien The Tran, Giang Huong Tran